id	sid	tid	token	lemma	pos
aji-167	1	1	_	_	PUNCT
aji-167	2	1	_	_	PUNCT
aji-167	3	1	_	_	PUNCT
aji-167	4	1	_	_	PUNCT
aji-167	5	1	_	_	PUNCT
aji-167	6	1	_	_	PUNCT
aji-167	7	1	_	_	PUNCT
aji-167	8	1	_	_	PUNCT
aji-167	9	1	_	_	PUNCT
aji-167	10	1	_	_	PUNCT
aji-167	11	1	_	_	PUNCT
aji-167	12	1	_	_	PUNCT
aji-167	13	1	_	_	PUNCT
aji-167	14	1	_	_	PUNCT
aji-167	15	1	_	_	PUNCT
aji-167	16	1	_	_	PUNCT
aji-167	17	1	_	_	PUNCT
aji-167	18	1	_	_	PUNCT
aji-167	19	1	_	_	PUNCT
aji-167	20	1	_	_	PUNCT
aji-167	21	1	_	_	PUNCT
aji-167	22	1	_	_	PUNCT
aji-167	23	1	_	_	PUNCT
aji-167	24	1	_	_	PUNCT
aji-167	25	1	_	_	PUNCT
aji-167	26	1	_	_	PUNCT
aji-167	27	1	_	_	PUNCT
aji-167	28	1	_	_	PUNCT
aji-167	29	1	_	_	PUNCT
aji-167	30	1	_	_	PUNCT
aji-167	31	1	_	_	PUNCT
aji-167	32	1	_	_	PUNCT
aji-167	33	1	_	_	PUNCT
aji-167	34	1	_	_	PUNCT
aji-167	35	1	_	_	PUNCT
aji-167	36	1	_	_	PUNCT
aji-167	37	1	_	_	PUNCT
aji-167	38	1	_	_	PUNCT
aji-167	39	1	_	_	PUNCT
aji-167	40	1	_	_	PUNCT
aji-167	41	1	_	_	PUNCT
aji-167	42	1	_	_	PUNCT
aji-167	43	1	_	_	PUNCT
aji-167	44	1	_	_	PUNCT
aji-167	45	1	_	_	PUNCT
aji-167	46	1	_	_	PUNCT
aji-167	47	1	_	_	PUNCT
aji-167	48	1	_	_	PUNCT
aji-167	49	1	_	_	PUNCT
aji-167	50	1	_	_	PUNCT
aji-167	51	1	_	_	PUNCT
aji-167	52	1	_	_	PUNCT
aji-167	53	1	_	_	PUNCT
aji-167	54	1	_	_	PUNCT
aji-167	55	1	_	_	PUNCT
aji-167	56	1	_	_	PUNCT
aji-167	57	1	_	_	PUNCT
aji-167	58	1	_	_	PUNCT
aji-167	59	1	_	_	PUNCT
aji-167	60	1	_	_	PUNCT
aji-167	61	1	_	_	PUNCT
aji-167	62	1	_	_	PUNCT
aji-167	63	1	_	_	PUNCT
aji-167	64	1	_	_	PUNCT
aji-167	65	1	_	_	PUNCT
aji-167	66	1	_	_	PUNCT
aji-167	67	1	_	_	PUNCT
aji-167	68	1	_	_	PUNCT
aji-167	69	1	_	_	PUNCT
aji-167	70	1	_	_	PUNCT
aji-167	71	1	_	_	PUNCT
aji-167	72	1	_	_	PUNCT
aji-167	73	1	_	_	PUNCT
aji-167	74	1	_	_	PUNCT
aji-167	75	1	_	_	PUNCT
aji-167	76	1	_	_	PUNCT
aji-167	77	1	_	_	PUNCT
aji-167	78	1	_	_	PUNCT
aji-167	79	1	_	_	PUNCT
aji-167	80	1	_	_	PUNCT
aji-167	81	1	_	_	PUNCT
aji-167	82	1	_	_	PUNCT
aji-167	83	1	_	_	PUNCT
aji-167	84	1	_	_	PUNCT
aji-167	85	1	_	_	PUNCT
aji-167	86	1	_	_	PUNCT
aji-167	87	1	_	_	PUNCT
aji-167	88	1	_	_	PUNCT
aji-167	89	1	_	_	PUNCT
aji-167	90	1	_	_	PUNCT
aji-167	91	1	_	_	PUNCT
aji-167	92	1	_	_	PUNCT
aji-167	93	1	_	_	PUNCT
aji-167	94	1	_	_	PUNCT
aji-167	95	1	_	_	PUNCT
aji-167	96	1	_	_	PUNCT
aji-167	97	1	_	_	PUNCT
aji-167	98	1	_	_	PUNCT
aji-167	99	1	_	_	PUNCT
aji-167	100	1	_	_	PUNCT
aji-167	101	1	_	_	PUNCT
aji-167	102	1	*	*	PUNCT
aji-167	102	2	corresponding	correspond	VERB
aji-167	102	3	author	author	NOUN
aji-167	102	4	:	:	PUNCT
aji-167	102	5	e	e	NOUN
aji-167	102	6	-	-	NOUN
aji-167	102	7	mail	mail	NOUN
aji-167	102	8	:	:	PUNCT
aji-167	102	9	jehiaghe@biu.edu.ng	jehiaghe@biu.edu.ng	VERB
aji-167	102	10	;	;	PUNCT
aji-167	102	11	cite	cite	VERB
aji-167	102	12	as	as	ADP
aji-167	102	13	:	:	PUNCT
aji-167	102	14	f.a	f.a	PROPN
aji-167	102	15	.	.	PROPN
aji-167	102	16	,	,	PUNCT
aji-167	102	17	ehiaghe	ehiaghe	PROPN
aji-167	102	18	,	,	PUNCT
aji-167	102	19	nworah	nworah	PROPN
aji-167	102	20	,	,	PUNCT
aji-167	102	21	c.m	c.m	PROPN
aji-167	102	22	.	.	PROPN
aji-167	102	23	,	,	PUNCT
aji-167	102	24	ehiaghe	ehiaghe	PROPN
aji-167	102	25	,	,	PUNCT
aji-167	102	26	j.i	j.i	PROPN
aji-167	102	27	.	.	PROPN
aji-167	102	28	,	,	PUNCT
aji-167	102	29	osakue	osakue	PROPN
aji-167	102	30	,	,	PUNCT
aji-167	102	31	o.n	o.n	PROPN
aji-167	102	32	.	.	PROPN
aji-167	102	33	,	,	PUNCT
aji-167	102	34	olisah	olisah	PROPN
aji-167	102	35	,	,	PUNCT
aji-167	102	36	m.c	m.c	PROPN
aji-167	102	37	.	.	PROPN
aji-167	102	38	,	,	PUNCT
aji-167	102	39	ize	ize	PROPN
aji-167	102	40	-	-	PUNCT
aji-167	102	41	iyamu	iyamu	PROPN
aji-167	102	42	,	,	PUNCT
aji-167	102	43	j.	j.	PROPN
aji-167	102	44	,	,	PUNCT
aji-167	102	45	amengialue	amengialue	NOUN
aji-167	102	46	,	,	PUNCT
aji-167	102	47	o.o	o.o	PROPN
aji-167	102	48	.	.	PROPN
aji-167	102	49	,	,	PUNCT
aji-167	102	50	and	and	CCONJ
aji-167	102	51	ogoegbunam	ogoegbunam	NOUN
aji-167	102	52	,	,	PUNCT
aji-167	102	53	n.d	n.d	PROPN
aji-167	102	54	.	.	PROPN
aji-167	102	55	2025	2025	NUM
aji-167	102	56	.	.	PUNCT
aji-167	103	1	“	"	PUNCT
aji-167	103	2	serum	serum	NOUN
aji-167	103	3	levels	level	NOUN
aji-167	103	4	of	of	ADP
aji-167	103	5	tnfα	tnfα	NOUN
aji-167	103	6	,	,	PUNCT
aji-167	103	7	il-10	il-10	NOUN
aji-167	103	8	and	and	CCONJ
aji-167	103	9	albumin	albumin	NOUN
aji-167	103	10	in	in	ADP
aji-167	103	11	female	female	ADJ
aji-167	103	12	patients	patient	NOUN
aji-167	103	13	with	with	ADP
aji-167	103	14	post	post	ADJ
aji-167	103	15	-	-	ADJ
aji-167	103	16	surgical	surgical	ADJ
aji-167	103	17	wound	wound	NOUN
aji-167	103	18	infection	infection	NOUN
aji-167	103	19	in	in	ADP
aji-167	103	20	asaba	asaba	PROPN
aji-167	103	21	delta	delta	PROPN
aji-167	103	22	state	state	PROPN
aji-167	103	23	,	,	PUNCT
aji-167	103	24	nigeria	nigeria	PROPN
aji-167	103	25	”	"	PUNCT
aji-167	103	26	.	.	PUNCT
aji-167	104	1	asian	asian	ADJ
aji-167	104	2	journal	journal	NOUN
aji-167	104	3	of	of	ADP
aji-167	104	4	immunology	immunology	NOUN
aji-167	104	5	8	8	NUM
aji-167	104	6	(	(	PUNCT
aji-167	104	7	1):134	1):134	NUM
aji-167	104	8	-	-	SYM
aji-167	104	9	41	41	NUM
aji-167	104	10	.	.	PUNCT
aji-167	105	1	https://doi.org/10.9734/aji/2025/v8i1167	https://doi.org/10.9734/aji/2025/v8i1167	PROPN
aji-167	105	2	.	.	PUNCT
aji-167	106	1	asian	asian	PROPN
aji-167	106	2	journal	journal	PROPN
aji-167	106	3	of	of	ADP
aji-167	106	4	immunology	immunology	NOUN
aji-167	106	5	volume	volume	NOUN
aji-167	106	6	8	8	NUM
aji-167	106	7	,	,	PUNCT
aji-167	106	8	issue	issue	NOUN
aji-167	106	9	1	1	NUM
aji-167	106	10	,	,	PUNCT
aji-167	106	11	page	page	NOUN
aji-167	106	12	134	134	NUM
aji-167	106	13	-	-	SYM
aji-167	106	14	141	141	NUM
aji-167	106	15	,	,	PUNCT
aji-167	106	16	2025	2025	NUM
aji-167	106	17	;	;	PUNCT
aji-167	106	18	article	article	NOUN
aji-167	106	19	no.aji.137461	no.aji.137461	NOUN
aji-167	106	20	serum	serum	PROPN
aji-167	106	21	levels	level	NOUN
aji-167	106	22	of	of	ADP
aji-167	106	23	tnfα	tnfα	NOUN
aji-167	106	24	,	,	PUNCT
aji-167	106	25	il-10	il-10	NOUN
aji-167	106	26	and	and	CCONJ
aji-167	106	27	albumin	albumin	NOUN
aji-167	106	28	in	in	ADP
aji-167	106	29	female	female	ADJ
aji-167	106	30	patients	patient	NOUN
aji-167	106	31	with	with	ADP
aji-167	106	32	postsurgical	postsurgical	ADJ
aji-167	106	33	wound	wound	NOUN
aji-167	106	34	infection	infection	NOUN
aji-167	106	35	in	in	ADP
aji-167	106	36	asaba	asaba	PROPN
aji-167	106	37	delta	delta	PROPN
aji-167	106	38	state	state	PROPN
aji-167	106	39	,	,	PUNCT
aji-167	106	40	nigeria	nigeria	PROPN
aji-167	106	41	ehiaghe	ehiaghe	PROPN
aji-167	106	42	,	,	PUNCT
aji-167	106	43	f.a	f.a	PROPN
aji-167	106	44	.	.	PROPN
aji-167	107	1	a	a	DET
aji-167	107	2	,	,	PUNCT
aji-167	107	3	nworah	nworah	PROPN
aji-167	107	4	,	,	PUNCT
aji-167	107	5	c.m	c.m	PROPN
aji-167	107	6	.	.	PROPN
aji-167	107	7	b	b	PROPN
aji-167	107	8	,	,	PUNCT
aji-167	107	9	ehiaghe	ehiaghe	PROPN
aji-167	107	10	,	,	PUNCT
aji-167	107	11	j.i	j.i	PROPN
aji-167	107	12	.	.	PROPN
aji-167	107	13	c	c	PROPN
aji-167	107	14	*	*	PUNCT
aji-167	107	15	,	,	PUNCT
aji-167	107	16	osakue	osakue	PROPN
aji-167	107	17	,	,	PUNCT
aji-167	107	18	o.n	o.n	PROPN
aji-167	107	19	.	.	PROPN
aji-167	107	20	b	b	PROPN
aji-167	107	21	,	,	PUNCT
aji-167	107	22	olisah	olisah	PROPN
aji-167	107	23	,	,	PUNCT
aji-167	107	24	m.c	m.c	PROPN
aji-167	107	25	.	.	PROPN
aji-167	107	26	d	d	PROPN
aji-167	107	27	,	,	PUNCT
aji-167	107	28	ize	ize	NOUN
aji-167	107	29	-	-	PUNCT
aji-167	107	30	iyamu	iyamu	PROPN
aji-167	107	31	,	,	PUNCT
aji-167	107	32	j.	j.	PROPN
aji-167	107	33	e	e	PROPN
aji-167	107	34	,	,	PUNCT
aji-167	107	35	amengialue	amengialue	NOUN
aji-167	107	36	,	,	PUNCT
aji-167	107	37	o.o	o.o	PROPN
aji-167	107	38	.	.	PROPN
aji-167	107	39	f	f	PROPN
aji-167	107	40	and	and	CCONJ
aji-167	107	41	ogoegbunam	ogoegbunam	PROPN
aji-167	107	42	,	,	PUNCT
aji-167	107	43	n.d	n.d	PROPN
aji-167	107	44	.	.	PROPN
aji-167	108	1	a	a	DET
aji-167	108	2	a	a	DET
aji-167	108	3	department	department	NOUN
aji-167	108	4	of	of	ADP
aji-167	108	5	immunology	immunology	NOUN
aji-167	108	6	and	and	CCONJ
aji-167	108	7	immunochemistry	immunochemistry	PROPN
aji-167	108	8	,	,	PUNCT
aji-167	108	9	nnamdi	nnamdi	PROPN
aji-167	108	10	azikiwe	azikiwe	PROPN
aji-167	108	11	university	university	PROPN
aji-167	108	12	,	,	PUNCT
aji-167	108	13	anambra	anambra	PROPN
aji-167	108	14	state	state	PROPN
aji-167	108	15	,	,	PUNCT
aji-167	108	16	nigeria	nigeria	PROPN
aji-167	108	17	.	.	PUNCT
aji-167	109	1	b	b	X
aji-167	109	2	department	department	NOUN
aji-167	109	3	of	of	ADP
aji-167	109	4	clinical	clinical	ADJ
aji-167	109	5	chemistry	chemistry	NOUN
aji-167	109	6	,	,	PUNCT
aji-167	109	7	nnamdi	nnamdi	PROPN
aji-167	109	8	azikiwe	azikiwe	PROPN
aji-167	109	9	university	university	PROPN
aji-167	109	10	,	,	PUNCT
aji-167	109	11	anambra	anambra	PROPN
aji-167	109	12	state	state	PROPN
aji-167	109	13	,	,	PUNCT
aji-167	109	14	nigeria	nigeria	PROPN
aji-167	109	15	.	.	PUNCT
aji-167	110	1	c	c	PROPN
aji-167	110	2	department	department	PROPN
aji-167	110	3	of	of	ADP
aji-167	110	4	medical	medical	ADJ
aji-167	110	5	laboratory	laboratory	NOUN
aji-167	110	6	science	science	NOUN
aji-167	110	7	,	,	PUNCT
aji-167	110	8	faculty	faculty	NOUN
aji-167	110	9	of	of	ADP
aji-167	110	10	allied	ally	VERB
aji-167	110	11	health	health	NOUN
aji-167	110	12	sciences	science	NOUN
aji-167	110	13	,	,	PUNCT
aji-167	110	14	benson	benson	PROPN
aji-167	110	15	idahosa	idahosa	PROPN
aji-167	110	16	university	university	PROPN
aji-167	110	17	,	,	PUNCT
aji-167	110	18	benin	benin	PROPN
aji-167	110	19	city	city	PROPN
aji-167	110	20	,	,	PUNCT
aji-167	110	21	nigeria	nigeria	PROPN
aji-167	110	22	.	.	PUNCT
aji-167	111	1	d	d	DET
aji-167	111	2	department	department	PROPN
aji-167	111	3	of	of	ADP
aji-167	111	4	medical	medical	ADJ
aji-167	111	5	biochemistry	biochemistry	NOUN
aji-167	111	6	,	,	PUNCT
aji-167	111	7	faculty	faculty	NOUN
aji-167	111	8	of	of	ADP
aji-167	111	9	basic	basic	ADJ
aji-167	111	10	medical	medical	ADJ
aji-167	111	11	sciences	science	NOUN
aji-167	111	12	,	,	PUNCT
aji-167	111	13	chukwuemeka	chukwuemeka	PROPN
aji-167	111	14	odimegwu	odimegwu	PROPN
aji-167	111	15	ojukwu	ojukwu	PROPN
aji-167	111	16	university	university	PROPN
aji-167	111	17	,	,	PUNCT
aji-167	111	18	uli	uli	PROPN
aji-167	111	19	,	,	PUNCT
aji-167	111	20	nigeria	nigeria	PROPN
aji-167	111	21	.	.	PUNCT
aji-167	112	1	e	e	X
aji-167	112	2	edo	edo	PROPN
aji-167	112	3	state	state	PROPN
aji-167	112	4	health	health	PROPN
aji-167	112	5	management	management	PROPN
aji-167	112	6	board	board	PROPN
aji-167	112	7	,	,	PUNCT
aji-167	112	8	benin	benin	PROPN
aji-167	112	9	city	city	PROPN
aji-167	112	10	,	,	PUNCT
aji-167	112	11	edo	edo	PROPN
aji-167	112	12	state	state	PROPN
aji-167	112	13	,	,	PUNCT
aji-167	112	14	nigeria	nigeria	PROPN
aji-167	112	15	.	.	PUNCT
aji-167	113	1	f	f	PROPN
aji-167	113	2	department	department	PROPN
aji-167	113	3	of	of	ADP
aji-167	113	4	medical	medical	ADJ
aji-167	113	5	microbiology	microbiology	NOUN
aji-167	113	6	,	,	PUNCT
aji-167	113	7	wellspring	wellspre	VERB
aji-167	113	8	university	university	PROPN
aji-167	113	9	,	,	PUNCT
aji-167	113	10	benin	benin	PROPN
aji-167	113	11	city	city	PROPN
aji-167	113	12	,	,	PUNCT
aji-167	113	13	edo	edo	PROPN
aji-167	113	14	state	state	PROPN
aji-167	113	15	,	,	PUNCT
aji-167	113	16	nigeria	nigeria	PROPN
aji-167	113	17	.	.	PUNCT
aji-167	114	1	authors	author	NOUN
aji-167	114	2	’	'	PUNCT
aji-167	114	3	contributions	contribution	NOUN
aji-167	114	4	this	this	DET
aji-167	114	5	work	work	NOUN
aji-167	114	6	was	be	AUX
aji-167	114	7	carried	carry	VERB
aji-167	114	8	out	out	ADP
aji-167	114	9	in	in	ADP
aji-167	114	10	collaboration	collaboration	NOUN
aji-167	114	11	among	among	ADP
aji-167	114	12	all	all	DET
aji-167	114	13	authors	author	NOUN
aji-167	114	14	.	.	PUNCT
aji-167	115	1	all	all	DET
aji-167	115	2	authors	author	NOUN
aji-167	115	3	read	read	VERB
aji-167	115	4	and	and	CCONJ
aji-167	115	5	approved	approve	VERB
aji-167	115	6	the	the	DET
aji-167	115	7	final	final	ADJ
aji-167	115	8	manuscript	manuscript	NOUN
aji-167	115	9	.	.	PUNCT
aji-167	116	1	article	article	NOUN
aji-167	116	2	information	information	PROPN
aji-167	116	3	doi	doi	PROPN
aji-167	116	4	:	:	PUNCT
aji-167	116	5	https://doi.org/10.9734/aji/2025/v8i1167	https://doi.org/10.9734/aji/2025/v8i1167	ADJ
aji-167	116	6	open	open	ADJ
aji-167	116	7	peer	peer	NOUN
aji-167	116	8	review	review	NOUN
aji-167	116	9	history	history	NOUN
aji-167	116	10	:	:	PUNCT
aji-167	116	11	this	this	DET
aji-167	116	12	journal	journal	NOUN
aji-167	116	13	follows	follow	VERB
aji-167	116	14	the	the	DET
aji-167	116	15	advanced	advance	VERB
aji-167	116	16	open	open	ADJ
aji-167	116	17	peer	peer	NOUN
aji-167	116	18	review	review	NOUN
aji-167	116	19	policy	policy	NOUN
aji-167	116	20	.	.	PUNCT
aji-167	117	1	identity	identity	NOUN
aji-167	117	2	of	of	ADP
aji-167	117	3	the	the	DET
aji-167	117	4	reviewers	reviewer	NOUN
aji-167	117	5	,	,	PUNCT
aji-167	117	6	editor(s	editor(s	NOUN
aji-167	117	7	)	)	PUNCT
aji-167	117	8	and	and	CCONJ
aji-167	117	9	additional	additional	ADJ
aji-167	117	10	reviewers	reviewer	NOUN
aji-167	117	11	,	,	PUNCT
aji-167	117	12	peer	peer	NOUN
aji-167	117	13	review	review	NOUN
aji-167	117	14	comments	comment	NOUN
aji-167	117	15	,	,	PUNCT
aji-167	117	16	different	different	ADJ
aji-167	117	17	versions	version	NOUN
aji-167	117	18	of	of	ADP
aji-167	117	19	the	the	DET
aji-167	117	20	manuscript	manuscript	NOUN
aji-167	117	21	,	,	PUNCT
aji-167	117	22	comments	comment	NOUN
aji-167	117	23	of	of	ADP
aji-167	117	24	the	the	DET
aji-167	117	25	editors	editor	NOUN
aji-167	117	26	,	,	PUNCT
aji-167	117	27	etc	etc	X
aji-167	117	28	are	be	AUX
aji-167	117	29	available	available	ADJ
aji-167	117	30	here	here	ADV
aji-167	117	31	:	:	PUNCT
aji-167	117	32	https://pr.sdiarticle5.com/review-history/137461	https://pr.sdiarticle5.com/review-history/137461	NUM
aji-167	117	33	received	receive	VERB
aji-167	117	34	:	:	PUNCT
aji-167	117	35	03/04/2025	03/04/2025	NUM
aji-167	117	36	published	publish	VERB
aji-167	117	37	:	:	PUNCT
aji-167	117	38	11/06/2025	11/06/2025	NUM
aji-167	117	39	original	original	ADJ
aji-167	117	40	research	research	NOUN
aji-167	117	41	article	article	NOUN
aji-167	117	42	https://doi.org/10.9734/aji/2025/v8i1167	https://doi.org/10.9734/aji/2025/v8i1167	PROPN
aji-167	117	43	https://pr.sdiarticle5.com/review-history/137461	https://pr.sdiarticle5.com/review-history/137461	PROPN
aji-167	117	44	ehiaghe	ehiaghe	PROPN
aji-167	117	45	et	et	PROPN
aji-167	117	46	al	al	PROPN
aji-167	117	47	.	.	PROPN
aji-167	117	48	;	;	PUNCT
aji-167	117	49	asian	asian	PROPN
aji-167	117	50	j.	j.	PROPN
aji-167	117	51	immunol	immunol	PROPN
aji-167	117	52	.	.	PROPN
aji-167	117	53	,	,	PUNCT
aji-167	117	54	vol	vol	NOUN
aji-167	117	55	.	.	PROPN
aji-167	117	56	8	8	NUM
aji-167	117	57	,	,	PUNCT
aji-167	117	58	no	no	INTJ
aji-167	117	59	.	.	NOUN
aji-167	117	60	1	1	NUM
aji-167	117	61	,	,	PUNCT
aji-167	117	62	pp	pp	ADJ
aji-167	117	63	.	.	PUNCT
aji-167	118	1	134	134	NUM
aji-167	118	2	-	-	SYM
aji-167	118	3	141	141	NUM
aji-167	118	4	,	,	PUNCT
aji-167	118	5	2025	2025	NUM
aji-167	118	6	;	;	PUNCT
aji-167	118	7	article	article	NOUN
aji-167	118	8	no.aji.137461	no.aji.137461	PART
aji-167	118	9	135	135	NUM
aji-167	118	10	abstract	abstract	ADJ
aji-167	118	11	post	post	ADJ
aji-167	118	12	-	-	ADJ
aji-167	118	13	operative	operative	ADJ
aji-167	118	14	wound	wound	NOUN
aji-167	118	15	infections	infection	NOUN
aji-167	118	16	(	(	PUNCT
aji-167	118	17	powis	powis	NOUN
aji-167	118	18	)	)	PUNCT
aji-167	118	19	,	,	PUNCT
aji-167	118	20	sometimes	sometimes	ADV
aji-167	118	21	referred	refer	VERB
aji-167	118	22	to	to	ADP
aji-167	118	23	as	as	ADP
aji-167	118	24	post	post	ADJ
aji-167	118	25	-	-	ADJ
aji-167	118	26	surgical	surgical	ADJ
aji-167	118	27	wound	wound	NOUN
aji-167	118	28	infections	infection	NOUN
aji-167	118	29	(	(	PUNCT
aji-167	118	30	pswis	pswis	NOUN
aji-167	118	31	)	)	PUNCT
aji-167	118	32	,	,	PUNCT
aji-167	118	33	are	be	AUX
aji-167	118	34	a	a	DET
aji-167	118	35	common	common	ADJ
aji-167	118	36	complication	complication	NOUN
aji-167	118	37	following	follow	VERB
aji-167	118	38	surgery	surgery	NOUN
aji-167	118	39	.	.	PUNCT
aji-167	119	1	surgeries	surgery	NOUN
aji-167	119	2	frequently	frequently	ADV
aji-167	119	3	elicit	elicit	VERB
aji-167	119	4	a	a	DET
aji-167	119	5	variety	variety	NOUN
aji-167	119	6	of	of	ADP
aji-167	119	7	immunological	immunological	ADJ
aji-167	119	8	responses	response	NOUN
aji-167	119	9	subsequent	subsequent	ADJ
aji-167	119	10	to	to	ADP
aji-167	119	11	tissue	tissue	NOUN
aji-167	119	12	damage	damage	NOUN
aji-167	119	13	and	and	CCONJ
aji-167	119	14	incision	incision	NOUN
aji-167	119	15	which	which	PRON
aji-167	119	16	may	may	AUX
aji-167	119	17	hinder	hinder	VERB
aji-167	119	18	wound	wound	VERB
aji-167	119	19	healing	healing	NOUN
aji-167	119	20	and	and	CCONJ
aji-167	119	21	infection	infection	NOUN
aji-167	119	22	resolution	resolution	NOUN
aji-167	119	23	leading	lead	VERB
aji-167	119	24	to	to	ADP
aji-167	119	25	poor	poor	ADJ
aji-167	119	26	patient	patient	ADJ
aji-167	119	27	outcome	outcome	NOUN
aji-167	119	28	.	.	PUNCT
aji-167	120	1	this	this	DET
aji-167	120	2	cross	cross	ADJ
aji-167	120	3	-	-	ADJ
aji-167	120	4	sectional	sectional	ADJ
aji-167	120	5	study	study	NOUN
aji-167	120	6	assessed	assess	VERB
aji-167	120	7	the	the	DET
aji-167	120	8	serum	serum	NOUN
aji-167	120	9	levels	level	NOUN
aji-167	120	10	of	of	ADP
aji-167	120	11	tnf	tnf	PROPN
aji-167	120	12	-	-	PUNCT
aji-167	120	13	α	α	PROPN
aji-167	120	14	,	,	PUNCT
aji-167	120	15	il-10	il-10	NOUN
aji-167	120	16	and	and	CCONJ
aji-167	120	17	albumin	albumin	NOUN
aji-167	120	18	in	in	ADP
aji-167	120	19	female	female	ADJ
aji-167	120	20	patients	patient	NOUN
aji-167	120	21	with	with	ADP
aji-167	120	22	post	post	ADJ
aji-167	120	23	-	-	ADJ
aji-167	120	24	surgical	surgical	ADJ
aji-167	120	25	wound	wound	NOUN
aji-167	120	26	infection	infection	NOUN
aji-167	120	27	in	in	ADP
aji-167	120	28	asaba	asaba	PROPN
aji-167	120	29	delta	delta	PROPN
aji-167	120	30	state	state	PROPN
aji-167	120	31	,	,	PUNCT
aji-167	120	32	nigeria	nigeria	PROPN
aji-167	120	33	.	.	PUNCT
aji-167	121	1	twenty	twenty	NUM
aji-167	121	2	-	-	PUNCT
aji-167	121	3	five	five	NUM
aji-167	121	4	(	(	PUNCT
aji-167	121	5	25	25	NUM
aji-167	121	6	)	)	PUNCT
aji-167	121	7	patients	patient	NOUN
aji-167	121	8	with	with	ADP
aji-167	121	9	pswis	pswis	NOUN
aji-167	121	10	and	and	CCONJ
aji-167	121	11	25	25	NUM
aji-167	121	12	apparently	apparently	ADV
aji-167	121	13	healthy	healthy	ADJ
aji-167	121	14	individuals	individual	NOUN
aji-167	121	15	(	(	PUNCT
aji-167	121	16	control	control	NOUN
aji-167	121	17	group	group	NOUN
aji-167	121	18	)	)	PUNCT
aji-167	121	19	were	be	AUX
aji-167	121	20	recruited	recruit	VERB
aji-167	121	21	by	by	ADP
aji-167	121	22	random	random	ADJ
aji-167	121	23	sampling	sampling	NOUN
aji-167	121	24	method	method	NOUN
aji-167	121	25	.	.	PUNCT
aji-167	122	1	four	four	NUM
aji-167	122	2	millilitres	millilitre	NOUN
aji-167	122	3	(	(	PUNCT
aji-167	122	4	4	4	NUM
aji-167	122	5	ml	ml	NOUN
aji-167	122	6	)	)	PUNCT
aji-167	122	7	of	of	ADP
aji-167	122	8	venous	venous	ADJ
aji-167	122	9	blood	blood	NOUN
aji-167	122	10	samples	sample	NOUN
aji-167	122	11	were	be	AUX
aji-167	122	12	collected	collect	VERB
aji-167	122	13	for	for	ADP
aji-167	122	14	the	the	DET
aji-167	122	15	determination	determination	NOUN
aji-167	122	16	of	of	ADP
aji-167	122	17	serum	serum	PROPN
aji-167	122	18	tnf	tnf	PROPN
aji-167	122	19	-	-	PUNCT
aji-167	122	20	α	α	PROPN
aji-167	122	21	,	,	PUNCT
aji-167	122	22	il-10	il-10	NOUN
aji-167	122	23	and	and	CCONJ
aji-167	122	24	albumin	albumin	ADJ
aji-167	122	25	levels	level	NOUN
aji-167	122	26	.	.	PUNCT
aji-167	123	1	tnf	tnf	PROPN
aji-167	123	2	-	-	PUNCT
aji-167	123	3	α	α	PROPN
aji-167	123	4	and	and	CCONJ
aji-167	123	5	il-10	il-10	NOUN
aji-167	123	6	levels	level	NOUN
aji-167	123	7	were	be	AUX
aji-167	123	8	estimated	estimate	VERB
aji-167	123	9	with	with	ADP
aji-167	123	10	a	a	DET
aji-167	123	11	sandwich	sandwich	NOUN
aji-167	123	12	enzyme	enzyme	NOUN
aji-167	123	13	-	-	PUNCT
aji-167	123	14	linked	link	VERB
aji-167	123	15	immunosorbent	immunosorbent	NOUN
aji-167	123	16	assay	assay	ADV
aji-167	123	17	,	,	PUNCT
aji-167	123	18	whereas	whereas	SCONJ
aji-167	123	19	serum	serum	NOUN
aji-167	123	20	albumin	albumin	NOUN
aji-167	123	21	was	be	AUX
aji-167	123	22	assessed	assess	VERB
aji-167	123	23	with	with	ADP
aji-167	123	24	the	the	DET
aji-167	123	25	bromocresol	bromocresol	ADJ
aji-167	123	26	green	green	NOUN
aji-167	123	27	(	(	PUNCT
aji-167	123	28	bcg	bcg	PROPN
aji-167	123	29	)	)	PUNCT
aji-167	123	30	method	method	NOUN
aji-167	123	31	.	.	PUNCT
aji-167	124	1	the	the	DET
aji-167	124	2	data	datum	NOUN
aji-167	124	3	obtained	obtain	VERB
aji-167	124	4	was	be	AUX
aji-167	124	5	analyzed	analyze	VERB
aji-167	124	6	using	use	VERB
aji-167	124	7	an	an	DET
aji-167	124	8	independent	independent	ADJ
aji-167	124	9	t	t	NOUN
aji-167	124	10	-	-	PUNCT
aji-167	124	11	test	test	NOUN
aji-167	124	12	and	and	CCONJ
aji-167	124	13	pearson	pearson	PROPN
aji-167	124	14	correlation	correlation	NOUN
aji-167	124	15	,	,	PUNCT
aji-167	124	16	with	with	ADP
aji-167	124	17	a	a	DET
aji-167	124	18	p	p	NOUN
aji-167	124	19	-	-	PUNCT
aji-167	124	20	value	value	NOUN
aji-167	124	21	of	of	ADP
aji-167	124	22	<	<	X
aji-167	124	23	0.05	0.05	NUM
aji-167	124	24	indicating	indicate	VERB
aji-167	124	25	statistical	statistical	ADJ
aji-167	124	26	significance	significance	NOUN
aji-167	124	27	.	.	PUNCT
aji-167	125	1	the	the	DET
aji-167	125	2	mean	mean	PROPN
aji-167	125	3	serum	serum	PROPN
aji-167	125	4	tnf	tnf	PROPN
aji-167	125	5	-	-	PUNCT
aji-167	125	6	α	α	PROPN
aji-167	125	7	(	(	PUNCT
aji-167	125	8	143.44	143.44	NUM
aji-167	125	9	±7.35	±7.35	NOUN
aji-167	125	10	vs	vs	ADP
aji-167	125	11	37.32	37.32	NUM
aji-167	125	12	±8.92	±8.92	NUM
aji-167	125	13	;	;	PUNCT
aji-167	125	14	p	p	PROPN
aji-167	125	15	=	=	NOUN
aji-167	125	16	0.001	0.001	NUM
aji-167	125	17	)	)	PUNCT
aji-167	125	18	and	and	CCONJ
aji-167	125	19	il-10	il-10	X
aji-167	125	20	(	(	PUNCT
aji-167	125	21	27.52	27.52	NUM
aji-167	125	22	±7.77	±7.77	NOUN
aji-167	125	23	vs	vs	ADP
aji-167	125	24	17.12	17.12	NUM
aji-167	125	25	±6.23	±6.23	NOUN
aji-167	125	26	;	;	PUNCT
aji-167	125	27	p	p	PROPN
aji-167	125	28	=	=	NOUN
aji-167	125	29	0.001	0.001	NUM
aji-167	125	30	)	)	PUNCT
aji-167	125	31	levels	level	NOUN
aji-167	125	32	were	be	AUX
aji-167	125	33	significantly	significantly	ADV
aji-167	125	34	higher	high	ADJ
aji-167	125	35	while	while	SCONJ
aji-167	125	36	serum	serum	NOUN
aji-167	125	37	albumin	albumin	ADJ
aji-167	125	38	level	level	NOUN
aji-167	125	39	was	be	AUX
aji-167	125	40	significantly	significantly	ADV
aji-167	125	41	lower	low	ADJ
aji-167	125	42	(	(	PUNCT
aji-167	125	43	34.14	34.14	NUM
aji-167	125	44	±5.43	±5.43	NOUN
aji-167	125	45	vs	vs	ADP
aji-167	125	46	40.19	40.19	NUM
aji-167	125	47	±3.38	±3.38	NOUN
aji-167	125	48	;	;	PUNCT
aji-167	125	49	p	p	NOUN
aji-167	125	50	=	=	NOUN
aji-167	125	51	0.001	0.001	NUM
aji-167	125	52	)	)	PUNCT
aji-167	125	53	in	in	ADP
aji-167	125	54	the	the	DET
aji-167	125	55	female	female	ADJ
aji-167	125	56	patients	patient	NOUN
aji-167	125	57	with	with	ADP
aji-167	125	58	pswis	pswis	NOUN
aji-167	125	59	than	than	ADP
aji-167	125	60	in	in	ADP
aji-167	125	61	the	the	DET
aji-167	125	62	control	control	NOUN
aji-167	125	63	group	group	NOUN
aji-167	125	64	.	.	PUNCT
aji-167	126	1	however	however	ADV
aji-167	126	2	,	,	PUNCT
aji-167	126	3	no	no	DET
aji-167	126	4	significant	significant	ADJ
aji-167	126	5	correlation	correlation	NOUN
aji-167	126	6	was	be	AUX
aji-167	126	7	observed	observe	VERB
aji-167	126	8	between	between	ADP
aji-167	126	9	the	the	DET
aji-167	126	10	levels	level	NOUN
aji-167	126	11	of	of	ADP
aji-167	126	12	tnf	tnf	PROPN
aji-167	126	13	-	-	PUNCT
aji-167	126	14	α	α	PROPN
aji-167	126	15	vs	vs	ADP
aji-167	126	16	albumin	albumin	NOUN
aji-167	126	17	and	and	CCONJ
aji-167	126	18	il-10	il-10	NOUN
aji-167	126	19	vs	vs	ADP
aji-167	126	20	albumin	albumin	NOUN
aji-167	126	21	(	(	PUNCT
aji-167	126	22	p>0.05	p>0.05	PROPN
aji-167	126	23	)	)	PUNCT
aji-167	126	24	.	.	PUNCT
aji-167	127	1	the	the	DET
aji-167	127	2	elevated	elevated	ADJ
aji-167	127	3	levels	level	NOUN
aji-167	127	4	of	of	ADP
aji-167	127	5	proinflammatory	proinflammatory	ADJ
aji-167	127	6	cytokine	cytokine	NOUN
aji-167	127	7	tnf	tnf	PROPN
aji-167	127	8	-	-	PUNCT
aji-167	127	9	α	α	PROPN
aji-167	127	10	may	may	AUX
aji-167	127	11	lead	lead	VERB
aji-167	127	12	to	to	ADP
aji-167	127	13	adverse	adverse	ADJ
aji-167	127	14	patient	patient	NOUN
aji-167	127	15	outcomes	outcome	NOUN
aji-167	127	16	by	by	ADP
aji-167	127	17	hindering	hinder	VERB
aji-167	127	18	wound	wound	NOUN
aji-167	127	19	healing	healing	NOUN
aji-167	127	20	and	and	CCONJ
aji-167	127	21	slowing	slow	VERB
aji-167	127	22	infection	infection	NOUN
aji-167	127	23	resolution	resolution	NOUN
aji-167	127	24	.	.	PUNCT
aji-167	128	1	keywords	keyword	NOUN
aji-167	128	2	:	:	PUNCT
aji-167	128	3	powis	powis	VERB
aji-167	128	4	;	;	PUNCT
aji-167	128	5	tnf	tnf	PROPN
aji-167	128	6	-	-	PUNCT
aji-167	128	7	α	α	PROPN
aji-167	128	8	;	;	PUNCT
aji-167	128	9	il-10	il-10	PRON
aji-167	128	10	;	;	PUNCT
aji-167	128	11	albumin	albumin	NOUN
aji-167	128	12	;	;	PUNCT
aji-167	128	13	patients	patient	NOUN
aji-167	128	14	.	.	PUNCT
aji-167	129	1	1	1	X
aji-167	129	2	.	.	X
aji-167	129	3	introduction	introduction	NOUN
aji-167	129	4	post	post	ADJ
aji-167	129	5	-	-	ADJ
aji-167	129	6	operative	operative	ADJ
aji-167	129	7	wound	wound	NOUN
aji-167	129	8	infections	infection	NOUN
aji-167	129	9	(	(	PUNCT
aji-167	129	10	powis	powis	NOUN
aji-167	129	11	)	)	PUNCT
aji-167	129	12	,	,	PUNCT
aji-167	129	13	sometimes	sometimes	ADV
aji-167	129	14	referred	refer	VERB
aji-167	129	15	to	to	ADP
aji-167	129	16	as	as	ADP
aji-167	129	17	postsurgical	postsurgical	ADJ
aji-167	129	18	wound	wound	NOUN
aji-167	129	19	infections	infection	NOUN
aji-167	129	20	(	(	PUNCT
aji-167	129	21	pswis	pswis	NOUN
aji-167	129	22	)	)	PUNCT
aji-167	129	23	,	,	PUNCT
aji-167	129	24	are	be	AUX
aji-167	129	25	a	a	DET
aji-167	129	26	common	common	ADJ
aji-167	129	27	complication	complication	NOUN
aji-167	129	28	following	follow	VERB
aji-167	129	29	surgery	surgery	NOUN
aji-167	129	30	,	,	PUNCT
aji-167	129	31	characterized	characterize	VERB
aji-167	129	32	by	by	ADP
aji-167	129	33	complex	complex	ADJ
aji-167	129	34	and	and	CCONJ
aji-167	129	35	multifaceted	multifaceted	ADJ
aji-167	129	36	pathophysiology	pathophysiology	NOUN
aji-167	129	37	(	(	PUNCT
aji-167	129	38	zabaglo	zabaglo	INTJ
aji-167	129	39	et	et	PROPN
aji-167	129	40	al	al	PROPN
aji-167	129	41	.	.	PROPN
aji-167	129	42	,	,	PUNCT
aji-167	129	43	2025	2025	NUM
aji-167	129	44	)	)	PUNCT
aji-167	129	45	.	.	PUNCT
aji-167	130	1	post	post	ADJ
aji-167	130	2	-	-	ADJ
aji-167	130	3	operative	operative	ADJ
aji-167	130	4	wound	wound	NOUN
aji-167	130	5	infection	infection	NOUN
aji-167	130	6	(	(	PUNCT
aji-167	130	7	powis	powis	NOUN
aji-167	130	8	)	)	PUNCT
aji-167	130	9	is	be	AUX
aji-167	130	10	still	still	ADV
aji-167	130	11	a	a	DET
aji-167	130	12	leading	lead	VERB
aji-167	130	13	cause	cause	NOUN
aji-167	130	14	of	of	ADP
aji-167	130	15	morbidity	morbidity	NOUN
aji-167	130	16	and	and	CCONJ
aji-167	130	17	death	death	NOUN
aji-167	130	18	for	for	ADP
aji-167	130	19	patients	patient	NOUN
aji-167	130	20	having	have	VERB
aji-167	130	21	surgery	surgery	NOUN
aji-167	130	22	,	,	PUNCT
aji-167	130	23	even	even	ADV
aji-167	130	24	with	with	ADP
aji-167	130	25	improvements	improvement	NOUN
aji-167	130	26	in	in	ADP
aji-167	130	27	surgical	surgical	ADJ
aji-167	130	28	techniques	technique	NOUN
aji-167	130	29	and	and	CCONJ
aji-167	130	30	a	a	DET
aji-167	130	31	better	well	ADJ
aji-167	130	32	understanding	understanding	NOUN
aji-167	130	33	of	of	ADP
aji-167	130	34	the	the	DET
aji-167	130	35	pathophysiology	pathophysiology	NOUN
aji-167	130	36	of	of	ADP
aji-167	130	37	wound	wound	ADJ
aji-167	130	38	infection	infection	NOUN
aji-167	130	39	(	(	PUNCT
aji-167	130	40	kallakuri	kallakuri	PROPN
aji-167	130	41	et	et	PROPN
aji-167	130	42	al	al	PROPN
aji-167	130	43	.	.	PROPN
aji-167	130	44	,	,	PUNCT
aji-167	130	45	2024	2024	NUM
aji-167	130	46	)	)	PUNCT
aji-167	130	47	.	.	PUNCT
aji-167	131	1	the	the	DET
aji-167	131	2	prevalence	prevalence	NOUN
aji-167	131	3	of	of	ADP
aji-167	131	4	powis	powis	NOUN
aji-167	131	5	is	be	AUX
aji-167	131	6	still	still	ADV
aji-167	131	7	rising	rise	VERB
aji-167	131	8	in	in	ADP
aji-167	131	9	many	many	ADJ
aji-167	131	10	nations	nation	NOUN
aji-167	131	11	,	,	PUNCT
aji-167	131	12	communities	community	NOUN
aji-167	131	13	,	,	PUNCT
aji-167	131	14	and	and	CCONJ
aji-167	131	15	hospitals	hospital	NOUN
aji-167	131	16	,	,	PUNCT
aji-167	131	17	albeit	albeit	SCONJ
aji-167	131	18	it	it	PRON
aji-167	131	19	varies	vary	VERB
aji-167	131	20	greatly	greatly	ADV
aji-167	131	21	(	(	PUNCT
aji-167	131	22	ehiaghe	ehiaghe	PROPN
aji-167	131	23	et	et	PROPN
aji-167	131	24	al	al	PROPN
aji-167	131	25	.	.	PROPN
aji-167	131	26	,	,	PUNCT
aji-167	131	27	2025b	2025b	NUM
aji-167	131	28	;	;	PUNCT
aji-167	131	29	kallakuri	kallakuri	PROPN
aji-167	131	30	et	et	PROPN
aji-167	131	31	al	al	PROPN
aji-167	131	32	.	.	PROPN
aji-167	131	33	,	,	PUNCT
aji-167	131	34	2024	2024	NUM
aji-167	131	35	)	)	PUNCT
aji-167	131	36	.	.	PUNCT
aji-167	132	1	surgeries	surgery	NOUN
aji-167	132	2	frequently	frequently	ADV
aji-167	132	3	elicit	elicit	VERB
aji-167	132	4	a	a	DET
aji-167	132	5	variety	variety	NOUN
aji-167	132	6	of	of	ADP
aji-167	132	7	immunological	immunological	ADJ
aji-167	132	8	responses	response	NOUN
aji-167	132	9	subsequent	subsequent	ADJ
aji-167	132	10	to	to	ADP
aji-167	132	11	tissue	tissue	NOUN
aji-167	132	12	damage	damage	NOUN
aji-167	132	13	and	and	CCONJ
aji-167	132	14	incision	incision	NOUN
aji-167	132	15	(	(	PUNCT
aji-167	132	16	weledji	weledji	ADJ
aji-167	132	17	,	,	PUNCT
aji-167	132	18	2021	2021	NUM
aji-167	132	19	)	)	PUNCT
aji-167	132	20	.	.	PUNCT
aji-167	133	1	this	this	PRON
aji-167	133	2	include	include	VERB
aji-167	133	3	the	the	DET
aji-167	133	4	secretion	secretion	NOUN
aji-167	133	5	of	of	ADP
aji-167	133	6	cytokines	cytokine	NOUN
aji-167	133	7	,	,	PUNCT
aji-167	133	8	stress	stress	NOUN
aji-167	133	9	responses	response	NOUN
aji-167	133	10	,	,	PUNCT
aji-167	133	11	and	and	CCONJ
aji-167	133	12	acute	acute	ADJ
aji-167	133	13	phase	phase	NOUN
aji-167	133	14	proteins	protein	NOUN
aji-167	133	15	,	,	PUNCT
aji-167	133	16	which	which	PRON
aji-167	133	17	can	can	AUX
aji-167	133	18	be	be	AUX
aji-167	133	19	detrimental	detrimental	ADJ
aji-167	133	20	when	when	SCONJ
aji-167	133	21	excessive	excessive	ADJ
aji-167	133	22	(	(	PUNCT
aji-167	133	23	chidambaran	chidambaran	NOUN
aji-167	133	24	et	et	PROPN
aji-167	133	25	al	al	PROPN
aji-167	133	26	.	.	PROPN
aji-167	133	27	,	,	PUNCT
aji-167	133	28	2024	2024	NUM
aji-167	133	29	;	;	PUNCT
aji-167	133	30	hsing	hsing	PROPN
aji-167	133	31	and	and	CCONJ
aji-167	133	32	wang	wang	PROPN
aji-167	133	33	,	,	PUNCT
aji-167	133	34	2015	2015	NUM
aji-167	133	35	)	)	PUNCT
aji-167	133	36	.	.	PUNCT
aji-167	134	1	cytokines	cytokine	NOUN
aji-167	134	2	represent	represent	VERB
aji-167	134	3	a	a	DET
aji-167	134	4	viable	viable	ADJ
aji-167	134	5	therapeutic	therapeutic	ADJ
aji-167	134	6	target	target	NOUN
aji-167	134	7	,	,	PUNCT
aji-167	134	8	as	as	SCONJ
aji-167	134	9	they	they	PRON
aji-167	134	10	regulate	regulate	VERB
aji-167	134	11	all	all	DET
aji-167	134	12	phases	phase	NOUN
aji-167	134	13	of	of	ADP
aji-167	134	14	wound	wound	ADJ
aji-167	134	15	healing	healing	NOUN
aji-167	134	16	,	,	PUNCT
aji-167	134	17	and	and	CCONJ
aji-167	134	18	abnormalities	abnormality	NOUN
aji-167	134	19	in	in	ADP
aji-167	134	20	cytokine	cytokine	ADJ
aji-167	134	21	production	production	NOUN
aji-167	134	22	can	can	AUX
aji-167	134	23	lead	lead	VERB
aji-167	134	24	to	to	ADP
aji-167	134	25	inflammatory	inflammatory	ADJ
aji-167	134	26	non	non	ADJ
aji-167	134	27	-	-	ADJ
aji-167	134	28	healing	healing	ADJ
aji-167	134	29	wounds	wound	NOUN
aji-167	134	30	(	(	PUNCT
aji-167	134	31	wong	wong	PROPN
aji-167	134	32	et	et	PROPN
aji-167	134	33	al	al	PROPN
aji-167	134	34	.	.	PROPN
aji-167	134	35	,	,	PUNCT
aji-167	134	36	2025	2025	NUM
aji-167	134	37	)	)	PUNCT
aji-167	134	38	.	.	PUNCT
aji-167	135	1	cytokines	cytokine	NOUN
aji-167	135	2	are	be	AUX
aji-167	135	3	soluble	soluble	ADJ
aji-167	135	4	molecular	molecular	ADJ
aji-167	135	5	entities	entity	NOUN
aji-167	135	6	synthesized	synthesize	VERB
aji-167	135	7	by	by	ADP
aji-167	135	8	inflammatory	inflammatory	ADJ
aji-167	135	9	cells	cell	NOUN
aji-167	135	10	.	.	PUNCT
aji-167	136	1	they	they	PRON
aji-167	136	2	can	can	AUX
aji-167	136	3	be	be	AUX
aji-167	136	4	broadly	broadly	ADV
aji-167	136	5	classified	classify	VERB
aji-167	136	6	as	as	ADP
aji-167	136	7	either	either	CCONJ
aji-167	136	8	pro	pro	ADJ
aji-167	136	9	-	-	ADJ
aji-167	136	10	inflammatory	inflammatory	ADJ
aji-167	136	11	cytokines	cytokine	NOUN
aji-167	136	12	(	(	PUNCT
aji-167	136	13	e.g.	e.g.	ADV
aji-167	136	14	,	,	PUNCT
aji-167	136	15	interleukins	interleukin	VERB
aji-167	136	16	(	(	PUNCT
aji-167	136	17	il)-1	il)-1	NOUN
aji-167	136	18	,	,	PUNCT
aji-167	136	19	2	2	NUM
aji-167	136	20	,	,	PUNCT
aji-167	136	21	8	8	NUM
aji-167	136	22	,	,	PUNCT
aji-167	136	23	12	12	NUM
aji-167	136	24	;	;	PUNCT
aji-167	136	25	tumor	tumor	NOUN
aji-167	136	26	necrosis	necrosis	NOUN
aji-167	136	27	factor	factor	NOUN
aji-167	136	28	α	α	PROPN
aji-167	136	29	(	(	PUNCT
aji-167	136	30	tnf	tnf	PROPN
aji-167	136	31	-	-	PUNCT
aji-167	136	32	α	α	NOUN
aji-167	136	33	)	)	PUNCT
aji-167	136	34	,	,	PUNCT
aji-167	136	35	interferon	interferon	ADJ
aji-167	136	36	γ	γ	X
aji-167	136	37	(	(	PUNCT
aji-167	136	38	ifnγ	ifnγ	NOUN
aji-167	136	39	)	)	PUNCT
aji-167	136	40	,	,	PUNCT
aji-167	136	41	etc	etc	X
aji-167	136	42	.	.	X
aji-167	136	43	)	)	PUNCT
aji-167	136	44	,	,	PUNCT
aji-167	136	45	or	or	CCONJ
aji-167	136	46	anti	anti	ADJ
aji-167	136	47	-	-	ADJ
aji-167	136	48	inflammatory	inflammatory	ADJ
aji-167	136	49	cytokines	cytokine	NOUN
aji-167	136	50	e.g.	e.g.	ADV
aji-167	136	51	,	,	PUNCT
aji-167	136	52	transforming	transform	VERB
aji-167	136	53	growth	growth	NOUN
aji-167	136	54	factor	factor	NOUN
aji-167	136	55	beta	beta	NOUN
aji-167	136	56	(	(	PUNCT
aji-167	136	57	tgfβ	tgfβ	ADJ
aji-167	136	58	)	)	PUNCT
aji-167	136	59	,	,	PUNCT
aji-167	136	60	il-4	il-4	X
aji-167	136	61	,	,	PUNCT
aji-167	136	62	il10	il10	PROPN
aji-167	136	63	,	,	PUNCT
aji-167	136	64	il-13	il-13	VERB
aji-167	136	65	while	while	SCONJ
aji-167	136	66	others	other	NOUN
aji-167	136	67	,	,	PUNCT
aji-167	136	68	like	like	ADP
aji-167	136	69	il-6	il-6	NUM
aji-167	136	70	,	,	PUNCT
aji-167	136	71	can	can	AUX
aji-167	136	72	be	be	AUX
aji-167	136	73	both	both	DET
aji-167	136	74	(	(	PUNCT
aji-167	136	75	chidambaran	chidambaran	NOUN
aji-167	136	76	et	et	PROPN
aji-167	136	77	al	al	PROPN
aji-167	136	78	.	.	PROPN
aji-167	136	79	,	,	PUNCT
aji-167	136	80	2024	2024	NUM
aji-167	136	81	)	)	PUNCT
aji-167	136	82	.	.	PUNCT
aji-167	137	1	tnf	tnf	PROPN
aji-167	137	2	-	-	PUNCT
aji-167	137	3	α	α	PROPN
aji-167	137	4	attracts	attract	VERB
aji-167	137	5	pro	pro	ADJ
aji-167	137	6	-	-	ADJ
aji-167	137	7	inflammatory	inflammatory	ADJ
aji-167	137	8	cells	cell	NOUN
aji-167	137	9	including	include	VERB
aji-167	137	10	neutrophils	neutrophil	NOUN
aji-167	137	11	,	,	PUNCT
aji-167	137	12	macrophages	macrophage	NOUN
aji-167	137	13	,	,	PUNCT
aji-167	137	14	and	and	CCONJ
aji-167	137	15	fibroblasts	fibroblast	NOUN
aji-167	137	16	to	to	ADP
aji-167	137	17	the	the	DET
aji-167	137	18	wound	wound	NOUN
aji-167	137	19	site	site	NOUN
aji-167	137	20	,	,	PUNCT
aji-167	137	21	where	where	SCONJ
aji-167	137	22	they	they	PRON
aji-167	137	23	assist	assist	VERB
aji-167	137	24	remove	remove	VERB
aji-167	137	25	debris	debris	NOUN
aji-167	137	26	and	and	CCONJ
aji-167	137	27	pathogens	pathogen	NOUN
aji-167	137	28	(	(	PUNCT
aji-167	137	29	wong	wong	PROPN
aji-167	137	30	et	et	PROPN
aji-167	137	31	al	al	PROPN
aji-167	137	32	.	.	PROPN
aji-167	137	33	,	,	PUNCT
aji-167	137	34	2025	2025	NUM
aji-167	137	35	;	;	PUNCT
aji-167	137	36	jang	jang	PROPN
aji-167	137	37	et	et	PROPN
aji-167	137	38	al	al	PROPN
aji-167	137	39	.	.	PROPN
aji-167	137	40	,	,	PUNCT
aji-167	137	41	2021	2021	NUM
aji-167	137	42	)	)	PUNCT
aji-167	137	43	,	,	PUNCT
aji-167	137	44	thereby	thereby	ADV
aji-167	137	45	facilitating	facilitate	VERB
aji-167	137	46	wound	wound	NOUN
aji-167	137	47	healing	healing	NOUN
aji-167	137	48	or	or	CCONJ
aji-167	137	49	resolution	resolution	NOUN
aji-167	137	50	under	under	ADP
aji-167	137	51	physiological	physiological	ADJ
aji-167	137	52	state	state	NOUN
aji-167	137	53	.	.	PUNCT
aji-167	138	1	however	however	ADV
aji-167	138	2	,	,	PUNCT
aji-167	138	3	exaggerated	exaggerated	ADJ
aji-167	138	4	tnf	tnf	PROPN
aji-167	138	5	-	-	PUNCT
aji-167	138	6	α	α	PROPN
aji-167	138	7	responses	response	NOUN
aji-167	138	8	can	can	AUX
aji-167	138	9	culminate	culminate	VERB
aji-167	138	10	in	in	ADP
aji-167	138	11	failed	fail	VERB
aji-167	138	12	wound	wound	NOUN
aji-167	138	13	infection	infection	NOUN
aji-167	138	14	resolution	resolution	NOUN
aji-167	138	15	(	(	PUNCT
aji-167	138	16	choy	choy	NOUN
aji-167	138	17	et	et	NOUN
aji-167	138	18	al	al	PROPN
aji-167	138	19	.	.	PROPN
aji-167	138	20	,	,	PUNCT
aji-167	138	21	2023	2023	NUM
aji-167	138	22	;	;	PUNCT
aji-167	138	23	jang	jang	PROPN
aji-167	138	24	et	et	PROPN
aji-167	138	25	al	al	PROPN
aji-167	138	26	.	.	PROPN
aji-167	138	27	,	,	PUNCT
aji-167	138	28	2021	2021	NUM
aji-167	138	29	)	)	PUNCT
aji-167	138	30	.	.	PUNCT
aji-167	139	1	interleukin	interleukin	NOUN
aji-167	139	2	10	10	NUM
aji-167	139	3	(	(	PUNCT
aji-167	139	4	il-10	il-10	NUM
aji-167	139	5	)	)	PUNCT
aji-167	139	6	is	be	AUX
aji-167	139	7	an	an	DET
aji-167	139	8	important	important	ADJ
aji-167	139	9	antiinflammatory	antiinflammatory	NOUN
aji-167	139	10	cytokine	cytokine	NOUN
aji-167	139	11	produced	produce	VERB
aji-167	139	12	mainly	mainly	ADV
aji-167	139	13	by	by	ADP
aji-167	139	14	the	the	DET
aji-167	139	15	cd4	cd4	PROPN
aji-167	139	16	+	+	PROPN
aji-167	139	17	t	t	NOUN
aji-167	139	18	cells	cell	NOUN
aji-167	139	19	although	although	SCONJ
aji-167	139	20	other	other	ADJ
aji-167	139	21	leukocytes	leukocyte	NOUN
aji-167	139	22	such	such	ADJ
aji-167	139	23	as	as	ADP
aji-167	139	24	neutrophils	neutrophil	NOUN
aji-167	139	25	,	,	PUNCT
aji-167	139	26	b	b	NOUN
aji-167	139	27	cells	cell	NOUN
aji-167	139	28	,	,	PUNCT
aji-167	139	29	dendritic	dendritic	ADJ
aji-167	139	30	cells	cell	NOUN
aji-167	139	31	,	,	PUNCT
aji-167	139	32	natural	natural	ADJ
aji-167	139	33	killer	killer	NOUN
aji-167	139	34	cells	cell	NOUN
aji-167	139	35	,	,	PUNCT
aji-167	139	36	and	and	CCONJ
aji-167	139	37	macrophages	macrophage	NOUN
aji-167	139	38	also	also	ADV
aji-167	139	39	secret	secret	VERB
aji-167	139	40	it	it	PRON
aji-167	139	41	as	as	ADV
aji-167	139	42	well	well	ADV
aji-167	139	43	(	(	PUNCT
aji-167	139	44	sun	sun	NOUN
aji-167	139	45	et	et	PROPN
aji-167	139	46	al	al	PROPN
aji-167	139	47	.	.	PROPN
aji-167	139	48	,	,	PUNCT
aji-167	139	49	2020	2020	NUM
aji-167	139	50	)	)	PUNCT
aji-167	139	51	.	.	PUNCT
aji-167	140	1	its	its	PRON
aji-167	140	2	primary	primary	ADJ
aji-167	140	3	functions	function	NOUN
aji-167	140	4	include	include	VERB
aji-167	140	5	anti	anti	ADJ
aji-167	140	6	-	-	ADJ
aji-167	140	7	inflammatory	inflammatory	ADJ
aji-167	140	8	,	,	PUNCT
aji-167	140	9	inhibitory	inhibitory	ADJ
aji-167	140	10	,	,	PUNCT
aji-167	140	11	or	or	CCONJ
aji-167	140	12	self	self	NOUN
aji-167	140	13	-	-	PUNCT
aji-167	140	14	regulating	regulating	NOUN
aji-167	140	15	,	,	PUNCT
aji-167	140	16	as	as	SCONJ
aji-167	140	17	il-10	il-10	PRON
aji-167	140	18	appears	appear	VERB
aji-167	140	19	to	to	PART
aji-167	140	20	be	be	AUX
aji-167	140	21	a	a	DET
aji-167	140	22	potent	potent	ADJ
aji-167	140	23	negative	negative	ADJ
aji-167	140	24	feedback	feedback	NOUN
aji-167	140	25	regulator	regulator	NOUN
aji-167	140	26	that	that	PRON
aji-167	140	27	influences	influence	VERB
aji-167	140	28	inflammation	inflammation	ADJ
aji-167	140	29	management	management	NOUN
aji-167	140	30	and	and	CCONJ
aji-167	140	31	resolution	resolution	NOUN
aji-167	140	32	(	(	PUNCT
aji-167	140	33	al	al	PROPN
aji-167	140	34	-	-	PUNCT
aji-167	140	35	qahtani	qahtani	PROPN
aji-167	140	36	et	et	PROPN
aji-167	140	37	al	al	PROPN
aji-167	140	38	.	.	PROPN
aji-167	140	39	,	,	PUNCT
aji-167	140	40	2024	2024	NUM
aji-167	140	41	;	;	PUNCT
aji-167	140	42	steen	steen	PROPN
aji-167	140	43	et	et	PROPN
aji-167	140	44	al	al	PROPN
aji-167	140	45	.	.	PROPN
aji-167	140	46	,	,	PUNCT
aji-167	140	47	2020	2020	NUM
aji-167	140	48	)	)	PUNCT
aji-167	140	49	.	.	PUNCT
aji-167	141	1	by	by	ADP
aji-167	141	2	suppressing	suppress	VERB
aji-167	141	3	the	the	DET
aji-167	141	4	activity	activity	NOUN
aji-167	141	5	of	of	ADP
aji-167	141	6	macrophages	macrophage	NOUN
aji-167	141	7	and	and	CCONJ
aji-167	141	8	dendritic	dendritic	ADJ
aji-167	141	9	cells	cell	NOUN
aji-167	141	10	,	,	PUNCT
aji-167	141	11	il-10	il-10	PRON
aji-167	141	12	directly	directly	ADV
aji-167	141	13	shuts	shut	VERB
aji-167	141	14	down	down	ADP
aji-167	141	15	the	the	DET
aji-167	141	16	inflammatory	inflammatory	ADJ
aji-167	141	17	immune	immune	ADJ
aji-167	141	18	response	response	NOUN
aji-167	141	19	(	(	PUNCT
aji-167	141	20	cocea	cocea	NOUN
aji-167	141	21	and	and	CCONJ
aji-167	141	22	stoica	stoica	ADJ
aji-167	141	23	,	,	PUNCT
aji-167	141	24	2024	2024	NUM
aji-167	141	25	;	;	PUNCT
aji-167	141	26	saraiva	saraiva	NOUN
aji-167	141	27	et	et	PROPN
aji-167	141	28	al	al	PROPN
aji-167	141	29	.	.	PROPN
aji-167	141	30	,	,	PUNCT
aji-167	141	31	2020	2020	NUM
aji-167	141	32	;	;	PUNCT
aji-167	141	33	mittal	mittal	PROPN
aji-167	141	34	et	et	PROPN
aji-167	141	35	al	al	PROPN
aji-167	141	36	.	.	PROPN
aji-167	141	37	,	,	PUNCT
aji-167	141	38	2015	2015	NUM
aji-167	141	39	)	)	PUNCT
aji-167	141	40	.	.	PUNCT
aji-167	142	1	it	it	PRON
aji-167	142	2	also	also	ADV
aji-167	142	3	indirectly	indirectly	ADV
aji-167	142	4	does	do	VERB
aji-167	142	5	so	so	ADV
aji-167	142	6	by	by	ADP
aji-167	142	7	restricting	restrict	VERB
aji-167	142	8	t	t	NOUN
aji-167	142	9	cell	cell	NOUN
aji-167	142	10	activation	activation	NOUN
aji-167	142	11	,	,	PUNCT
aji-167	142	12	differentiation	differentiation	NOUN
aji-167	142	13	,	,	PUNCT
aji-167	142	14	and	and	CCONJ
aji-167	142	15	effector	effector	NOUN
aji-167	142	16	function	function	NOUN
aji-167	142	17	and	and	CCONJ
aji-167	142	18	encouraging	encourage	VERB
aji-167	142	19	peripheral	peripheral	ADJ
aji-167	142	20	tolerance	tolerance	NOUN
aji-167	142	21	(	(	PUNCT
aji-167	142	22	saraiva	saraiva	NOUN
aji-167	142	23	et	et	PROPN
aji-167	142	24	al	al	PROPN
aji-167	142	25	.	.	PROPN
aji-167	142	26	,	,	PUNCT
aji-167	142	27	ehiaghe	ehiaghe	PROPN
aji-167	142	28	et	et	PROPN
aji-167	142	29	al	al	PROPN
aji-167	142	30	.	.	PROPN
aji-167	142	31	;	;	PUNCT
aji-167	143	1	asian	asian	PROPN
aji-167	143	2	j.	j.	PROPN
aji-167	143	3	immunol	immunol	PROPN
aji-167	143	4	.	.	PROPN
aji-167	143	5	,	,	PUNCT
aji-167	143	6	vol	vol	NOUN
aji-167	143	7	.	.	PROPN
aji-167	143	8	8	8	NUM
aji-167	143	9	,	,	PUNCT
aji-167	143	10	no	no	INTJ
aji-167	143	11	.	.	NOUN
aji-167	143	12	1	1	NUM
aji-167	143	13	,	,	PUNCT
aji-167	143	14	pp	pp	ADJ
aji-167	143	15	.	.	PUNCT
aji-167	144	1	134	134	NUM
aji-167	144	2	-	-	SYM
aji-167	144	3	141	141	NUM
aji-167	144	4	,	,	PUNCT
aji-167	144	5	2025	2025	NUM
aji-167	144	6	;	;	PUNCT
aji-167	144	7	article	article	NOUN
aji-167	144	8	no.aji.137461	no.aji.137461	ADV
aji-167	144	9	136	136	NUM
aji-167	144	10	2020	2020	NUM
aji-167	144	11	;	;	PUNCT
aji-167	144	12	mittal	mittal	PROPN
aji-167	144	13	et	et	PROPN
aji-167	144	14	al	al	PROPN
aji-167	144	15	.	.	PROPN
aji-167	144	16	,	,	PUNCT
aji-167	144	17	2015	2015	NUM
aji-167	144	18	)	)	PUNCT
aji-167	144	19	.	.	PUNCT
aji-167	145	1	excessive	excessive	ADJ
aji-167	145	2	il-10	il-10	DET
aji-167	145	3	production	production	NOUN
aji-167	145	4	or	or	CCONJ
aji-167	145	5	signaling	signal	VERB
aji-167	145	6	can	can	AUX
aji-167	145	7	suppress	suppress	VERB
aji-167	145	8	host	host	NOUN
aji-167	145	9	's	's	PART
aji-167	145	10	effective	effective	ADJ
aji-167	145	11	inflammatory	inflammatory	ADJ
aji-167	145	12	responses	response	NOUN
aji-167	145	13	,	,	PUNCT
aji-167	145	14	induce	induce	VERB
aji-167	145	15	tolerance	tolerance	NOUN
aji-167	145	16	and	and	CCONJ
aji-167	145	17	immune	immune	ADJ
aji-167	145	18	escape	escape	NOUN
aji-167	145	19	,	,	PUNCT
aji-167	145	20	and	and	CCONJ
aji-167	145	21	favor	favor	VERB
aji-167	145	22	microbial	microbial	ADJ
aji-167	145	23	persistence	persistence	NOUN
aji-167	145	24	,	,	PUNCT
aji-167	145	25	which	which	PRON
aji-167	145	26	can	can	AUX
aji-167	145	27	lead	lead	VERB
aji-167	145	28	to	to	ADP
aji-167	145	29	the	the	DET
aji-167	145	30	establishment	establishment	NOUN
aji-167	145	31	of	of	ADP
aji-167	145	32	chronic	chronic	ADJ
aji-167	145	33	or	or	CCONJ
aji-167	145	34	latent	latent	NOUN
aji-167	145	35	infections	infection	NOUN
aji-167	145	36	(	(	PUNCT
aji-167	145	37	carlini	carlini	PROPN
aji-167	145	38	et	et	PROPN
aji-167	145	39	al	al	PROPN
aji-167	145	40	.	.	PROPN
aji-167	145	41	,	,	PUNCT
aji-167	145	42	2023	2023	NUM
aji-167	145	43	;	;	PUNCT
aji-167	145	44	rojas	rojas	PROPN
aji-167	145	45	et	et	PROPN
aji-167	145	46	al	al	PROPN
aji-167	145	47	.	.	PROPN
aji-167	145	48	,	,	PUNCT
aji-167	145	49	2017	2017	NUM
aji-167	145	50	;	;	PUNCT
aji-167	145	51	iyer	iyer	PROPN
aji-167	145	52	and	and	CCONJ
aji-167	145	53	cheng	cheng	PROPN
aji-167	145	54	,	,	PUNCT
aji-167	145	55	2012	2012	NUM
aji-167	145	56	)	)	PUNCT
aji-167	145	57	.	.	PUNCT
aji-167	146	1	in	in	ADP
aji-167	146	2	contrast	contrast	NOUN
aji-167	146	3	,	,	PUNCT
aji-167	146	4	during	during	ADP
aji-167	146	5	acute	acute	ADJ
aji-167	146	6	infections	infection	NOUN
aji-167	146	7	,	,	PUNCT
aji-167	146	8	il-10	il-10	PRON
aji-167	146	9	limits	limit	VERB
aji-167	146	10	the	the	DET
aji-167	146	11	magnitude	magnitude	NOUN
aji-167	146	12	of	of	ADP
aji-167	146	13	the	the	DET
aji-167	146	14	immune	immune	ADJ
aji-167	146	15	responses	response	NOUN
aji-167	146	16	,	,	PUNCT
aji-167	146	17	preventing	prevent	VERB
aji-167	146	18	excessive	excessive	ADJ
aji-167	146	19	inflammation	inflammation	NOUN
aji-167	146	20	and	and	CCONJ
aji-167	146	21	protecting	protect	VERB
aji-167	146	22	tissues	tissue	NOUN
aji-167	146	23	from	from	ADP
aji-167	146	24	immune	immune	NOUN
aji-167	146	25	-	-	PUNCT
aji-167	146	26	mediated	mediate	VERB
aji-167	146	27	damage	damage	NOUN
aji-167	146	28	by	by	ADP
aji-167	146	29	allowing	allow	VERB
aji-167	146	30	inflammation	inflammation	ADJ
aji-167	146	31	resolution	resolution	NOUN
aji-167	146	32	when	when	SCONJ
aji-167	146	33	the	the	DET
aji-167	146	34	pathogen	pathogen	NOUN
aji-167	146	35	is	be	AUX
aji-167	146	36	cleared	clear	VERB
aji-167	146	37	(	(	PUNCT
aji-167	146	38	carlini	carlini	PROPN
aji-167	146	39	et	et	PROPN
aji-167	146	40	al	al	PROPN
aji-167	146	41	.	.	PROPN
aji-167	146	42	,	,	PUNCT
aji-167	146	43	2023	2023	NUM
aji-167	146	44	;	;	PUNCT
aji-167	146	45	rojas	rojas	PROPN
aji-167	146	46	et	et	PROPN
aji-167	146	47	al	al	PROPN
aji-167	146	48	.	.	PROPN
aji-167	146	49	,	,	PUNCT
aji-167	146	50	2017	2017	NUM
aji-167	146	51	)	)	PUNCT
aji-167	146	52	.	.	PUNCT
aji-167	147	1	nutritional	nutritional	ADJ
aji-167	147	2	deficiency	deficiency	NOUN
aji-167	147	3	has	have	AUX
aji-167	147	4	been	be	AUX
aji-167	147	5	associated	associate	VERB
aji-167	147	6	with	with	ADP
aji-167	147	7	an	an	DET
aji-167	147	8	increased	increase	VERB
aji-167	147	9	risk	risk	NOUN
aji-167	147	10	of	of	ADP
aji-167	147	11	wound	wound	NOUN
aji-167	147	12	infections	infection	NOUN
aji-167	147	13	(	(	PUNCT
aji-167	147	14	tfaily	tfaily	ADV
aji-167	147	15	et	et	PROPN
aji-167	147	16	al	al	PROPN
aji-167	147	17	.	.	PROPN
aji-167	147	18	,	,	PUNCT
aji-167	147	19	2022	2022	NUM
aji-167	147	20	)	)	PUNCT
aji-167	147	21	and	and	CCONJ
aji-167	147	22	serum	serum	NOUN
aji-167	147	23	albumin	albumin	ADJ
aji-167	147	24	level	level	NOUN
aji-167	147	25	can	can	AUX
aji-167	147	26	be	be	AUX
aji-167	147	27	used	use	VERB
aji-167	147	28	to	to	PART
aji-167	147	29	determine	determine	VERB
aji-167	147	30	an	an	DET
aji-167	147	31	individual	individual	NOUN
aji-167	147	32	’s	’s	PART
aji-167	147	33	nutritional	nutritional	ADJ
aji-167	147	34	and	and	CCONJ
aji-167	147	35	inflammatory	inflammatory	ADJ
aji-167	147	36	condition	condition	NOUN
aji-167	147	37	(	(	PUNCT
aji-167	147	38	keller	keller	PROPN
aji-167	147	39	,	,	PUNCT
aji-167	147	40	2019	2019	NUM
aji-167	147	41	)	)	PUNCT
aji-167	147	42	.	.	PUNCT
aji-167	148	1	hypoalbuminemia	hypoalbuminemia	PROPN
aji-167	148	2	has	have	AUX
aji-167	148	3	been	be	AUX
aji-167	148	4	identified	identify	VERB
aji-167	148	5	as	as	ADP
aji-167	148	6	one	one	NUM
aji-167	148	7	of	of	ADP
aji-167	148	8	the	the	DET
aji-167	148	9	risk	risk	NOUN
aji-167	148	10	factors	factor	NOUN
aji-167	148	11	for	for	ADP
aji-167	148	12	surgical	surgical	ADJ
aji-167	148	13	site	site	NOUN
aji-167	148	14	infections	infection	NOUN
aji-167	148	15	(	(	PUNCT
aji-167	148	16	ssis	ssis	NOUN
aji-167	148	17	)	)	PUNCT
aji-167	148	18	in	in	ADP
aji-167	148	19	surgery	surgery	NOUN
aji-167	148	20	populations	population	NOUN
aji-167	148	21	(	(	PUNCT
aji-167	148	22	mostafa	mostafa	PROPN
aji-167	148	23	et	et	PROPN
aji-167	148	24	al	al	PROPN
aji-167	148	25	.	.	PROPN
aji-167	148	26	,	,	PUNCT
aji-167	148	27	2024	2024	NUM
aji-167	148	28	;	;	PUNCT
aji-167	148	29	ryan	ryan	PROPN
aji-167	148	30	et	et	PROPN
aji-167	148	31	al	al	PROPN
aji-167	148	32	.	.	PROPN
aji-167	148	33	,	,	PUNCT
aji-167	148	34	2018	2018	NUM
aji-167	148	35	)	)	PUNCT
aji-167	148	36	.	.	PUNCT
aji-167	149	1	hypoalbuminemia	hypoalbuminemia	PROPN
aji-167	149	2	,	,	PUNCT
aji-167	149	3	on	on	ADP
aji-167	149	4	the	the	DET
aji-167	149	5	other	other	ADJ
aji-167	149	6	hand	hand	NOUN
aji-167	149	7	,	,	PUNCT
aji-167	149	8	can	can	AUX
aji-167	149	9	increase	increase	VERB
aji-167	149	10	the	the	DET
aji-167	149	11	expression	expression	NOUN
aji-167	149	12	of	of	ADP
aji-167	149	13	tnfɑ	tnfɑ	NOUN
aji-167	149	14	,	,	PUNCT
aji-167	149	15	c	c	NOUN
aji-167	149	16	-	-	PUNCT
aji-167	149	17	reactive	reactive	ADJ
aji-167	149	18	protein	protein	NOUN
aji-167	149	19	(	(	PUNCT
aji-167	149	20	crp	crp	PROPN
aji-167	149	21	)	)	PUNCT
aji-167	149	22	and	and	CCONJ
aji-167	149	23	several	several	ADJ
aji-167	149	24	interleukins	interleukin	NOUN
aji-167	149	25	,	,	PUNCT
aji-167	149	26	all	all	PRON
aji-167	149	27	known	know	VERB
aji-167	149	28	to	to	PART
aji-167	149	29	be	be	AUX
aji-167	149	30	acute	acute	ADJ
aji-167	149	31	-	-	PUNCT
aji-167	149	32	phase	phase	NOUN
aji-167	149	33	proteins	protein	NOUN
aji-167	149	34	that	that	PRON
aji-167	149	35	promote	promote	VERB
aji-167	149	36	tissue	tissue	NOUN
aji-167	149	37	damage	damage	NOUN
aji-167	149	38	(	(	PUNCT
aji-167	149	39	cooper	cooper	NOUN
aji-167	149	40	et	et	PROPN
aji-167	149	41	al	al	PROPN
aji-167	149	42	.	.	PROPN
aji-167	149	43	,	,	PUNCT
aji-167	149	44	2004	2004	NUM
aji-167	149	45	;	;	PUNCT
aji-167	149	46	yildirim	yildirim	PROPN
aji-167	149	47	et	et	PROPN
aji-167	149	48	al	al	PROPN
aji-167	149	49	.	.	PROPN
aji-167	149	50	,	,	PUNCT
aji-167	149	51	2004	2004	NUM
aji-167	149	52	)	)	PUNCT
aji-167	149	53	.	.	PUNCT
aji-167	150	1	albumin	albumin	ADJ
aji-167	150	2	influences	influence	NOUN
aji-167	150	3	wound	wound	VERB
aji-167	150	4	healing	healing	NOUN
aji-167	150	5	by	by	ADP
aji-167	150	6	increasing	increase	VERB
aji-167	150	7	the	the	DET
aji-167	150	8	transcription	transcription	NOUN
aji-167	150	9	of	of	ADP
aji-167	150	10	tissue	tissue	NOUN
aji-167	150	11	-	-	PUNCT
aji-167	150	12	forming	form	VERB
aji-167	150	13	proteins	protein	NOUN
aji-167	150	14	,	,	PUNCT
aji-167	150	15	which	which	PRON
aji-167	150	16	in	in	ADP
aji-167	150	17	turn	turn	NOUN
aji-167	150	18	triggers	trigger	VERB
aji-167	150	19	the	the	DET
aji-167	150	20	nfkb	nfkb	PROPN
aji-167	150	21	pathway	pathway	NOUN
aji-167	150	22	and	and	CCONJ
aji-167	150	23	speeds	speed	VERB
aji-167	150	24	up	up	ADP
aji-167	150	25	the	the	DET
aji-167	150	26	healing	healing	NOUN
aji-167	150	27	process	process	NOUN
aji-167	150	28	(	(	PUNCT
aji-167	150	29	utariani	utariani	PROPN
aji-167	150	30	et	et	PROPN
aji-167	150	31	al	al	PROPN
aji-167	150	32	.	.	PROPN
aji-167	150	33	,	,	PUNCT
aji-167	150	34	2020	2020	NUM
aji-167	150	35	)	)	PUNCT
aji-167	150	36	.	.	PUNCT
aji-167	151	1	identifying	identify	VERB
aji-167	151	2	risk	risk	NOUN
aji-167	151	3	factors	factor	NOUN
aji-167	151	4	for	for	ADP
aji-167	151	5	surgical	surgical	ADJ
aji-167	151	6	site	site	NOUN
aji-167	151	7	infections	infection	NOUN
aji-167	151	8	early	early	ADV
aji-167	151	9	can	can	AUX
aji-167	151	10	improve	improve	VERB
aji-167	151	11	post	post	ADJ
aji-167	151	12	-	-	ADJ
aji-167	151	13	operative	operative	ADJ
aji-167	151	14	outcomes	outcome	NOUN
aji-167	151	15	,	,	PUNCT
aji-167	151	16	minimize	minimize	VERB
aji-167	151	17	re	re	NOUN
aji-167	151	18	-	-	NOUN
aji-167	151	19	admission	admission	NOUN
aji-167	151	20	rates	rate	NOUN
aji-167	151	21	(	(	PUNCT
aji-167	151	22	he	he	PRON
aji-167	151	23	et	et	PROPN
aji-167	151	24	al	al	PROPN
aji-167	151	25	.	.	PROPN
aji-167	151	26	,	,	PUNCT
aji-167	151	27	2019	2019	NUM
aji-167	151	28	;	;	PUNCT
aji-167	151	29	fong	fong	PROPN
aji-167	151	30	et	et	PROPN
aji-167	151	31	al	al	PROPN
aji-167	151	32	.	.	PROPN
aji-167	151	33	,	,	PUNCT
aji-167	151	34	2014	2014	NUM
aji-167	151	35	)	)	PUNCT
aji-167	151	36	,	,	PUNCT
aji-167	151	37	and	and	CCONJ
aji-167	151	38	reduce	reduce	VERB
aji-167	151	39	treatment	treatment	NOUN
aji-167	151	40	costs	cost	NOUN
aji-167	151	41	by	by	ADP
aji-167	151	42	23.8	23.8	NUM
aji-167	151	43	%	%	NOUN
aji-167	151	44	(	(	PUNCT
aji-167	151	45	javed	javed	PROPN
aji-167	151	46	et	et	PROPN
aji-167	151	47	al	al	PROPN
aji-167	151	48	.	.	PROPN
aji-167	151	49	,	,	PUNCT
aji-167	151	50	2019	2019	NUM
aji-167	151	51	)	)	PUNCT
aji-167	151	52	.	.	PUNCT
aji-167	152	1	in	in	ADP
aji-167	152	2	view	view	NOUN
aji-167	152	3	of	of	ADP
aji-167	152	4	all	all	DET
aji-167	152	5	these	these	PRON
aji-167	152	6	,	,	PUNCT
aji-167	152	7	it	it	PRON
aji-167	152	8	has	have	AUX
aji-167	152	9	become	become	VERB
aji-167	152	10	pertinent	pertinent	ADJ
aji-167	152	11	to	to	PART
aji-167	152	12	evaluate	evaluate	VERB
aji-167	152	13	the	the	DET
aji-167	152	14	serum	serum	NOUN
aji-167	152	15	levels	level	NOUN
aji-167	152	16	of	of	ADP
aji-167	152	17	tnf	tnf	PROPN
aji-167	152	18	-	-	PUNCT
aji-167	152	19	α	α	PROPN
aji-167	152	20	,	,	PUNCT
aji-167	152	21	il-10	il-10	NOUN
aji-167	152	22	and	and	CCONJ
aji-167	152	23	albumin	albumin	NOUN
aji-167	152	24	circulating	circulate	VERB
aji-167	152	25	among	among	ADP
aji-167	152	26	female	female	ADJ
aji-167	152	27	patients	patient	NOUN
aji-167	152	28	with	with	ADP
aji-167	152	29	post	post	ADJ
aji-167	152	30	-	-	ADJ
aji-167	152	31	surgical	surgical	ADJ
aji-167	152	32	wound	wound	NOUN
aji-167	152	33	infection	infection	NOUN
aji-167	152	34	in	in	ADP
aji-167	152	35	asaba	asaba	PROPN
aji-167	152	36	delta	delta	PROPN
aji-167	152	37	state	state	PROPN
aji-167	152	38	,	,	PUNCT
aji-167	152	39	nigeria	nigeria	PROPN
aji-167	152	40	.	.	PUNCT
aji-167	153	1	2	2	X
aji-167	153	2	.	.	X
aji-167	153	3	materials	material	NOUN
aji-167	153	4	and	and	CCONJ
aji-167	153	5	methods	method	NOUN
aji-167	153	6	2.1	2.1	NUM
aji-167	153	7	study	study	NOUN
aji-167	153	8	site	site	NOUN
aji-167	153	9	the	the	DET
aji-167	153	10	study	study	NOUN
aji-167	153	11	was	be	AUX
aji-167	153	12	conducted	conduct	VERB
aji-167	153	13	at	at	ADP
aji-167	153	14	the	the	DET
aji-167	153	15	federal	federal	ADJ
aji-167	153	16	medical	medical	ADJ
aji-167	153	17	center	center	NOUN
aji-167	153	18	in	in	ADP
aji-167	153	19	asaba	asaba	NOUN
aji-167	153	20	,	,	PUNCT
aji-167	153	21	delta	delta	NOUN
aji-167	153	22	state	state	PROPN
aji-167	153	23	,	,	PUNCT
aji-167	153	24	nigeria	nigeria	PROPN
aji-167	153	25	.	.	PUNCT
aji-167	154	1	2.2	2.2	NUM
aji-167	154	2	study	study	NOUN
aji-167	154	3	design	design	NOUN
aji-167	154	4	this	this	DET
aji-167	154	5	cross	cross	ADJ
aji-167	154	6	-	-	ADJ
aji-167	154	7	sectional	sectional	ADJ
aji-167	154	8	study	study	NOUN
aji-167	154	9	examined	examine	VERB
aji-167	154	10	the	the	DET
aji-167	154	11	serum	serum	NOUN
aji-167	154	12	levels	level	NOUN
aji-167	154	13	of	of	ADP
aji-167	154	14	tumor	tumor	NOUN
aji-167	154	15	necrosis	necrosis	NOUN
aji-167	154	16	factor	factor	NOUN
aji-167	154	17	-	-	PUNCT
aji-167	154	18	alpha	alpha	NOUN
aji-167	154	19	,	,	PUNCT
aji-167	154	20	interleukin10	interleukin10	NOUN
aji-167	154	21	,	,	PUNCT
aji-167	154	22	and	and	CCONJ
aji-167	154	23	albumin	albumin	NOUN
aji-167	154	24	in	in	ADP
aji-167	154	25	female	female	ADJ
aji-167	154	26	patients	patient	NOUN
aji-167	154	27	with	with	ADP
aji-167	154	28	postsurgical	postsurgical	ADJ
aji-167	154	29	wound	wound	NOUN
aji-167	154	30	infection	infection	NOUN
aji-167	154	31	in	in	ADP
aji-167	154	32	asaba	asaba	NOUN
aji-167	154	33	,	,	PUNCT
aji-167	154	34	nigeria	nigeria	PROPN
aji-167	154	35	.	.	PUNCT
aji-167	155	1	2.3	2.3	NUM
aji-167	155	2	study	study	NOUN
aji-167	155	3	population	population	NOUN
aji-167	155	4	simple	simple	ADJ
aji-167	155	5	random	random	ADJ
aji-167	155	6	sampling	sampling	NOUN
aji-167	155	7	was	be	AUX
aji-167	155	8	used	use	VERB
aji-167	155	9	to	to	PART
aji-167	155	10	select	select	VERB
aji-167	155	11	50	50	NUM
aji-167	155	12	participants	participant	NOUN
aji-167	155	13	for	for	ADP
aji-167	155	14	the	the	DET
aji-167	155	15	study	study	NOUN
aji-167	155	16	.	.	PUNCT
aji-167	156	1	the	the	DET
aji-167	156	2	test	test	NOUN
aji-167	156	3	group	group	NOUN
aji-167	156	4	consisted	consist	VERB
aji-167	156	5	of	of	ADP
aji-167	156	6	25	25	NUM
aji-167	156	7	female	female	ADJ
aji-167	156	8	patients	patient	NOUN
aji-167	156	9	with	with	ADP
aji-167	156	10	post	post	ADJ
aji-167	156	11	-	-	ADJ
aji-167	156	12	surgical	surgical	ADJ
aji-167	156	13	wound	wound	NOUN
aji-167	156	14	infection	infection	NOUN
aji-167	156	15	,	,	PUNCT
aji-167	156	16	while	while	SCONJ
aji-167	156	17	the	the	DET
aji-167	156	18	control	control	NOUN
aji-167	156	19	group	group	NOUN
aji-167	156	20	included	include	VERB
aji-167	156	21	25	25	NUM
aji-167	156	22	apparently	apparently	ADV
aji-167	156	23	healthy	healthy	ADJ
aji-167	156	24	participants	participant	NOUN
aji-167	156	25	.	.	PUNCT
aji-167	157	1	2.4	2.4	NUM
aji-167	157	2	sample	sample	NOUN
aji-167	157	3	size	size	NOUN
aji-167	157	4	and	and	CCONJ
aji-167	157	5	sample	sample	NOUN
aji-167	157	6	size	size	NOUN
aji-167	157	7	calculation	calculation	NOUN
aji-167	157	8	the	the	DET
aji-167	157	9	sample	sample	NOUN
aji-167	157	10	size	size	NOUN
aji-167	157	11	(	(	PUNCT
aji-167	157	12	n	n	CCONJ
aji-167	157	13	)	)	PUNCT
aji-167	157	14	was	be	AUX
aji-167	157	15	calculated	calculate	VERB
aji-167	157	16	using	use	VERB
aji-167	157	17	prevalence	prevalence	NOUN
aji-167	157	18	from	from	ADP
aji-167	157	19	previous	previous	ADJ
aji-167	157	20	studies	study	NOUN
aji-167	157	21	on	on	ADP
aji-167	157	22	the	the	DET
aji-167	157	23	prevalence	prevalence	NOUN
aji-167	157	24	of	of	ADP
aji-167	157	25	post	post	ADJ
aji-167	157	26	-	-	ADJ
aji-167	157	27	surgical	surgical	ADJ
aji-167	157	28	wound	wound	NOUN
aji-167	157	29	infections	infection	NOUN
aji-167	157	30	globally	globally	ADV
aji-167	157	31	which	which	PRON
aji-167	157	32	was	be	AUX
aji-167	157	33	found	find	VERB
aji-167	157	34	to	to	PART
aji-167	157	35	be	be	AUX
aji-167	157	36	2.5	2.5	NUM
aji-167	157	37	%	%	NOUN
aji-167	157	38	(	(	PUNCT
aji-167	157	39	mengistu	mengistu	PROPN
aji-167	157	40	et	et	PROPN
aji-167	157	41	al	al	PROPN
aji-167	157	42	.	.	PROPN
aji-167	157	43	,	,	PUNCT
aji-167	157	44	2023	2023	NUM
aji-167	157	45	)	)	PUNCT
aji-167	157	46	according	accord	VERB
aji-167	157	47	to	to	ADP
aji-167	157	48	the	the	DET
aji-167	157	49	sample	sample	NOUN
aji-167	157	50	size	size	NOUN
aji-167	157	51	calculation	calculation	NOUN
aji-167	157	52	formula	formula	NOUN
aji-167	157	53	described	describe	VERB
aji-167	157	54	by	by	ADP
aji-167	157	55	daniel	daniel	PROPN
aji-167	157	56	and	and	CCONJ
aji-167	157	57	cross	cross	PROPN
aji-167	157	58	(	(	PUNCT
aji-167	157	59	1999	1999	NUM
aji-167	157	60	)	)	PUNCT
aji-167	157	61	.	.	PUNCT
aji-167	158	1	𝑁	𝑁	PROPN
aji-167	158	2	=	=	PUNCT
aji-167	158	3	𝑍2𝑃(1	𝑍2𝑃(1	NOUN
aji-167	158	4	–	–	PUNCT
aji-167	158	5	𝑃	𝑃	NOUN
aji-167	158	6	)	)	PUNCT
aji-167	158	7	𝐷2	𝐷2	NOUN
aji-167	158	8	n	n	NOUN
aji-167	158	9	=	=	NUM
aji-167	158	10	required	require	VERB
aji-167	158	11	sample	sample	NOUN
aji-167	158	12	size	size	NOUN
aji-167	158	13	z	z	NOUN
aji-167	158	14	=	=	NOUN
aji-167	158	15	confidence	confidence	NOUN
aji-167	158	16	level	level	NOUN
aji-167	158	17	at	at	ADP
aji-167	158	18	95	95	NUM
aji-167	158	19	%	%	NOUN
aji-167	158	20	(	(	PUNCT
aji-167	158	21	standard	standard	ADJ
aji-167	158	22	value	value	NOUN
aji-167	158	23	of	of	ADP
aji-167	158	24	1.96	1.96	NUM
aji-167	158	25	)	)	PUNCT
aji-167	159	1	p	p	NOUN
aji-167	159	2	=	=	PUNCT
aji-167	159	3	estimated	estimate	VERB
aji-167	159	4	prevalence	prevalence	NOUN
aji-167	159	5	of	of	ADP
aji-167	159	6	post	post	ADJ
aji-167	159	7	-	-	ADJ
aji-167	159	8	surgical	surgical	ADJ
aji-167	159	9	wound	wound	NOUN
aji-167	159	10	infections	infection	NOUN
aji-167	159	11	globally	globally	ADV
aji-167	159	12	which	which	PRON
aji-167	159	13	was	be	AUX
aji-167	159	14	found	find	VERB
aji-167	159	15	to	to	PART
aji-167	159	16	be	be	AUX
aji-167	159	17	2.5	2.5	NUM
aji-167	159	18	%	%	NOUN
aji-167	159	19	(	(	PUNCT
aji-167	159	20	mengistu	mengistu	PROPN
aji-167	159	21	et	et	PROPN
aji-167	159	22	al	al	PROPN
aji-167	159	23	.	.	PROPN
aji-167	159	24	,	,	PUNCT
aji-167	159	25	2023	2023	NUM
aji-167	159	26	)	)	PUNCT
aji-167	159	27	.	.	PUNCT
aji-167	160	1	d	d	NOUN
aji-167	160	2	=	=	PUNCT
aji-167	160	3	margin	margin	NOUN
aji-167	160	4	of	of	ADP
aji-167	160	5	error	error	NOUN
aji-167	160	6	at	at	ADP
aji-167	160	7	5	5	NUM
aji-167	160	8	%	%	NOUN
aji-167	160	9	(	(	PUNCT
aji-167	160	10	standard	standard	ADJ
aji-167	160	11	value	value	NOUN
aji-167	160	12	=	=	NOUN
aji-167	160	13	0.05	0.05	NUM
aji-167	160	14	)	)	PUNCT
aji-167	160	15	𝑁	𝑁	PROPN
aji-167	160	16	=	=	SYM
aji-167	160	17	1.9620.025(1	1.9620.025(1	NUM
aji-167	160	18	−	−	ADP
aji-167	160	19	0.025	0.025	NUM
aji-167	160	20	)	)	PUNCT
aji-167	160	21	0.052	0.052	NUM
aji-167	161	1	3.8416	3.8416	NUM
aji-167	161	2	𝑋	𝑋	PROPN
aji-167	161	3	0.025(0.975	0.025(0.975	NOUN
aji-167	161	4	)	)	PUNCT
aji-167	161	5	0.0025	0.0025	NUM
aji-167	161	6	n	n	NOUN
aji-167	161	7	=	=	SYM
aji-167	161	8	37	37	NUM
aji-167	161	9	minimum	minimum	NOUN
aji-167	161	10	sample	sample	NOUN
aji-167	161	11	size	size	NOUN
aji-167	161	12	therefore	therefore	ADV
aji-167	161	13	,	,	PUNCT
aji-167	161	14	a	a	DET
aji-167	161	15	minimum	minimum	NOUN
aji-167	161	16	of	of	ADP
aji-167	161	17	50	50	NUM
aji-167	161	18	participants	participant	NOUN
aji-167	161	19	was	be	AUX
aji-167	161	20	used	use	VERB
aji-167	161	21	for	for	ADP
aji-167	161	22	this	this	DET
aji-167	161	23	study	study	NOUN
aji-167	161	24	.	.	PUNCT
aji-167	162	1	2.5	2.5	NUM
aji-167	162	2	inclusion	inclusion	NOUN
aji-167	162	3	criteria	criterion	NOUN
aji-167	162	4	female	female	ADJ
aji-167	162	5	patients	patient	NOUN
aji-167	162	6	with	with	ADP
aji-167	162	7	confirmed	confirm	VERB
aji-167	162	8	cases	case	NOUN
aji-167	162	9	of	of	ADP
aji-167	162	10	postsurgical	postsurgical	ADJ
aji-167	162	11	wound	wound	NOUN
aji-167	162	12	infection	infection	NOUN
aji-167	162	13	as	as	ADV
aji-167	162	14	well	well	ADV
aji-167	162	15	as	as	ADP
aji-167	162	16	healthy	healthy	ADJ
aji-167	162	17	female	female	ADJ
aji-167	162	18	participants	participant	NOUN
aji-167	162	19	who	who	PRON
aji-167	162	20	provided	provide	VERB
aji-167	162	21	informed	informed	ADJ
aji-167	162	22	consent	consent	NOUN
aji-167	162	23	were	be	AUX
aji-167	162	24	included	include	VERB
aji-167	162	25	for	for	ADP
aji-167	162	26	this	this	DET
aji-167	162	27	study	study	NOUN
aji-167	162	28	.	.	PUNCT
aji-167	163	1	2.6	2.6	NUM
aji-167	163	2	exclusion	exclusion	NOUN
aji-167	163	3	criteria	criterion	NOUN
aji-167	163	4	female	female	ADJ
aji-167	163	5	patients	patient	NOUN
aji-167	163	6	with	with	ADP
aji-167	163	7	post	post	ADJ
aji-167	163	8	-	-	ADJ
aji-167	163	9	surgical	surgical	ADJ
aji-167	163	10	wound	wound	NOUN
aji-167	163	11	infection	infection	NOUN
aji-167	163	12	and	and	CCONJ
aji-167	163	13	apparently	apparently	ADV
aji-167	163	14	healthy	healthy	ADJ
aji-167	163	15	female	female	ADJ
aji-167	163	16	individuals	individual	NOUN
aji-167	163	17	without	without	ADP
aji-167	163	18	post	post	ADJ
aji-167	163	19	-	-	ADJ
aji-167	163	20	surgical	surgical	ADJ
aji-167	163	21	wound	wound	NOUN
aji-167	163	22	infection	infection	NOUN
aji-167	163	23	ehiaghe	ehiaghe	PROPN
aji-167	163	24	et	et	PROPN
aji-167	163	25	al	al	PROPN
aji-167	163	26	.	.	PROPN
aji-167	163	27	;	;	PUNCT
aji-167	163	28	asian	asian	PROPN
aji-167	163	29	j.	j.	PROPN
aji-167	163	30	immunol	immunol	PROPN
aji-167	163	31	.	.	PROPN
aji-167	163	32	,	,	PUNCT
aji-167	163	33	vol	vol	NOUN
aji-167	163	34	.	.	PROPN
aji-167	163	35	8	8	NUM
aji-167	163	36	,	,	PUNCT
aji-167	163	37	no	no	INTJ
aji-167	163	38	.	.	NOUN
aji-167	163	39	1	1	NUM
aji-167	163	40	,	,	PUNCT
aji-167	163	41	pp	pp	ADJ
aji-167	163	42	.	.	PUNCT
aji-167	164	1	134	134	NUM
aji-167	164	2	-	-	SYM
aji-167	164	3	141	141	NUM
aji-167	164	4	,	,	PUNCT
aji-167	164	5	2025	2025	NUM
aji-167	164	6	;	;	PUNCT
aji-167	164	7	article	article	NOUN
aji-167	164	8	no.aji.137461	no.aji.137461	VERB
aji-167	164	9	137	137	NUM
aji-167	164	10	who	who	PRON
aji-167	164	11	did	do	AUX
aji-167	164	12	not	not	PART
aji-167	164	13	give	give	VERB
aji-167	164	14	their	their	PRON
aji-167	164	15	informed	inform	VERB
aji-167	164	16	consent	consent	NOUN
aji-167	164	17	were	be	AUX
aji-167	164	18	excluded	exclude	VERB
aji-167	164	19	from	from	ADP
aji-167	164	20	this	this	DET
aji-167	164	21	study	study	NOUN
aji-167	164	22	.	.	PUNCT
aji-167	165	1	2.7	2.7	NUM
aji-167	165	2	sample	sample	NOUN
aji-167	165	3	collection	collection	NOUN
aji-167	165	4	each	each	DET
aji-167	165	5	participant	participant	NOUN
aji-167	165	6	provided	provide	VERB
aji-167	165	7	five	five	NUM
aji-167	165	8	milliliters	milliliter	NOUN
aji-167	165	9	(	(	PUNCT
aji-167	165	10	5	5	NUM
aji-167	165	11	ml	ml	NOUN
aji-167	165	12	)	)	PUNCT
aji-167	165	13	of	of	ADP
aji-167	165	14	venous	venous	ADJ
aji-167	165	15	blood	blood	NOUN
aji-167	165	16	into	into	ADP
aji-167	165	17	a	a	DET
aji-167	165	18	plain	plain	ADJ
aji-167	165	19	container	container	NOUN
aji-167	165	20	for	for	ADP
aji-167	165	21	cytokine	cytokine	NOUN
aji-167	165	22	and	and	CCONJ
aji-167	165	23	albumin	albumin	ADJ
aji-167	165	24	analysis	analysis	NOUN
aji-167	165	25	.	.	PUNCT
aji-167	166	1	blood	blood	NOUN
aji-167	166	2	samples	sample	NOUN
aji-167	166	3	were	be	AUX
aji-167	166	4	allowed	allow	VERB
aji-167	166	5	to	to	PART
aji-167	166	6	clot	clot	VERB
aji-167	166	7	before	before	ADP
aji-167	166	8	being	be	AUX
aji-167	166	9	retracted	retract	VERB
aji-167	166	10	and	and	CCONJ
aji-167	166	11	centrifuged	centrifuge	VERB
aji-167	166	12	for	for	ADP
aji-167	166	13	10	10	NUM
aji-167	166	14	minutes	minute	NOUN
aji-167	166	15	at	at	ADP
aji-167	166	16	4000	4000	NUM
aji-167	166	17	rpm	rpm	NOUN
aji-167	166	18	.	.	PUNCT
aji-167	167	1	serum	serum	NOUN
aji-167	167	2	samples	sample	NOUN
aji-167	167	3	were	be	AUX
aji-167	167	4	separated	separate	VERB
aji-167	167	5	and	and	CCONJ
aji-167	167	6	kept	keep	VERB
aji-167	167	7	frozen	freeze	VERB
aji-167	167	8	at	at	ADP
aji-167	167	9	20	20	NUM
aji-167	167	10	°	°	NOUN
aji-167	167	11	c	c	NOUN
aji-167	167	12	until	until	ADP
aji-167	167	13	analysis	analysis	NOUN
aji-167	167	14	.	.	PUNCT
aji-167	168	1	2.8	2.8	NUM
aji-167	168	2	estimation	estimation	NOUN
aji-167	168	3	of	of	ADP
aji-167	168	4	cytokine	cytokine	ADJ
aji-167	168	5	levels	level	NOUN
aji-167	168	6	the	the	DET
aji-167	168	7	levels	level	NOUN
aji-167	168	8	of	of	ADP
aji-167	168	9	tumor	tumor	NOUN
aji-167	168	10	necrosis	necrosis	NOUN
aji-167	168	11	factor	factor	NOUN
aji-167	168	12	-	-	PUNCT
aji-167	168	13	alpha	alpha	NOUN
aji-167	168	14	and	and	CCONJ
aji-167	168	15	interleukin-10	interleukin-10	PROPN
aji-167	168	16	were	be	AUX
aji-167	168	17	determined	determine	VERB
aji-167	168	18	using	use	VERB
aji-167	168	19	the	the	DET
aji-167	168	20	sandwich	sandwich	NOUN
aji-167	168	21	enzyme	enzyme	NOUN
aji-167	168	22	-	-	PUNCT
aji-167	168	23	linked	link	VERB
aji-167	168	24	immunosorbent	immunosorbent	ADJ
aji-167	168	25	assay	assay	NOUN
aji-167	168	26	technique	technique	NOUN
aji-167	168	27	.	.	PUNCT
aji-167	169	1	2.9	2.9	NUM
aji-167	169	2	estimation	estimation	NOUN
aji-167	169	3	of	of	ADP
aji-167	169	4	serum	serum	NOUN
aji-167	169	5	albumin	albumin	NOUN
aji-167	169	6	this	this	PRON
aji-167	169	7	was	be	AUX
aji-167	169	8	determined	determine	VERB
aji-167	169	9	using	use	VERB
aji-167	169	10	the	the	DET
aji-167	169	11	bromocresol	bromocresol	ADJ
aji-167	169	12	green	green	ADJ
aji-167	169	13	method	method	NOUN
aji-167	169	14	(	(	PUNCT
aji-167	169	15	bcg	bcg	PROPN
aji-167	169	16	)	)	PUNCT
aji-167	169	17	,	,	PUNCT
aji-167	169	18	as	as	SCONJ
aji-167	169	19	described	describe	VERB
aji-167	169	20	by	by	ADP
aji-167	169	21	doumas	doumas	PROPN
aji-167	169	22	and	and	CCONJ
aji-167	169	23	watson	watson	PROPN
aji-167	169	24	(	(	PUNCT
aji-167	169	25	1971	1971	NUM
aji-167	169	26	)	)	PUNCT
aji-167	169	27	and	and	CCONJ
aji-167	169	28	cited	cite	VERB
aji-167	169	29	by	by	ADP
aji-167	169	30	okpogba	okpogba	PROPN
aji-167	169	31	et	et	PROPN
aji-167	169	32	al	al	PROPN
aji-167	169	33	.	.	PROPN
aji-167	170	1	(	(	PUNCT
aji-167	170	2	2021	2021	NUM
aji-167	170	3	)	)	PUNCT
aji-167	170	4	.	.	PUNCT
aji-167	171	1	2.10	2.10	NUM
aji-167	171	2	statistical	statistical	ADJ
aji-167	171	3	analysis	analysis	NOUN
aji-167	171	4	the	the	DET
aji-167	171	5	data	datum	NOUN
aji-167	171	6	was	be	AUX
aji-167	171	7	analyzed	analyze	VERB
aji-167	171	8	using	use	VERB
aji-167	171	9	spss	spss	PROPN
aji-167	171	10	20.0	20.0	NUM
aji-167	171	11	and	and	CCONJ
aji-167	171	12	represented	represent	VERB
aji-167	171	13	as	as	ADP
aji-167	171	14	mean	mean	NOUN
aji-167	171	15	±	±	NUM
aji-167	171	16	standard	standard	ADJ
aji-167	171	17	deviation	deviation	NOUN
aji-167	171	18	.	.	PUNCT
aji-167	172	1	the	the	DET
aji-167	172	2	independent	independent	ADJ
aji-167	172	3	t	t	PROPN
aji-167	172	4	-	-	PUNCT
aji-167	172	5	test	test	NOUN
aji-167	172	6	and	and	CCONJ
aji-167	172	7	pearson	pearson	PROPN
aji-167	172	8	correlation	correlation	NOUN
aji-167	172	9	were	be	AUX
aji-167	172	10	employed	employ	VERB
aji-167	172	11	to	to	PART
aji-167	172	12	determine	determine	VERB
aji-167	172	13	the	the	DET
aji-167	172	14	statistical	statistical	ADJ
aji-167	172	15	difference	difference	NOUN
aji-167	172	16	and	and	CCONJ
aji-167	172	17	association	association	NOUN
aji-167	172	18	between	between	ADP
aji-167	172	19	variables	variable	NOUN
aji-167	172	20	.	.	PUNCT
aji-167	173	1	a	a	DET
aji-167	173	2	p	p	NOUN
aji-167	173	3	value	value	NOUN
aji-167	173	4	of	of	ADP
aji-167	173	5	<	<	X
aji-167	173	6	0.05	0.05	NUM
aji-167	173	7	was	be	AUX
aji-167	173	8	considered	consider	VERB
aji-167	173	9	statistically	statistically	ADV
aji-167	173	10	significant	significant	ADJ
aji-167	173	11	.	.	PUNCT
aji-167	174	1	3	3	X
aji-167	174	2	.	.	X
aji-167	174	3	results	result	VERB
aji-167	174	4	the	the	DET
aji-167	174	5	mean	mean	NOUN
aji-167	174	6	serum	serum	PROPN
aji-167	174	7	tnf	tnf	PROPN
aji-167	174	8	-	-	PUNCT
aji-167	174	9	α	α	PROPN
aji-167	174	10	level	level	NOUN
aji-167	174	11	was	be	AUX
aji-167	174	12	significantly	significantly	ADV
aji-167	174	13	higher	high	ADJ
aji-167	174	14	in	in	ADP
aji-167	174	15	the	the	DET
aji-167	174	16	female	female	ADJ
aji-167	174	17	patients	patient	NOUN
aji-167	174	18	with	with	ADP
aji-167	174	19	post	post	ADJ
aji-167	174	20	-	-	ADJ
aji-167	174	21	surgical	surgical	ADJ
aji-167	174	22	wound	wound	NOUN
aji-167	174	23	infections	infection	NOUN
aji-167	174	24	than	than	ADP
aji-167	174	25	in	in	ADP
aji-167	174	26	the	the	DET
aji-167	174	27	control	control	NOUN
aji-167	174	28	group	group	NOUN
aji-167	174	29	(	(	PUNCT
aji-167	174	30	143.44	143.44	NUM
aji-167	174	31	±7.35	±7.35	NOUN
aji-167	174	32	vs	vs	ADP
aji-167	174	33	37.32	37.32	NUM
aji-167	174	34	±8.92	±8.92	NUM
aji-167	174	35	;	;	PUNCT
aji-167	174	36	p	p	PROPN
aji-167	174	37	=	=	NOUN
aji-167	174	38	0.001	0.001	NUM
aji-167	174	39	)	)	PUNCT
aji-167	174	40	.	.	PUNCT
aji-167	175	1	in	in	ADP
aji-167	175	2	like	like	ADP
aji-167	175	3	manner	manner	NOUN
aji-167	175	4	,	,	PUNCT
aji-167	175	5	the	the	DET
aji-167	175	6	mean	mean	ADJ
aji-167	175	7	serum	serum	NOUN
aji-167	175	8	il-10	il-10	DET
aji-167	175	9	level	level	NOUN
aji-167	175	10	was	be	AUX
aji-167	175	11	significantly	significantly	ADV
aji-167	175	12	higher	high	ADJ
aji-167	175	13	in	in	ADP
aji-167	175	14	the	the	DET
aji-167	175	15	female	female	ADJ
aji-167	175	16	patients	patient	NOUN
aji-167	175	17	with	with	ADP
aji-167	175	18	post	post	ADJ
aji-167	175	19	-	-	ADJ
aji-167	175	20	surgical	surgical	ADJ
aji-167	175	21	wound	wound	NOUN
aji-167	175	22	infections	infection	NOUN
aji-167	175	23	compared	compare	VERB
aji-167	175	24	to	to	ADP
aji-167	175	25	the	the	DET
aji-167	175	26	control	control	NOUN
aji-167	175	27	group	group	NOUN
aji-167	175	28	(	(	PUNCT
aji-167	175	29	27.52	27.52	NUM
aji-167	175	30	±7.77	±7.77	NOUN
aji-167	175	31	vs	vs	ADP
aji-167	175	32	17.12	17.12	NUM
aji-167	175	33	±6.23	±6.23	NOUN
aji-167	175	34	;	;	PUNCT
aji-167	175	35	p	p	PROPN
aji-167	175	36	=	=	NOUN
aji-167	175	37	0.001	0.001	NUM
aji-167	175	38	)	)	PUNCT
aji-167	175	39	.	.	PUNCT
aji-167	176	1	however	however	ADV
aji-167	176	2	,	,	PUNCT
aji-167	176	3	there	there	PRON
aji-167	176	4	was	be	VERB
aji-167	176	5	a	a	DET
aji-167	176	6	statistically	statistically	ADV
aji-167	176	7	significant	significant	ADJ
aji-167	176	8	decrease	decrease	NOUN
aji-167	176	9	in	in	ADP
aji-167	176	10	the	the	DET
aji-167	176	11	mean	mean	ADJ
aji-167	176	12	serum	serum	NOUN
aji-167	176	13	albumin	albumin	ADJ
aji-167	176	14	level	level	NOUN
aji-167	176	15	observed	observe	VERB
aji-167	176	16	in	in	ADP
aji-167	176	17	the	the	DET
aji-167	176	18	female	female	ADJ
aji-167	176	19	patients	patient	NOUN
aji-167	176	20	with	with	ADP
aji-167	176	21	postsurgical	postsurgical	ADJ
aji-167	176	22	wound	wound	NOUN
aji-167	176	23	infections	infection	NOUN
aji-167	176	24	than	than	ADP
aji-167	176	25	in	in	ADP
aji-167	176	26	the	the	DET
aji-167	176	27	control	control	NOUN
aji-167	176	28	group	group	NOUN
aji-167	176	29	(	(	PUNCT
aji-167	176	30	34.14	34.14	NUM
aji-167	176	31	±5.43	±5.43	NOUN
aji-167	176	32	vs	vs	ADP
aji-167	176	33	40.19	40.19	NUM
aji-167	176	34	±3.38	±3.38	NOUN
aji-167	176	35	;	;	PUNCT
aji-167	176	36	p	p	NOUN
aji-167	176	37	=	=	NOUN
aji-167	176	38	0.001	0.001	NUM
aji-167	176	39	)	)	PUNCT
aji-167	176	40	,	,	PUNCT
aji-167	176	41	(	(	PUNCT
aji-167	176	42	see	see	VERB
aji-167	176	43	table	table	NOUN
aji-167	176	44	1	1	NUM
aji-167	176	45	)	)	PUNCT
aji-167	176	46	.	.	PUNCT
aji-167	177	1	furthermore	furthermore	ADV
aji-167	177	2	,	,	PUNCT
aji-167	177	3	there	there	PRON
aji-167	177	4	was	be	VERB
aji-167	177	5	no	no	DET
aji-167	177	6	significant	significant	ADJ
aji-167	177	7	correlation	correlation	NOUN
aji-167	177	8	observed	observe	VERB
aji-167	177	9	between	between	ADP
aji-167	177	10	the	the	DET
aji-167	177	11	levels	level	NOUN
aji-167	177	12	tnf	tnf	PROPN
aji-167	177	13	-	-	PUNCT
aji-167	177	14	α	α	PROPN
aji-167	177	15	and	and	CCONJ
aji-167	177	16	albumin	albumin	ADJ
aji-167	177	17	(	(	PUNCT
aji-167	177	18	r	r	NOUN
aji-167	177	19	-	-	PUNCT
aji-167	177	20	value	value	NOUN
aji-167	177	21	=	=	PUNCT
aji-167	177	22	-0.154	-0.154	PROPN
aji-167	177	23	;	;	PUNCT
aji-167	177	24	p	p	X
aji-167	177	25	=	=	NOUN
aji-167	177	26	0.470	0.470	NUM
aji-167	177	27	)	)	PUNCT
aji-167	177	28	as	as	ADV
aji-167	177	29	well	well	ADV
aji-167	177	30	as	as	ADP
aji-167	177	31	between	between	ADP
aji-167	177	32	il-10	il-10	PRON
aji-167	177	33	and	and	CCONJ
aji-167	177	34	albumin	albumin	ADJ
aji-167	177	35	levels	level	NOUN
aji-167	177	36	(	(	PUNCT
aji-167	177	37	r	r	NOUN
aji-167	177	38	-	-	PUNCT
aji-167	177	39	value	value	NOUN
aji-167	177	40	=	=	NOUN
aji-167	177	41	0.271	0.271	NUM
aji-167	177	42	;	;	PUNCT
aji-167	177	43	p	p	X
aji-167	177	44	=	=	NOUN
aji-167	177	45	0.190	0.190	NUM
aji-167	177	46	)	)	PUNCT
aji-167	177	47	in	in	ADP
aji-167	177	48	the	the	DET
aji-167	177	49	study	study	NOUN
aji-167	177	50	participants	participant	NOUN
aji-167	177	51	(	(	PUNCT
aji-167	177	52	see	see	VERB
aji-167	177	53	table	table	NOUN
aji-167	177	54	2	2	NUM
aji-167	177	55	)	)	PUNCT
aji-167	177	56	.	.	PUNCT
aji-167	178	1	4	4	X
aji-167	178	2	.	.	X
aji-167	178	3	discussion	discussion	NOUN
aji-167	178	4	the	the	DET
aji-167	178	5	present	present	ADJ
aji-167	178	6	study	study	NOUN
aji-167	178	7	noted	note	VERB
aji-167	178	8	a	a	DET
aji-167	178	9	significantly	significantly	ADV
aji-167	178	10	higher	high	ADJ
aji-167	178	11	mean	mean	PROPN
aji-167	178	12	serum	serum	PROPN
aji-167	178	13	tnf	tnf	PROPN
aji-167	178	14	-	-	PUNCT
aji-167	178	15	α	α	NOUN
aji-167	178	16	level	level	NOUN
aji-167	178	17	in	in	ADP
aji-167	178	18	the	the	DET
aji-167	178	19	female	female	ADJ
aji-167	178	20	patients	patient	NOUN
aji-167	178	21	with	with	ADP
aji-167	178	22	post	post	ADJ
aji-167	178	23	-	-	ADJ
aji-167	178	24	surgical	surgical	ADJ
aji-167	178	25	wound	wound	NOUN
aji-167	178	26	infections	infection	NOUN
aji-167	178	27	than	than	ADP
aji-167	178	28	in	in	ADP
aji-167	178	29	the	the	DET
aji-167	178	30	control	control	NOUN
aji-167	178	31	group	group	NOUN
aji-167	178	32	.	.	PUNCT
aji-167	179	1	elevated	elevate	VERB
aji-167	179	2	tnf	tnf	PROPN
aji-167	179	3	-	-	PUNCT
aji-167	179	4	α	α	PROPN
aji-167	179	5	levels	level	NOUN
aji-167	179	6	indicate	indicate	VERB
aji-167	179	7	a	a	DET
aji-167	179	8	pro	pro	ADJ
aji-167	179	9	-	-	ADJ
aji-167	179	10	inflammatory	inflammatory	ADJ
aji-167	179	11	response	response	NOUN
aji-167	179	12	linked	link	VERB
aji-167	179	13	to	to	ADP
aji-167	179	14	chronic	chronic	ADJ
aji-167	179	15	illnesses	illness	NOUN
aji-167	179	16	and	and	CCONJ
aji-167	179	17	infections	infection	NOUN
aji-167	179	18	(	(	PUNCT
aji-167	179	19	chen	chen	PROPN
aji-167	179	20	et	et	PROPN
aji-167	179	21	al	al	PROPN
aji-167	179	22	.	.	PROPN
aji-167	179	23	,	,	PUNCT
aji-167	179	24	2017	2017	NUM
aji-167	179	25	)	)	PUNCT
aji-167	179	26	.	.	PUNCT
aji-167	180	1	this	this	DET
aji-167	180	2	finding	finding	NOUN
aji-167	180	3	aligns	align	VERB
aji-167	180	4	with	with	ADP
aji-167	180	5	the	the	DET
aji-167	180	6	reports	report	NOUN
aji-167	180	7	of	of	ADP
aji-167	180	8	other	other	ADJ
aji-167	180	9	similar	similar	ADJ
aji-167	180	10	studies	study	NOUN
aji-167	180	11	(	(	PUNCT
aji-167	180	12	ehiaghe	ehiaghe	PROPN
aji-167	180	13	et	et	PROPN
aji-167	180	14	al	al	PROPN
aji-167	180	15	.	.	PROPN
aji-167	180	16	,	,	PUNCT
aji-167	180	17	2025a	2025a	NUM
aji-167	180	18	;	;	PUNCT
aji-167	180	19	ehiaghe	ehiaghe	PROPN
aji-167	180	20	et	et	PROPN
aji-167	180	21	al	al	PROPN
aji-167	180	22	.	.	PROPN
aji-167	180	23	,	,	PUNCT
aji-167	180	24	2025b	2025b	NUM
aji-167	180	25	)	)	PUNCT
aji-167	180	26	.	.	PUNCT
aji-167	181	1	exaggerated	exaggerated	ADJ
aji-167	181	2	tnf	tnf	PROPN
aji-167	181	3	-	-	PUNCT
aji-167	181	4	α	α	PROPN
aji-167	181	5	responses	response	NOUN
aji-167	181	6	may	may	AUX
aji-167	181	7	culminate	culminate	VERB
aji-167	181	8	in	in	ADP
aji-167	181	9	failed	fail	VERB
aji-167	181	10	wound	wound	NOUN
aji-167	181	11	infection	infection	NOUN
aji-167	181	12	resolution	resolution	NOUN
aji-167	181	13	(	(	PUNCT
aji-167	181	14	choy	choy	NOUN
aji-167	181	15	et	et	NOUN
aji-167	181	16	al	al	PROPN
aji-167	181	17	.	.	PROPN
aji-167	181	18	,	,	PUNCT
aji-167	181	19	2023	2023	NUM
aji-167	181	20	)	)	PUNCT
aji-167	181	21	.	.	PUNCT
aji-167	182	1	furthermore	furthermore	ADV
aji-167	182	2	,	,	PUNCT
aji-167	182	3	the	the	DET
aji-167	182	4	higher	high	ADJ
aji-167	182	5	il-10	il-10	DET
aji-167	182	6	level	level	NOUN
aji-167	182	7	observed	observe	VERB
aji-167	182	8	in	in	ADP
aji-167	182	9	the	the	DET
aji-167	182	10	female	female	ADJ
aji-167	182	11	patients	patient	NOUN
aji-167	182	12	with	with	ADP
aji-167	182	13	post	post	ADJ
aji-167	182	14	-	-	ADJ
aji-167	182	15	surgical	surgical	ADJ
aji-167	182	16	wound	wound	NOUN
aji-167	182	17	infections	infection	NOUN
aji-167	182	18	show	show	VERB
aji-167	182	19	an	an	DET
aji-167	182	20	attempt	attempt	NOUN
aji-167	182	21	by	by	ADP
aji-167	182	22	the	the	DET
aji-167	182	23	body	body	NOUN
aji-167	182	24	to	to	PART
aji-167	182	25	moderate	moderate	VERB
aji-167	182	26	the	the	DET
aji-167	182	27	excessive	excessive	ADJ
aji-167	182	28	inflammatory	inflammatory	ADJ
aji-167	182	29	responses	response	NOUN
aji-167	182	30	,	,	PUNCT
aji-167	182	31	a	a	DET
aji-167	182	32	phenomenon	phenomenon	NOUN
aji-167	182	33	commonly	commonly	ADV
aji-167	182	34	observed	observe	VERB
aji-167	182	35	in	in	ADP
aji-167	182	36	chronic	chronic	ADJ
aji-167	182	37	inflammation	inflammation	NOUN
aji-167	182	38	,	,	PUNCT
aji-167	182	39	where	where	SCONJ
aji-167	182	40	anti	anti	ADJ
aji-167	182	41	-	-	ADJ
aji-167	182	42	inflammatory	inflammatory	ADJ
aji-167	182	43	cytokines	cytokine	NOUN
aji-167	182	44	act	act	VERB
aji-167	182	45	to	to	PART
aji-167	182	46	avoid	avoid	VERB
aji-167	182	47	tissue	tissue	NOUN
aji-167	182	48	damage	damage	NOUN
aji-167	182	49	.	.	PUNCT
aji-167	183	1	il-10	il-10	X
aji-167	183	2	limits	limit	VERB
aji-167	183	3	the	the	DET
aji-167	183	4	magnitude	magnitude	NOUN
aji-167	183	5	of	of	ADP
aji-167	183	6	the	the	DET
aji-167	183	7	immune	immune	ADJ
aji-167	183	8	responses	response	NOUN
aji-167	183	9	,	,	PUNCT
aji-167	183	10	preventing	prevent	VERB
aji-167	183	11	excessive	excessive	ADJ
aji-167	183	12	inflammation	inflammation	NOUN
aji-167	183	13	and	and	CCONJ
aji-167	183	14	protecting	protect	VERB
aji-167	183	15	tissues	tissue	NOUN
aji-167	183	16	from	from	ADP
aji-167	183	17	immune	immune	NOUN
aji-167	183	18	-	-	PUNCT
aji-167	183	19	mediated	mediate	VERB
aji-167	183	20	damage	damage	NOUN
aji-167	183	21	by	by	ADP
aji-167	183	22	allowing	allow	VERB
aji-167	183	23	inflammation	inflammation	ADJ
aji-167	183	24	resolution	resolution	NOUN
aji-167	183	25	when	when	SCONJ
aji-167	183	26	the	the	DET
aji-167	183	27	pathogen	pathogen	NOUN
aji-167	183	28	is	be	AUX
aji-167	183	29	cleared	clear	VERB
aji-167	183	30	(	(	PUNCT
aji-167	183	31	carlini	carlini	PROPN
aji-167	183	32	et	et	PROPN
aji-167	183	33	al	al	PROPN
aji-167	183	34	.	.	PROPN
aji-167	183	35	,	,	PUNCT
aji-167	183	36	2023	2023	NUM
aji-167	183	37	)	)	PUNCT
aji-167	183	38	.	.	PUNCT
aji-167	184	1	table	table	NOUN
aji-167	184	2	1	1	NUM
aji-167	184	3	.	.	PUNCT
aji-167	185	1	levels	level	NOUN
aji-167	185	2	of	of	ADP
aji-167	185	3	serum	serum	PROPN
aji-167	185	4	tnf	tnf	PROPN
aji-167	185	5	-	-	PUNCT
aji-167	185	6	α	α	PROPN
aji-167	185	7	,	,	PUNCT
aji-167	185	8	il-10	il-10	NOUN
aji-167	185	9	and	and	CCONJ
aji-167	185	10	albumin	albumin	NOUN
aji-167	185	11	circulating	circulate	VERB
aji-167	185	12	among	among	ADP
aji-167	185	13	female	female	ADJ
aji-167	185	14	patients	patient	NOUN
aji-167	185	15	with	with	ADP
aji-167	185	16	post	post	ADJ
aji-167	185	17	-	-	ADJ
aji-167	185	18	surgical	surgical	ADJ
aji-167	185	19	wound	wound	NOUN
aji-167	185	20	infection	infection	NOUN
aji-167	185	21	and	and	CCONJ
aji-167	185	22	apparently	apparently	ADV
aji-167	185	23	healthy	healthy	ADJ
aji-167	185	24	individuals	individual	NOUN
aji-167	185	25	(	(	PUNCT
aji-167	185	26	mean	mean	PROPN
aji-167	185	27	±sd	±sd	ADJ
aji-167	185	28	)	)	PUNCT
aji-167	185	29	parameter	parameter	NOUN
aji-167	185	30	group	group	NOUN
aji-167	185	31	n	n	CCONJ
aji-167	185	32	mean	mean	VERB
aji-167	185	33	±sd	±sd	PROPN
aji-167	185	34	t	t	PROPN
aji-167	185	35	value	value	NOUN
aji-167	185	36	p	p	PROPN
aji-167	185	37	value	value	NOUN
aji-167	185	38	tnf	tnf	PROPN
aji-167	185	39	-	-	PUNCT
aji-167	185	40	α	α	PROPN
aji-167	185	41	il-10	il-10	X
aji-167	185	42	albumin	albumin	ADJ
aji-167	185	43	test	test	NOUN
aji-167	185	44	control	control	PROPN
aji-167	185	45	test	test	PROPN
aji-167	185	46	control	control	PROPN
aji-167	185	47	test	test	NOUN
aji-167	185	48	control	control	NOUN
aji-167	185	49	25	25	NUM
aji-167	185	50	25	25	NUM
aji-167	185	51	25	25	NUM
aji-167	185	52	25	25	NUM
aji-167	185	53	25	25	NUM
aji-167	185	54	25	25	NUM
aji-167	185	55	143.44	143.44	NUM
aji-167	185	56	±7.35	±7.35	PROPN
aji-167	185	57	37.32	37.32	NUM
aji-167	185	58	±8.92	±8.92	PROPN
aji-167	185	59	27.52	27.52	NUM
aji-167	185	60	±7.77	±7.77	NOUN
aji-167	185	61	17.12	17.12	NUM
aji-167	185	62	±6.23	±6.23	PROPN
aji-167	185	63	34.14	34.14	NUM
aji-167	185	64	±5.43	±5.43	NOUN
aji-167	185	65	40.19	40.19	NUM
aji-167	185	66	±3.38	±3.38	NOUN
aji-167	185	67	45.93	45.93	NUM
aji-167	185	68	5.22	5.22	NUM
aji-167	185	69	4.73	4.73	NUM
aji-167	185	70	0.001	0.001	NUM
aji-167	185	71	0.001	0.001	NUM
aji-167	185	72	0.001	0.001	NUM
aji-167	185	73	*	*	PUNCT
aji-167	185	74	statistically	statistically	ADV
aji-167	185	75	significant	significant	ADJ
aji-167	185	76	=	=	SYM
aji-167	185	77	p<0.05	p<0.05	NOUN
aji-167	185	78	;	;	PUNCT
aji-167	185	79	tnf	tnf	PROPN
aji-167	185	80	-	-	PUNCT
aji-167	185	81	α	α	NOUN
aji-167	185	82	=	=	X
aji-167	185	83	tumour	tumour	NOUN
aji-167	185	84	necrosis	necrosis	NOUN
aji-167	185	85	factoralpha	factoralpha	NOUN
aji-167	185	86	,	,	PUNCT
aji-167	185	87	il-10	il-10	NOUN
aji-167	185	88	=	=	PUNCT
aji-167	185	89	interleukin	interleukin	NOUN
aji-167	185	90	-10	-10	PUNCT
aji-167	185	91	.	.	PUNCT
aji-167	186	1	ehiaghe	ehiaghe	PROPN
aji-167	186	2	et	et	PROPN
aji-167	186	3	al	al	PROPN
aji-167	186	4	.	.	PROPN
aji-167	186	5	;	;	PUNCT
aji-167	186	6	asian	asian	PROPN
aji-167	186	7	j.	j.	PROPN
aji-167	186	8	immunol	immunol	PROPN
aji-167	186	9	.	.	PROPN
aji-167	186	10	,	,	PUNCT
aji-167	186	11	vol	vol	NOUN
aji-167	186	12	.	.	PROPN
aji-167	186	13	8	8	NUM
aji-167	186	14	,	,	PUNCT
aji-167	186	15	no	no	INTJ
aji-167	186	16	.	.	NOUN
aji-167	186	17	1	1	NUM
aji-167	186	18	,	,	PUNCT
aji-167	186	19	pp	pp	ADJ
aji-167	186	20	.	.	PUNCT
aji-167	187	1	134	134	NUM
aji-167	187	2	-	-	SYM
aji-167	187	3	141	141	NUM
aji-167	187	4	,	,	PUNCT
aji-167	187	5	2025	2025	NUM
aji-167	187	6	;	;	PUNCT
aji-167	188	1	article	article	NOUN
aji-167	188	2	no.aji.137461	no.aji.137461	VERB
aji-167	188	3	138	138	NUM
aji-167	188	4	table	table	NOUN
aji-167	188	5	2	2	NUM
aji-167	188	6	.	.	PUNCT
aji-167	188	7	the	the	DET
aji-167	188	8	correlation	correlation	NOUN
aji-167	188	9	between	between	ADP
aji-167	188	10	the	the	DET
aji-167	188	11	levels	level	NOUN
aji-167	188	12	of	of	ADP
aji-167	188	13	tnf	tnf	PROPN
aji-167	188	14	-	-	PUNCT
aji-167	188	15	α	α	PROPN
aji-167	188	16	,	,	PUNCT
aji-167	188	17	il-10	il-10	NOUN
aji-167	188	18	and	and	CCONJ
aji-167	188	19	albumin	albumin	NOUN
aji-167	188	20	in	in	ADP
aji-167	188	21	the	the	DET
aji-167	188	22	study	study	NOUN
aji-167	188	23	population	population	NOUN
aji-167	188	24	parameters	parameter	NOUN
aji-167	188	25	r	r	NOUN
aji-167	188	26	-	-	PUNCT
aji-167	188	27	value	value	NOUN
aji-167	188	28	p	p	NOUN
aji-167	188	29	-	-	PUNCT
aji-167	188	30	value	value	NOUN
aji-167	188	31	tnfα	tnfα	NOUN
aji-167	188	32	vs	vs	ADP
aji-167	188	33	albumin	albumin	NOUN
aji-167	188	34	-0.154	-0.154	PUNCT
aji-167	188	35	0.470	0.470	NUM
aji-167	188	36	il-10	il-10	NOUN
aji-167	188	37	vs	vs	ADP
aji-167	188	38	albumin	albumin	NOUN
aji-167	188	39	0.271	0.271	NUM
aji-167	188	40	0.190	0.190	NUM
aji-167	188	41	*	*	PUNCT
aji-167	188	42	statistically	statistically	ADV
aji-167	188	43	significant	significant	ADJ
aji-167	188	44	at	at	ADP
aji-167	188	45	p<0.05	p<0.05	NOUN
aji-167	188	46	nevertheless	nevertheless	ADV
aji-167	188	47	,	,	PUNCT
aji-167	188	48	elevating	elevate	VERB
aji-167	188	49	il-10	il-10	DET
aji-167	188	50	levels	level	NOUN
aji-167	188	51	can	can	AUX
aji-167	188	52	provide	provide	VERB
aji-167	188	53	some	some	DET
aji-167	188	54	anti	anti	ADJ
aji-167	188	55	-	-	ADJ
aji-167	188	56	inflammatory	inflammatory	ADJ
aji-167	188	57	buffering	buffering	NOUN
aji-167	188	58	,	,	PUNCT
aji-167	188	59	but	but	CCONJ
aji-167	188	60	its	its	PRON
aji-167	188	61	efficiency	efficiency	NOUN
aji-167	188	62	may	may	AUX
aji-167	188	63	be	be	AUX
aji-167	188	64	limited	limit	VERB
aji-167	188	65	by	by	ADP
aji-167	188	66	pro	pro	ADJ
aji-167	188	67	-	-	ADJ
aji-167	188	68	inflammatory	inflammatory	ADJ
aji-167	188	69	cytokines	cytokine	NOUN
aji-167	188	70	like	like	ADP
aji-167	188	71	tnf	tnf	PROPN
aji-167	188	72	-	-	PUNCT
aji-167	188	73	α	α	PROPN
aji-167	188	74	,	,	PUNCT
aji-167	188	75	leading	lead	VERB
aji-167	188	76	to	to	ADP
aji-167	188	77	an	an	DET
aji-167	188	78	unsustainable	unsustainable	ADJ
aji-167	188	79	immunological	immunological	ADJ
aji-167	188	80	balance	balance	NOUN
aji-167	188	81	.	.	PUNCT
aji-167	189	1	thus	thus	ADV
aji-167	189	2	,	,	PUNCT
aji-167	189	3	increased	increase	VERB
aji-167	189	4	inflammatory	inflammatory	ADJ
aji-167	189	5	response	response	NOUN
aji-167	189	6	shown	show	VERB
aji-167	189	7	in	in	ADP
aji-167	189	8	our	our	PRON
aji-167	189	9	current	current	ADJ
aji-167	189	10	investigation	investigation	NOUN
aji-167	189	11	may	may	AUX
aji-167	189	12	hamper	hamper	VERB
aji-167	189	13	infection	infection	NOUN
aji-167	189	14	resolution	resolution	NOUN
aji-167	189	15	,	,	PUNCT
aji-167	189	16	eventually	eventually	ADV
aji-167	189	17	leading	lead	VERB
aji-167	189	18	to	to	ADP
aji-167	189	19	poor	poor	ADJ
aji-167	189	20	treatment	treatment	NOUN
aji-167	189	21	outcome	outcome	NOUN
aji-167	189	22	in	in	ADP
aji-167	189	23	these	these	DET
aji-167	189	24	patients	patient	NOUN
aji-167	189	25	.	.	PUNCT
aji-167	190	1	in	in	ADP
aji-167	190	2	the	the	DET
aji-167	190	3	present	present	ADJ
aji-167	190	4	study	study	NOUN
aji-167	190	5	,	,	PUNCT
aji-167	190	6	the	the	DET
aji-167	190	7	mean	mean	ADJ
aji-167	190	8	serum	serum	NOUN
aji-167	190	9	albumin	albumin	ADJ
aji-167	190	10	level	level	NOUN
aji-167	190	11	was	be	AUX
aji-167	190	12	found	find	VERB
aji-167	190	13	to	to	PART
aji-167	190	14	be	be	AUX
aji-167	190	15	significantly	significantly	ADV
aji-167	190	16	lower	low	ADJ
aji-167	190	17	in	in	ADP
aji-167	190	18	the	the	DET
aji-167	190	19	female	female	ADJ
aji-167	190	20	patients	patient	NOUN
aji-167	190	21	with	with	ADP
aji-167	190	22	post	post	ADJ
aji-167	190	23	-	-	ADJ
aji-167	190	24	surgical	surgical	ADJ
aji-167	190	25	wound	wound	NOUN
aji-167	190	26	infection	infection	NOUN
aji-167	190	27	compared	compare	VERB
aji-167	190	28	to	to	ADP
aji-167	190	29	the	the	DET
aji-167	190	30	control	control	NOUN
aji-167	190	31	group	group	NOUN
aji-167	190	32	.	.	PUNCT
aji-167	191	1	this	this	DET
aji-167	191	2	result	result	NOUN
aji-167	191	3	agrees	agree	VERB
aji-167	191	4	with	with	ADP
aji-167	191	5	several	several	ADJ
aji-167	191	6	studies	study	NOUN
aji-167	191	7	that	that	PRON
aji-167	191	8	found	find	VERB
aji-167	191	9	significantly	significantly	ADV
aji-167	191	10	lower	low	ADJ
aji-167	191	11	serum	serum	NOUN
aji-167	191	12	albumin	albumin	ADJ
aji-167	191	13	levels	level	NOUN
aji-167	191	14	in	in	ADP
aji-167	191	15	pswis	pswis	NOUN
aji-167	191	16	patients	patient	NOUN
aji-167	191	17	(	(	PUNCT
aji-167	191	18	choudhary	choudhary	PROPN
aji-167	191	19	et	et	PROPN
aji-167	191	20	al	al	PROPN
aji-167	191	21	.	.	PROPN
aji-167	191	22	,	,	PUNCT
aji-167	191	23	2024	2024	NUM
aji-167	191	24	;	;	PUNCT
aji-167	191	25	sultana	sultana	NOUN
aji-167	191	26	et	et	PROPN
aji-167	191	27	al	al	PROPN
aji-167	191	28	.	.	PROPN
aji-167	191	29	,	,	PUNCT
aji-167	191	30	2024	2024	NUM
aji-167	191	31	;	;	PUNCT
aji-167	191	32	llombart	llombart	PROPN
aji-167	191	33	et	et	PROPN
aji-167	191	34	al	al	PROPN
aji-167	191	35	.	.	PROPN
aji-167	191	36	,	,	PUNCT
aji-167	191	37	2023	2023	NUM
aji-167	191	38	;	;	PUNCT
aji-167	191	39	singh	singh	PROPN
aji-167	191	40	et	et	PROPN
aji-167	191	41	al	al	PROPN
aji-167	191	42	.	.	PROPN
aji-167	191	43	,	,	PUNCT
aji-167	191	44	2023	2023	NUM
aji-167	191	45	;	;	PUNCT
aji-167	191	46	he	he	PRON
aji-167	191	47	et	et	PROPN
aji-167	191	48	al	al	PROPN
aji-167	191	49	.	.	PROPN
aji-167	191	50	,	,	PUNCT
aji-167	191	51	2020	2020	NUM
aji-167	191	52	)	)	PUNCT
aji-167	191	53	.	.	PUNCT
aji-167	192	1	hypoalbuminemia	hypoalbuminemia	PROPN
aji-167	192	2	,	,	PUNCT
aji-167	192	3	an	an	DET
aji-167	192	4	indicator	indicator	NOUN
aji-167	192	5	of	of	ADP
aji-167	192	6	malnutrition	malnutrition	NOUN
aji-167	192	7	and	and	CCONJ
aji-167	192	8	illness	illness	NOUN
aji-167	192	9	,	,	PUNCT
aji-167	192	10	has	have	AUX
aji-167	192	11	been	be	AUX
aji-167	192	12	shown	show	VERB
aji-167	192	13	to	to	PART
aji-167	192	14	increase	increase	VERB
aji-167	192	15	the	the	DET
aji-167	192	16	likelihood	likelihood	NOUN
aji-167	192	17	of	of	ADP
aji-167	192	18	poor	poor	ADJ
aji-167	192	19	postoperative	postoperative	ADJ
aji-167	192	20	outcomes	outcome	NOUN
aji-167	192	21	,	,	PUNCT
aji-167	192	22	especially	especially	ADV
aji-167	192	23	reduced	reduce	VERB
aji-167	192	24	wound	wound	NOUN
aji-167	192	25	healing	healing	NOUN
aji-167	192	26	(	(	PUNCT
aji-167	192	27	sultana	sultana	NOUN
aji-167	192	28	et	et	PROPN
aji-167	192	29	al	al	PROPN
aji-167	192	30	.	.	PROPN
aji-167	192	31	,	,	PUNCT
aji-167	192	32	2024	2024	NUM
aji-167	192	33	)	)	PUNCT
aji-167	192	34	.	.	PUNCT
aji-167	193	1	in	in	ADP
aji-167	193	2	addition	addition	NOUN
aji-167	193	3	to	to	ADP
aji-167	193	4	increasing	increase	VERB
aji-167	193	5	albumin	albumin	ADJ
aji-167	193	6	production	production	NOUN
aji-167	193	7	,	,	PUNCT
aji-167	193	8	inflammatory	inflammatory	ADJ
aji-167	193	9	conditions	condition	NOUN
aji-167	193	10	can	can	AUX
aji-167	193	11	enhance	enhance	VERB
aji-167	193	12	albumin	albumin	ADJ
aji-167	193	13	breakdown	breakdown	NOUN
aji-167	193	14	,	,	PUNCT
aji-167	193	15	which	which	PRON
aji-167	193	16	can	can	AUX
aji-167	193	17	result	result	VERB
aji-167	193	18	in	in	ADP
aji-167	193	19	hypoalbuminemia	hypoalbuminemia	NOUN
aji-167	193	20	(	(	PUNCT
aji-167	193	21	weaving	weave	VERB
aji-167	193	22	et	et	NOUN
aji-167	193	23	al	al	PROPN
aji-167	193	24	.	.	PROPN
aji-167	193	25	,	,	PUNCT
aji-167	193	26	2016	2016	NUM
aji-167	193	27	)	)	PUNCT
aji-167	193	28	.	.	PUNCT
aji-167	194	1	interstitial	interstitial	ADJ
aji-167	194	2	oedema	oedema	NOUN
aji-167	194	3	results	result	VERB
aji-167	194	4	from	from	ADP
aji-167	194	5	a	a	DET
aji-167	194	6	decrease	decrease	NOUN
aji-167	194	7	in	in	ADP
aji-167	194	8	oncotic	oncotic	ADJ
aji-167	194	9	pressure	pressure	NOUN
aji-167	194	10	caused	cause	VERB
aji-167	194	11	by	by	ADP
aji-167	194	12	a	a	DET
aji-167	194	13	decrease	decrease	NOUN
aji-167	194	14	in	in	ADP
aji-167	194	15	serum	serum	NOUN
aji-167	194	16	albumin	albumin	ADJ
aji-167	194	17	levels	level	NOUN
aji-167	194	18	,	,	PUNCT
aji-167	194	19	which	which	PRON
aji-167	194	20	might	might	AUX
aji-167	194	21	impede	impede	VERB
aji-167	194	22	the	the	DET
aji-167	194	23	healing	healing	NOUN
aji-167	194	24	and	and	CCONJ
aji-167	194	25	recovery	recovery	NOUN
aji-167	194	26	process	process	NOUN
aji-167	194	27	.	.	PUNCT
aji-167	195	1	5	5	X
aji-167	195	2	.	.	X
aji-167	195	3	conclusion	conclusion	NOUN
aji-167	195	4	this	this	DET
aji-167	195	5	study	study	NOUN
aji-167	195	6	found	find	VERB
aji-167	195	7	that	that	SCONJ
aji-167	195	8	female	female	ADJ
aji-167	195	9	patients	patient	NOUN
aji-167	195	10	with	with	ADP
aji-167	195	11	postsurgical	postsurgical	ADJ
aji-167	195	12	wound	wound	NOUN
aji-167	195	13	infections	infection	NOUN
aji-167	195	14	had	have	VERB
aji-167	195	15	significantly	significantly	ADV
aji-167	195	16	higher	high	ADJ
aji-167	195	17	mean	mean	PROPN
aji-167	195	18	serum	serum	PROPN
aji-167	195	19	tnf	tnf	PROPN
aji-167	195	20	-	-	PUNCT
aji-167	195	21	α	α	PROPN
aji-167	195	22	and	and	CCONJ
aji-167	195	23	il-10	il-10	ADJ
aji-167	195	24	levels	level	NOUN
aji-167	195	25	,	,	PUNCT
aji-167	195	26	as	as	ADV
aji-167	195	27	well	well	ADV
aji-167	195	28	as	as	ADP
aji-167	195	29	lower	low	ADJ
aji-167	195	30	mean	mean	NOUN
aji-167	195	31	serum	serum	NOUN
aji-167	195	32	albumin	albumin	ADJ
aji-167	195	33	levels	level	NOUN
aji-167	195	34	.	.	PUNCT
aji-167	196	1	findings	finding	NOUN
aji-167	196	2	presented	present	VERB
aji-167	196	3	in	in	ADP
aji-167	196	4	the	the	DET
aji-167	196	5	study	study	NOUN
aji-167	196	6	suggest	suggest	VERB
aji-167	196	7	that	that	SCONJ
aji-167	196	8	higher	high	ADJ
aji-167	196	9	levels	level	NOUN
aji-167	196	10	of	of	ADP
aji-167	196	11	the	the	DET
aji-167	196	12	pro	pro	ADJ
aji-167	196	13	-	-	ADJ
aji-167	196	14	inflammatory	inflammatory	ADJ
aji-167	196	15	cytokine	cytokine	NOUN
aji-167	196	16	tnf	tnf	PROPN
aji-167	196	17	𝛼	𝛼	PROPN
aji-167	196	18	,	,	PUNCT
aji-167	196	19	may	may	AUX
aji-167	196	20	adversely	adversely	ADV
aji-167	196	21	impact	impact	VERB
aji-167	196	22	wound	wound	NOUN
aji-167	196	23	healing	healing	NOUN
aji-167	196	24	and	and	CCONJ
aji-167	196	25	impede	impede	VERB
aji-167	196	26	resolution	resolution	NOUN
aji-167	196	27	of	of	ADP
aji-167	196	28	infection	infection	NOUN
aji-167	196	29	.	.	PUNCT
aji-167	197	1	consent	consent	NOUN
aji-167	197	2	and	and	CCONJ
aji-167	197	3	ethical	ethical	ADJ
aji-167	197	4	approval	approval	NOUN
aji-167	197	5	the	the	DET
aji-167	197	6	ethical	ethical	ADJ
aji-167	197	7	committee	committee	NOUN
aji-167	197	8	of	of	ADP
aji-167	197	9	the	the	DET
aji-167	197	10	federal	federal	ADJ
aji-167	197	11	medical	medical	ADJ
aji-167	197	12	centre	centre	NOUN
aji-167	197	13	in	in	ADP
aji-167	197	14	asaba	asaba	NOUN
aji-167	197	15	,	,	PUNCT
aji-167	197	16	delta	delta	NOUN
aji-167	197	17	state	state	NOUN
aji-167	197	18	,	,	PUNCT
aji-167	197	19	approved	approve	VERB
aji-167	197	20	the	the	DET
aji-167	197	21	study	study	NOUN
aji-167	197	22	before	before	SCONJ
aji-167	197	23	it	it	PRON
aji-167	197	24	commenced	commence	VERB
aji-167	197	25	.	.	PUNCT
aji-167	198	1	the	the	DET
aji-167	198	2	informed	informed	ADJ
aji-167	198	3	consent	consent	NOUN
aji-167	198	4	of	of	ADP
aji-167	198	5	all	all	DET
aji-167	198	6	involved	involved	ADJ
aji-167	198	7	participants	participant	NOUN
aji-167	198	8	was	be	AUX
aji-167	198	9	sought	seek	VERB
aji-167	198	10	and	and	CCONJ
aji-167	198	11	gained	gain	VERB
aji-167	198	12	.	.	PUNCT
aji-167	199	1	disclaimer	disclaimer	PROPN
aji-167	199	2	(	(	PUNCT
aji-167	199	3	artificial	artificial	ADJ
aji-167	199	4	intelligence	intelligence	NOUN
aji-167	199	5	)	)	PUNCT
aji-167	199	6	author(s	author(s	NOUN
aji-167	199	7	)	)	PUNCT
aji-167	199	8	hereby	hereby	ADV
aji-167	199	9	declare	declare	VERB
aji-167	199	10	that	that	SCONJ
aji-167	199	11	no	no	DET
aji-167	199	12	generative	generative	NOUN
aji-167	199	13	ai	ai	VERB
aji-167	199	14	technologies	technology	NOUN
aji-167	199	15	such	such	ADJ
aji-167	199	16	as	as	ADP
aji-167	199	17	large	large	ADJ
aji-167	199	18	language	language	NOUN
aji-167	199	19	models	model	NOUN
aji-167	199	20	(	(	PUNCT
aji-167	199	21	chatgpt	chatgpt	NOUN
aji-167	199	22	,	,	PUNCT
aji-167	199	23	copilot	copilot	NOUN
aji-167	199	24	,	,	PUNCT
aji-167	199	25	etc	etc	X
aji-167	199	26	.	.	X
aji-167	199	27	)	)	PUNCT
aji-167	199	28	and	and	CCONJ
aji-167	199	29	text	text	NOUN
aji-167	199	30	-	-	PUNCT
aji-167	199	31	to	to	ADP
aji-167	199	32	-	-	PUNCT
aji-167	199	33	image	image	NOUN
aji-167	199	34	generators	generator	NOUN
aji-167	199	35	have	have	AUX
aji-167	199	36	been	be	AUX
aji-167	199	37	used	use	VERB
aji-167	199	38	during	during	ADP
aji-167	199	39	the	the	DET
aji-167	199	40	writing	writing	NOUN
aji-167	199	41	or	or	CCONJ
aji-167	199	42	editing	editing	NOUN
aji-167	199	43	of	of	ADP
aji-167	199	44	this	this	DET
aji-167	199	45	manuscript	manuscript	NOUN
aji-167	199	46	.	.	PUNCT
aji-167	200	1	competing	compete	VERB
aji-167	200	2	interests	interest	NOUN
aji-167	200	3	authors	author	NOUN
aji-167	200	4	have	have	AUX
aji-167	200	5	declared	declare	VERB
aji-167	200	6	that	that	SCONJ
aji-167	200	7	no	no	DET
aji-167	200	8	competing	compete	VERB
aji-167	200	9	interests	interest	NOUN
aji-167	200	10	exist	exist	VERB
aji-167	200	11	.	.	PUNCT
aji-167	201	1	references	reference	NOUN
aji-167	201	2	al	al	PROPN
aji-167	201	3	-	-	PUNCT
aji-167	201	4	qahtani	qahtani	PROPN
aji-167	201	5	,	,	PUNCT
aji-167	201	6	a.a	a.a	PROPN
aji-167	201	7	.	.	PROPN
aji-167	201	8	,	,	PUNCT
aji-167	201	9	alhamlan	alhamlan	PROPN
aji-167	201	10	,	,	PUNCT
aji-167	201	11	f.s	f.s	PROPN
aji-167	201	12	.	.	PROPN
aji-167	201	13	,	,	PUNCT
aji-167	201	14	&	&	CCONJ
aji-167	201	15	al	al	PROPN
aji-167	201	16	-	-	PUNCT
aji-167	201	17	qahtani	qahtani	PROPN
aji-167	201	18	,	,	PUNCT
aji-167	201	19	a.a	a.a	PROPN
aji-167	201	20	.	.	PROPN
aji-167	201	21	(	(	PUNCT
aji-167	201	22	2024	2024	NUM
aji-167	201	23	)	)	PUNCT
aji-167	201	24	.	.	PUNCT
aji-167	202	1	pro	pro	ADJ
aji-167	202	2	-	-	ADJ
aji-167	202	3	inflammatory	inflammatory	ADJ
aji-167	202	4	and	and	CCONJ
aji-167	202	5	antiinflammatory	antiinflammatory	NOUN
aji-167	202	6	interleukins	interleukin	NOUN
aji-167	202	7	in	in	ADP
aji-167	202	8	infectious	infectious	ADJ
aji-167	202	9	diseases	disease	NOUN
aji-167	202	10	:	:	PUNCT
aji-167	202	11	a	a	DET
aji-167	202	12	comprehensive	comprehensive	ADJ
aji-167	202	13	review	review	NOUN
aji-167	202	14	.	.	PUNCT
aji-167	203	1	tropical	tropical	ADJ
aji-167	203	2	medicine	medicine	NOUN
aji-167	203	3	and	and	CCONJ
aji-167	203	4	infectious	infectious	ADJ
aji-167	203	5	disease	disease	NOUN
aji-167	203	6	,	,	PUNCT
aji-167	203	7	9(1	9(1	NUM
aji-167	203	8	)	)	PUNCT
aji-167	203	9	,	,	PUNCT
aji-167	203	10	13	13	NUM
aji-167	203	11	.	.	PUNCT
aji-167	204	1	https://doi.org/10.3390/tropicalmed901001	https://doi.org/10.3390/tropicalmed901001	NOUN
aji-167	204	2	3	3	NUM
aji-167	204	3	carlini	carlini	NOUN
aji-167	204	4	,	,	PUNCT
aji-167	204	5	v.	v.	PROPN
aji-167	204	6	,	,	PUNCT
aji-167	204	7	noonan	noonan	PROPN
aji-167	204	8	,	,	PUNCT
aji-167	204	9	d.m	d.m	PROPN
aji-167	204	10	.	.	PROPN
aji-167	204	11	,	,	PUNCT
aji-167	204	12	abdalalem	abdalalem	PROPN
aji-167	204	13	,	,	PUNCT
aji-167	204	14	e.	e.	PROPN
aji-167	204	15	,	,	PUNCT
aji-167	204	16	goletti	goletti	PROPN
aji-167	204	17	,	,	PUNCT
aji-167	204	18	d.	d.	PROPN
aji-167	204	19	,	,	PUNCT
aji-167	204	20	sansone	sansone	PROPN
aji-167	204	21	,	,	PUNCT
aji-167	204	22	c.	c.	PROPN
aji-167	204	23	,	,	PUNCT
aji-167	204	24	calabrone	calabrone	NOUN
aji-167	204	25	,	,	PUNCT
aji-167	204	26	l.	l.	PROPN
aji-167	204	27	,	,	PUNCT
aji-167	204	28	albini	albini	PROPN
aji-167	204	29	,	,	PUNCT
aji-167	204	30	a.	a.	NOUN
aji-167	204	31	(	(	PUNCT
aji-167	204	32	2023	2023	NUM
aji-167	204	33	)	)	PUNCT
aji-167	204	34	.	.	PUNCT
aji-167	205	1	the	the	DET
aji-167	205	2	multifaceted	multifaceted	ADJ
aji-167	205	3	nature	nature	NOUN
aji-167	205	4	of	of	ADP
aji-167	205	5	il-10	il-10	PRON
aji-167	205	6	:	:	PUNCT
aji-167	205	7	regulation	regulation	NOUN
aji-167	205	8	,	,	PUNCT
aji-167	205	9	role	role	NOUN
aji-167	205	10	in	in	ADP
aji-167	205	11	immunological	immunological	ADJ
aji-167	205	12	homeostasis	homeostasis	NOUN
aji-167	205	13	and	and	CCONJ
aji-167	205	14	its	its	PRON
aji-167	205	15	relevance	relevance	NOUN
aji-167	205	16	to	to	ADP
aji-167	205	17	cancer	cancer	NOUN
aji-167	205	18	,	,	PUNCT
aji-167	205	19	covid-19	covid-19	PROPN
aji-167	205	20	and	and	CCONJ
aji-167	205	21	post	post	ADJ
aji-167	205	22	-	-	ADJ
aji-167	205	23	covid	covid	ADJ
aji-167	205	24	conditions	condition	NOUN
aji-167	205	25	.	.	PUNCT
aji-167	206	1	frontiers	frontier	NOUN
aji-167	206	2	in	in	ADP
aji-167	206	3	immunology	immunology	NOUN
aji-167	206	4	,	,	PUNCT
aji-167	206	5	14	14	NUM
aji-167	206	6	.	.	PUNCT
aji-167	207	1	https://doi.org/10.3389/fimmu.2023.116106	https://doi.org/10.3389/fimmu.2023.116106	PROPN
aji-167	207	2	7	7	NUM
aji-167	207	3	chen	chen	PROPN
aji-167	207	4	,	,	PUNCT
aji-167	207	5	l.	l.	PROPN
aji-167	207	6	,	,	PUNCT
aji-167	207	7	deng	deng	PROPN
aji-167	207	8	,	,	PUNCT
aji-167	207	9	h.	h.	PROPN
aji-167	207	10	,	,	PUNCT
aji-167	207	11	cui	cui	PROPN
aji-167	207	12	,	,	PUNCT
aji-167	207	13	h.	h.	PROPN
aji-167	207	14	,	,	PUNCT
aji-167	207	15	fang	fang	PROPN
aji-167	207	16	,	,	PUNCT
aji-167	207	17	j.	j.	PROPN
aji-167	207	18	,	,	PUNCT
aji-167	207	19	zuo	zuo	PROPN
aji-167	207	20	,	,	PUNCT
aji-167	207	21	z.	z.	PROPN
aji-167	207	22	,	,	PUNCT
aji-167	207	23	deng	deng	PROPN
aji-167	207	24	,	,	PUNCT
aji-167	207	25	j.	j.	PROPN
aji-167	207	26	,	,	PUNCT
aji-167	207	27	li	li	PROPN
aji-167	207	28	,	,	PUNCT
aji-167	207	29	y.	y.	PROPN
aji-167	207	30	,	,	PUNCT
aji-167	207	31	wang	wang	PROPN
aji-167	207	32	,	,	PUNCT
aji-167	207	33	x.	x.	PROPN
aji-167	207	34	,	,	PUNCT
aji-167	207	35	&	&	CCONJ
aji-167	207	36	zhao	zhao	PROPN
aji-167	207	37	,	,	PUNCT
aji-167	207	38	l.	l.	PROPN
aji-167	207	39	(	(	PUNCT
aji-167	207	40	2017	2017	NUM
aji-167	207	41	)	)	PUNCT
aji-167	207	42	.	.	PUNCT
aji-167	208	1	inflammatory	inflammatory	ADJ
aji-167	208	2	responses	response	NOUN
aji-167	208	3	and	and	CCONJ
aji-167	208	4	inflammation	inflammation	NOUN
aji-167	208	5	-	-	PUNCT
aji-167	208	6	associated	associate	VERB
aji-167	208	7	diseases	disease	NOUN
aji-167	208	8	in	in	ADP
aji-167	208	9	organs	organ	NOUN
aji-167	208	10	.	.	PUNCT
aji-167	209	1	oncotarget	oncotarget	NOUN
aji-167	209	2	,	,	PUNCT
aji-167	209	3	9(6	9(6	NUM
aji-167	209	4	)	)	PUNCT
aji-167	209	5	,	,	PUNCT
aji-167	209	6	7204–7218	7204–7218	NUM
aji-167	209	7	.	.	PUNCT
aji-167	210	1	https://doi.org/10.18632/oncotarget.23208	https://doi.org/10.18632/oncotarget.23208	ADJ
aji-167	210	2	chidambaran	chidambaran	NOUN
aji-167	210	3	,	,	PUNCT
aji-167	210	4	v.	v.	PROPN
aji-167	210	5	,	,	PUNCT
aji-167	210	6	duan	duan	PROPN
aji-167	210	7	,	,	PUNCT
aji-167	210	8	q.	q.	PROPN
aji-167	210	9	,	,	PUNCT
aji-167	210	10	pilipenko	pilipenko	ADJ
aji-167	210	11	,	,	PUNCT
aji-167	210	12	v.	v.	PROPN
aji-167	210	13	,	,	PUNCT
aji-167	210	14	glynn	glynn	PROPN
aji-167	210	15	,	,	PUNCT
aji-167	210	16	s.	s.	PROPN
aji-167	210	17	m.	m.	PROPN
aji-167	210	18	,	,	PUNCT
aji-167	210	19	sproles	sprole	NOUN
aji-167	210	20	,	,	PUNCT
aji-167	210	21	a.	a.	NOUN
aji-167	210	22	,	,	PUNCT
aji-167	210	23	martin	martin	PROPN
aji-167	210	24	,	,	PUNCT
aji-167	210	25	l.	l.	PROPN
aji-167	210	26	j.	j.	PROPN
aji-167	210	27	,	,	PUNCT
aji-167	210	28	lacagnina	lacagnina	PROPN
aji-167	210	29	,	,	PUNCT
aji-167	210	30	m.	m.	PROPN
aji-167	210	31	j.	j.	PROPN
aji-167	210	32	,	,	PUNCT
aji-167	210	33	king	king	PROPN
aji-167	210	34	,	,	PUNCT
aji-167	210	35	c.	c.	PROPN
aji-167	210	36	d.	d.	PROPN
aji-167	210	37	,	,	PUNCT
aji-167	210	38	&	&	CCONJ
aji-167	210	39	ding	ding	PROPN
aji-167	210	40	,	,	PUNCT
aji-167	210	41	l.	l.	PROPN
aji-167	210	42	(	(	PUNCT
aji-167	210	43	2024	2024	NUM
aji-167	210	44	)	)	PUNCT
aji-167	210	45	.	.	PUNCT
aji-167	211	1	the	the	DET
aji-167	211	2	role	role	NOUN
aji-167	211	3	of	of	ADP
aji-167	211	4	cytokines	cytokine	NOUN
aji-167	211	5	in	in	ADP
aji-167	211	6	acute	acute	ADJ
aji-167	211	7	and	and	CCONJ
aji-167	211	8	chronic	chronic	ADJ
aji-167	211	9	postsurgical	postsurgical	ADJ
aji-167	211	10	pain	pain	NOUN
aji-167	211	11	in	in	ADP
aji-167	211	12	pediatric	pediatric	ADJ
aji-167	211	13	patients	patient	NOUN
aji-167	211	14	after	after	ADP
aji-167	211	15	https://doi.org/10.3389/fimmu.2023.1161067	https://doi.org/10.3389/fimmu.2023.1161067	PROPN
aji-167	211	16	https://doi.org/10.3389/fimmu.2023.1161067	https://doi.org/10.3389/fimmu.2023.1161067	PROPN
aji-167	211	17	https://doi.org/10.18632/oncotarget.23208	https://doi.org/10.18632/oncotarget.23208	NOUN
aji-167	211	18	ehiaghe	ehiaghe	NOUN
aji-167	211	19	et	et	PROPN
aji-167	211	20	al	al	PROPN
aji-167	211	21	.	.	PROPN
aji-167	211	22	;	;	PUNCT
aji-167	211	23	asian	asian	PROPN
aji-167	211	24	j.	j.	PROPN
aji-167	211	25	immunol	immunol	PROPN
aji-167	211	26	.	.	PROPN
aji-167	211	27	,	,	PUNCT
aji-167	211	28	vol	vol	NOUN
aji-167	211	29	.	.	PROPN
aji-167	211	30	8	8	NUM
aji-167	211	31	,	,	PUNCT
aji-167	211	32	no	no	INTJ
aji-167	211	33	.	.	NOUN
aji-167	211	34	1	1	NUM
aji-167	211	35	,	,	PUNCT
aji-167	211	36	pp	pp	ADJ
aji-167	211	37	.	.	PUNCT
aji-167	212	1	134	134	NUM
aji-167	212	2	-	-	SYM
aji-167	212	3	141	141	NUM
aji-167	212	4	,	,	PUNCT
aji-167	212	5	2025	2025	NUM
aji-167	212	6	;	;	PUNCT
aji-167	212	7	article	article	NOUN
aji-167	212	8	no.aji.137461	no.aji.137461	PART
aji-167	212	9	139	139	NUM
aji-167	212	10	major	major	ADJ
aji-167	212	11	musculoskeletal	musculoskeletal	ADJ
aji-167	212	12	surgeries	surgery	NOUN
aji-167	212	13	.	.	PUNCT
aji-167	213	1	medrxiv	medrxiv	X
aji-167	213	2	:	:	PUNCT
aji-167	213	3	the	the	DET
aji-167	213	4	preprint	preprint	NOUN
aji-167	213	5	server	server	NOUN
aji-167	213	6	for	for	ADP
aji-167	213	7	health	health	NOUN
aji-167	213	8	sciences	science	NOUN
aji-167	213	9	,	,	PUNCT
aji-167	213	10	2024.03.27.24304974	2024.03.27.24304974	NUM
aji-167	213	11	.	.	PUNCT
aji-167	214	1	https://doi.org/10.1101/2024.03.27.243049	https://doi.org/10.1101/2024.03.27.243049	PROPN
aji-167	214	2	74	74	NUM
aji-167	214	3	choudhary	choudhary	PROPN
aji-167	214	4	,	,	PUNCT
aji-167	214	5	s.	s.	PROPN
aji-167	214	6	,	,	PUNCT
aji-167	214	7	shaikh	shaikh	PROPN
aji-167	214	8	,	,	PUNCT
aji-167	214	9	a.i	a.i	PROPN
aji-167	214	10	.	.	PROPN
aji-167	214	11	,	,	PUNCT
aji-167	214	12	kansal	kansal	NOUN
aji-167	214	13	,	,	PUNCT
aji-167	214	14	a.	a.	NOUN
aji-167	214	15	,	,	PUNCT
aji-167	214	16	patidar	patidar	ADJ
aji-167	214	17	,	,	PUNCT
aji-167	214	18	n.	n.	NOUN
aji-167	214	19	(	(	PUNCT
aji-167	214	20	2024	2024	NUM
aji-167	214	21	)	)	PUNCT
aji-167	214	22	.	.	PUNCT
aji-167	215	1	role	role	NOUN
aji-167	215	2	of	of	ADP
aji-167	215	3	hypocholesterolemia	hypocholesterolemia	NOUN
aji-167	215	4	and	and	CCONJ
aji-167	215	5	hypoalbuminemia	hypoalbuminemia	ADV
aji-167	215	6	as	as	ADP
aji-167	215	7	a	a	DET
aji-167	215	8	predictor	predictor	NOUN
aji-167	215	9	of	of	ADP
aji-167	215	10	surgical	surgical	ADJ
aji-167	215	11	site	site	NOUN
aji-167	215	12	.	.	PUNCT
aji-167	216	1	journal	journal	NOUN
aji-167	216	2	of	of	ADP
aji-167	216	3	cardiovascular	cardiovascular	ADJ
aji-167	216	4	disease	disease	NOUN
aji-167	216	5	research	research	NOUN
aji-167	216	6	,	,	PUNCT
aji-167	216	7	15(7	15(7	NUM
aji-167	216	8	)	)	PUNCT
aji-167	216	9	,	,	PUNCT
aji-167	216	10	3190	3190	NUM
aji-167	216	11	-	-	SYM
aji-167	216	12	3206	3206	NUM
aji-167	216	13	.	.	PUNCT
aji-167	217	1	choy	choy	NOUN
aji-167	217	2	,	,	PUNCT
aji-167	217	3	e.	e.	PROPN
aji-167	217	4	,	,	PUNCT
aji-167	217	5	bykerk	bykerk	PROPN
aji-167	217	6	,	,	PUNCT
aji-167	217	7	v.	v.	PROPN
aji-167	217	8	,	,	PUNCT
aji-167	217	9	lee	lee	PROPN
aji-167	217	10	,	,	PUNCT
aji-167	217	11	y.	y.	PROPN
aji-167	217	12	c.	c.	PROPN
aji-167	217	13	,	,	PUNCT
aji-167	217	14	van	van	PROPN
aji-167	217	15	hoogstraten	hoogstraten	PROPN
aji-167	217	16	,	,	PUNCT
aji-167	217	17	h.	h.	PROPN
aji-167	217	18	,	,	PUNCT
aji-167	217	19	ford	ford	PROPN
aji-167	217	20	,	,	PUNCT
aji-167	217	21	k.	k.	PROPN
aji-167	217	22	,	,	PUNCT
aji-167	217	23	praestgaard	praestgaard	PROPN
aji-167	217	24	,	,	PUNCT
aji-167	217	25	a.	a.	PROPN
aji-167	217	26	,	,	PUNCT
aji-167	217	27	perrot	perrot	PROPN
aji-167	217	28	,	,	PUNCT
aji-167	217	29	s.	s.	PROPN
aji-167	217	30	,	,	PUNCT
aji-167	217	31	pope	pope	PROPN
aji-167	217	32	,	,	PUNCT
aji-167	217	33	j.	j.	PROPN
aji-167	217	34	,	,	PUNCT
aji-167	217	35	&	&	CCONJ
aji-167	217	36	sebba	sebba	PROPN
aji-167	217	37	,	,	PUNCT
aji-167	217	38	a.	a.	NOUN
aji-167	217	39	(	(	PUNCT
aji-167	217	40	2023	2023	NUM
aji-167	217	41	)	)	PUNCT
aji-167	217	42	.	.	PUNCT
aji-167	218	1	disproportionate	disproportionate	ADJ
aji-167	218	2	articular	articular	ADJ
aji-167	218	3	pain	pain	NOUN
aji-167	218	4	is	be	AUX
aji-167	218	5	a	a	DET
aji-167	218	6	frequent	frequent	ADJ
aji-167	218	7	phenomenon	phenomenon	NOUN
aji-167	218	8	in	in	ADP
aji-167	218	9	rheumatoid	rheumatoid	NOUN
aji-167	218	10	arthritis	arthritis	NOUN
aji-167	218	11	and	and	CCONJ
aji-167	218	12	responds	respond	VERB
aji-167	218	13	to	to	PART
aji-167	218	14	treatment	treatment	NOUN
aji-167	218	15	with	with	ADP
aji-167	218	16	sarilumab	sarilumab	NOUN
aji-167	218	17	.	.	PUNCT
aji-167	219	1	rheumatology	rheumatology	NOUN
aji-167	219	2	(	(	PUNCT
aji-167	219	3	oxford	oxford	PROPN
aji-167	219	4	,	,	PUNCT
aji-167	219	5	england	england	PROPN
aji-167	219	6	)	)	PUNCT
aji-167	219	7	,	,	PUNCT
aji-167	219	8	62(7	62(7	NOUN
aji-167	219	9	)	)	PUNCT
aji-167	219	10	,	,	PUNCT
aji-167	219	11	2386–2393	2386–2393	NUM
aji-167	219	12	.	.	PUNCT
aji-167	220	1	https://doi.org/10.1093/rheumatology/keac	https://doi.org/10.1093/rheumatology/keac	ADP
aji-167	220	2	659	659	NUM
aji-167	220	3	cocea	cocea	NOUN
aji-167	220	4	,	,	PUNCT
aji-167	220	5	a.-c	a.-c	PROPN
aji-167	220	6	.	.	PROPN
aji-167	220	7	,	,	PUNCT
aji-167	220	8	&	&	CCONJ
aji-167	220	9	stoica	stoica	PROPN
aji-167	220	10	,	,	PUNCT
aji-167	220	11	c.	c.	PROPN
aji-167	220	12	i.	i.	PROPN
aji-167	220	13	(	(	PUNCT
aji-167	220	14	2024	2024	NUM
aji-167	220	15	)	)	PUNCT
aji-167	220	16	.	.	PUNCT
aji-167	221	1	interactions	interaction	NOUN
aji-167	221	2	and	and	CCONJ
aji-167	221	3	trends	trend	NOUN
aji-167	221	4	of	of	ADP
aji-167	221	5	interleukins	interleukin	NOUN
aji-167	221	6	,	,	PUNCT
aji-167	221	7	pai-1	pai-1	X
aji-167	221	8	,	,	PUNCT
aji-167	221	9	crp	crp	PROPN
aji-167	221	10	,	,	PUNCT
aji-167	221	11	and	and	CCONJ
aji-167	221	12	tnf	tnf	PROPN
aji-167	221	13	-	-	PUNCT
aji-167	221	14	α	α	PROPN
aji-167	221	15	in	in	ADP
aji-167	221	16	inflammatory	inflammatory	ADJ
aji-167	221	17	responses	response	NOUN
aji-167	221	18	during	during	ADP
aji-167	221	19	the	the	DET
aji-167	221	20	perioperative	perioperative	ADJ
aji-167	221	21	period	period	NOUN
aji-167	221	22	of	of	ADP
aji-167	221	23	joint	joint	ADJ
aji-167	221	24	arthroplasty	arthroplasty	NOUN
aji-167	221	25	:	:	PUNCT
aji-167	221	26	implications	implication	NOUN
aji-167	221	27	for	for	ADP
aji-167	221	28	pain	pain	NOUN
aji-167	221	29	management	management	NOUN
aji-167	221	30	—	—	PUNCT
aji-167	221	31	a	a	DET
aji-167	221	32	narrative	narrative	NOUN
aji-167	221	33	review	review	NOUN
aji-167	221	34	.	.	PUNCT
aji-167	222	1	journal	journal	PROPN
aji-167	222	2	of	of	ADP
aji-167	222	3	personalized	personalized	ADJ
aji-167	222	4	medicine	medicine	NOUN
aji-167	222	5	,	,	PUNCT
aji-167	222	6	14(5	14(5	NUM
aji-167	222	7	)	)	PUNCT
aji-167	222	8	,	,	PUNCT
aji-167	222	9	537	537	NUM
aji-167	222	10	.	.	PUNCT
aji-167	222	11	https://doi.org/10.3390/jpm14050537	https://doi.org/10.3390/jpm14050537	PROPN
aji-167	222	12	cooper	cooper	PROPN
aji-167	222	13	,	,	PUNCT
aji-167	222	14	b.	b.	PROPN
aji-167	222	15	a.	a.	PROPN
aji-167	222	16	,	,	PUNCT
aji-167	222	17	penne	penne	PROPN
aji-167	222	18	,	,	PUNCT
aji-167	222	19	e.	e.	PROPN
aji-167	222	20	l.	l.	PROPN
aji-167	222	21	,	,	PUNCT
aji-167	222	22	bartlett	bartlett	PROPN
aji-167	222	23	,	,	PUNCT
aji-167	222	24	l.	l.	PROPN
aji-167	222	25	h.	h.	PROPN
aji-167	222	26	,	,	PUNCT
aji-167	222	27	&	&	CCONJ
aji-167	222	28	pollock	pollock	PROPN
aji-167	222	29	,	,	PUNCT
aji-167	222	30	c.	c.	PROPN
aji-167	222	31	a.	a.	PROPN
aji-167	222	32	(	(	PUNCT
aji-167	222	33	2004	2004	NUM
aji-167	222	34	)	)	PUNCT
aji-167	222	35	.	.	PUNCT
aji-167	223	1	protein	protein	NOUN
aji-167	223	2	malnutrition	malnutrition	NOUN
aji-167	223	3	and	and	CCONJ
aji-167	223	4	hypoalbuminemia	hypoalbuminemia	ADV
aji-167	223	5	as	as	ADP
aji-167	223	6	predictors	predictor	NOUN
aji-167	223	7	of	of	ADP
aji-167	223	8	vascular	vascular	ADJ
aji-167	223	9	events	event	NOUN
aji-167	223	10	and	and	CCONJ
aji-167	223	11	mortality	mortality	NOUN
aji-167	223	12	in	in	ADP
aji-167	223	13	esrd	esrd	PROPN
aji-167	223	14	.	.	PUNCT
aji-167	224	1	american	american	PROPN
aji-167	224	2	journal	journal	PROPN
aji-167	224	3	of	of	ADP
aji-167	224	4	kidney	kidney	NOUN
aji-167	224	5	diseases	disease	NOUN
aji-167	224	6	:	:	PUNCT
aji-167	224	7	the	the	DET
aji-167	224	8	official	official	ADJ
aji-167	224	9	journal	journal	NOUN
aji-167	224	10	of	of	ADP
aji-167	224	11	the	the	DET
aji-167	224	12	national	national	PROPN
aji-167	224	13	kidney	kidney	PROPN
aji-167	224	14	foundation	foundation	PROPN
aji-167	224	15	,	,	PUNCT
aji-167	224	16	43(1	43(1	NOUN
aji-167	224	17	)	)	PUNCT
aji-167	224	18	,	,	PUNCT
aji-167	224	19	61–66	61–66	NOUN
aji-167	224	20	.	.	PUNCT
aji-167	225	1	https://doi.org/10.1053/j.ajkd.2003.08.045	https://doi.org/10.1053/j.ajkd.2003.08.045	PROPN
aji-167	225	2	daniel	daniel	PROPN
aji-167	225	3	,	,	PUNCT
aji-167	225	4	w.w	w.w	PROPN
aji-167	225	5	.	.	PROPN
aji-167	225	6	,	,	PUNCT
aji-167	225	7	&	&	CCONJ
aji-167	225	8	cross	cross	PROPN
aji-167	225	9	,	,	PUNCT
aji-167	225	10	c.	c.	PROPN
aji-167	225	11	l.	l.	PROPN
aji-167	225	12	(	(	PUNCT
aji-167	225	13	1999	1999	NUM
aji-167	225	14	)	)	PUNCT
aji-167	225	15	.	.	PUNCT
aji-167	226	1	determination	determination	NOUN
aji-167	226	2	of	of	ADP
aji-167	226	3	sample	sample	NOUN
aji-167	226	4	size	size	NOUN
aji-167	226	5	for	for	ADP
aji-167	226	6	estimating	estimate	VERB
aji-167	226	7	proportions	proportion	NOUN
aji-167	226	8	.	.	PUNCT
aji-167	227	1	biostatistics	biostatistic	NOUN
aji-167	227	2	:	:	PUNCT
aji-167	227	3	a	a	DET
aji-167	227	4	foundation	foundation	NOUN
aji-167	227	5	for	for	ADP
aji-167	227	6	analysis	analysis	NOUN
aji-167	227	7	in	in	ADP
aji-167	227	8	the	the	DET
aji-167	227	9	health	health	NOUN
aji-167	227	10	sciences	science	NOUN
aji-167	227	11	,	,	PUNCT
aji-167	227	12	8	8	NUM
aji-167	227	13	,	,	PUNCT
aji-167	227	14	189	189	NUM
aji-167	227	15	-	-	SYM
aji-167	227	16	190	190	NUM
aji-167	227	17	.	.	PUNCT
aji-167	228	1	doumas	doumas	PROPN
aji-167	228	2	,	,	PUNCT
aji-167	228	3	b.t	b.t	PROPN
aji-167	228	4	.	.	PROPN
aji-167	228	5	,	,	PUNCT
aji-167	228	6	watson	watson	PROPN
aji-167	228	7	,	,	PUNCT
aji-167	228	8	w.a	w.a	PROPN
aji-167	228	9	.	.	PROPN
aji-167	228	10	,	,	PUNCT
aji-167	228	11	&	&	CCONJ
aji-167	228	12	biggs	biggs	PROPN
aji-167	228	13	,	,	PUNCT
aji-167	228	14	h.g	h.g	PROPN
aji-167	228	15	.	.	PROPN
aji-167	228	16	(	(	PUNCT
aji-167	228	17	1971	1971	NUM
aji-167	228	18	)	)	PUNCT
aji-167	228	19	.	.	PUNCT
aji-167	229	1	albumin	albumin	ADJ
aji-167	229	2	standards	standard	NOUN
aji-167	229	3	and	and	CCONJ
aji-167	229	4	the	the	DET
aji-167	229	5	measurement	measurement	NOUN
aji-167	229	6	of	of	ADP
aji-167	229	7	serum	serum	NOUN
aji-167	229	8	albumin	albumin	NOUN
aji-167	229	9	with	with	ADP
aji-167	229	10	bromcresol	bromcresol	PROPN
aji-167	229	11	green	green	PROPN
aji-167	229	12	.	.	PUNCT
aji-167	230	1	clinica	clinica	PROPN
aji-167	230	2	chimica	chimica	PROPN
aji-167	230	3	acta	acta	PROPN
aji-167	230	4	;	;	PUNCT
aji-167	230	5	international	international	ADJ
aji-167	230	6	journal	journal	NOUN
aji-167	230	7	of	of	ADP
aji-167	230	8	clinical	clinical	ADJ
aji-167	230	9	chemistry	chemistry	NOUN
aji-167	230	10	,	,	PUNCT
aji-167	230	11	31(1	31(1	NUM
aji-167	230	12	)	)	PUNCT
aji-167	230	13	,	,	PUNCT
aji-167	230	14	87–96	87–96	NUM
aji-167	230	15	.	.	PUNCT
aji-167	230	16	https://doi.org/10.1016/00098981(71)90365-2	https://doi.org/10.1016/00098981(71)90365-2	PROPN
aji-167	230	17	ehiaghe	ehiaghe	PROPN
aji-167	230	18	,	,	PUNCT
aji-167	230	19	f.a	f.a	PROPN
aji-167	230	20	.	.	PROPN
aji-167	230	21	,	,	PUNCT
aji-167	230	22	ogonna	ogonna	PROPN
aji-167	230	23	,	,	PUNCT
aji-167	230	24	j.	j.	PROPN
aji-167	230	25	,	,	PUNCT
aji-167	230	26	ehiaghe	ehiaghe	PROPN
aji-167	230	27	,	,	PUNCT
aji-167	230	28	i.j	i.j	PROPN
aji-167	230	29	.	.	PROPN
aji-167	230	30	,	,	PUNCT
aji-167	230	31	erhunmwunse	erhunmwunse	PROPN
aji-167	230	32	,	,	PUNCT
aji-167	230	33	r.u	r.u	PROPN
aji-167	230	34	.	.	PROPN
aji-167	230	35	,	,	PUNCT
aji-167	230	36	anyaegbu	anyaegbu	PROPN
aji-167	230	37	,	,	PUNCT
aji-167	230	38	i.h	i.h	PROPN
aji-167	230	39	.	.	PROPN
aji-167	230	40	,	,	PUNCT
aji-167	230	41	chukwuanukwu	chukwuanukwu	PROPN
aji-167	230	42	,	,	PUNCT
aji-167	230	43	r.c	r.c	PROPN
aji-167	230	44	.	.	PROPN
aji-167	230	45	,	,	PUNCT
aji-167	230	46	onyenekwe	onyenekwe	NOUN
aji-167	230	47	,	,	PUNCT
aji-167	230	48	c.c	c.c	PROPN
aji-167	230	49	.	.	PROPN
aji-167	230	50	,	,	PUNCT
aji-167	230	51	osakue	osakue	PROPN
aji-167	230	52	,	,	PUNCT
aji-167	230	53	o.n	o.n	PROPN
aji-167	230	54	.	.	PROPN
aji-167	230	55	,	,	PUNCT
aji-167	230	56	okafoanyali	okafoanyali	ADJ
aji-167	230	57	,	,	PUNCT
aji-167	230	58	o.	o.	PROPN
aji-167	230	59	,	,	PUNCT
aji-167	230	60	&	&	CCONJ
aji-167	230	61	ogbodo	ogbodo	PROPN
aji-167	230	62	,	,	PUNCT
aji-167	230	63	e.c	e.c	PROPN
aji-167	230	64	.	.	PROPN
aji-167	230	65	(	(	PUNCT
aji-167	230	66	2025a	2025a	NUM
aji-167	230	67	)	)	PUNCT
aji-167	230	68	.	.	PUNCT
aji-167	231	1	elevated	elevated	ADJ
aji-167	231	2	levels	level	NOUN
aji-167	231	3	of	of	ADP
aji-167	231	4	interferon	interferon	ADJ
aji-167	231	5	gamma	gamma	NOUN
aji-167	231	6	,	,	PUNCT
aji-167	231	7	interleukin-4	interleukin-4	PROPN
aji-167	231	8	,	,	PUNCT
aji-167	231	9	neutrophil	neutrophil	ADJ
aji-167	231	10	lymphocyte	lymphocyte	ADJ
aji-167	231	11	ratio	ratio	NOUN
aji-167	231	12	and	and	CCONJ
aji-167	231	13	plateletlymphocyte	plateletlymphocyte	NOUN
aji-167	231	14	ratio	ratio	NOUN
aji-167	231	15	as	as	ADP
aji-167	231	16	biomarkers	biomarker	NOUN
aji-167	231	17	of	of	ADP
aji-167	231	18	postsurgical	postsurgical	ADJ
aji-167	231	19	wound	wound	NOUN
aji-167	231	20	infections	infection	NOUN
aji-167	231	21	amongst	amongst	ADP
aji-167	231	22	female	female	ADJ
aji-167	231	23	patients	patient	NOUN
aji-167	231	24	in	in	ADP
aji-167	231	25	nnewi	nnewi	PROPN
aji-167	231	26	,	,	PUNCT
aji-167	231	27	nigeria	nigeria	PROPN
aji-167	231	28	.	.	PUNCT
aji-167	232	1	asian	asian	ADJ
aji-167	232	2	journal	journal	PROPN
aji-167	232	3	of	of	ADP
aji-167	232	4	medicine	medicine	NOUN
aji-167	232	5	and	and	CCONJ
aji-167	232	6	health	health	NOUN
aji-167	232	7	,	,	PUNCT
aji-167	232	8	23(4	23(4	NOUN
aji-167	232	9	)	)	PUNCT
aji-167	232	10	,	,	PUNCT
aji-167	232	11	109	109	NUM
aji-167	232	12	-	-	SYM
aji-167	232	13	114	114	NUM
aji-167	232	14	.	.	PUNCT
aji-167	233	1	https://doi.org/10.9734/ajmah/2025/v23i41	https://doi.org/10.9734/ajmah/2025/v23i41	NOUN
aji-167	233	2	211	211	NUM
aji-167	233	3	.	.	PUNCT
aji-167	234	1	ehiaghe	ehiaghe	PROPN
aji-167	234	2	,	,	PUNCT
aji-167	234	3	j.i	j.i	PROPN
aji-167	234	4	.	.	PROPN
aji-167	234	5	,	,	PUNCT
aji-167	234	6	ogbebor	ogbebor	PROPN
aji-167	234	7	,	,	PUNCT
aji-167	234	8	a.o	a.o	PROPN
aji-167	234	9	.	.	PROPN
aji-167	234	10	,	,	PUNCT
aji-167	234	11	asiriuwa	asiriuwa	PROPN
aji-167	234	12	,	,	PUNCT
aji-167	234	13	i.	i.	NOUN
aji-167	234	14	,	,	PUNCT
aji-167	234	15	erhunmwunse	erhunmwunse	NOUN
aji-167	234	16	,	,	PUNCT
aji-167	234	17	r.u	r.u	PROPN
aji-167	234	18	.	.	PROPN
aji-167	234	19	,	,	PUNCT
aji-167	234	20	ayanlere	ayanlere	ADV
aji-167	234	21	,	,	PUNCT
aji-167	234	22	km	km	PROPN
aji-167	234	23	.	.	PROPN
aji-167	234	24	,	,	PUNCT
aji-167	234	25	amengialue	amengialue	NOUN
aji-167	234	26	,	,	PUNCT
aji-167	234	27	o.o	o.o	PROPN
aji-167	234	28	,	,	PUNCT
aji-167	234	29	ehiaghe	ehiaghe	PROPN
aji-167	234	30	f.a	f.a	PROPN
aji-167	234	31	.	.	PROPN
aji-167	234	32	,	,	PUNCT
aji-167	234	33	&	&	CCONJ
aji-167	234	34	ogbodo	ogbodo	PROPN
aji-167	234	35	,	,	PUNCT
aji-167	234	36	e.c	e.c	PROPN
aji-167	234	37	.	.	PROPN
aji-167	234	38	(	(	PUNCT
aji-167	234	39	2025b	2025b	NUM
aji-167	234	40	)	)	PUNCT
aji-167	234	41	.	.	PUNCT
aji-167	235	1	effect	effect	NOUN
aji-167	235	2	of	of	ADP
aji-167	235	3	misuse	misuse	NOUN
aji-167	235	4	of	of	ADP
aji-167	235	5	antibiotics	antibiotic	NOUN
aji-167	235	6	on	on	ADP
aji-167	235	7	cytokine	cytokine	ADJ
aji-167	235	8	patterns	pattern	NOUN
aji-167	235	9	and	and	CCONJ
aji-167	235	10	antibiogram	antibiogram	NUM
aji-167	235	11	of	of	ADP
aji-167	235	12	bacteria	bacteria	NOUN
aji-167	235	13	isolates	isolate	NOUN
aji-167	235	14	from	from	ADP
aji-167	235	15	surgical	surgical	ADJ
aji-167	235	16	site	site	NOUN
aji-167	235	17	infection	infection	NOUN
aji-167	235	18	in	in	ADP
aji-167	235	19	benin	benin	PROPN
aji-167	235	20	city	city	PROPN
aji-167	235	21	,	,	PUNCT
aji-167	235	22	edo	edo	PROPN
aji-167	235	23	state	state	PROPN
aji-167	235	24	,	,	PUNCT
aji-167	235	25	nigeria	nigeria	PROPN
aji-167	235	26	.	.	PUNCT
aji-167	236	1	asian	asian	ADJ
aji-167	236	2	journal	journal	PROPN
aji-167	236	3	of	of	ADP
aji-167	236	4	medicine	medicine	NOUN
aji-167	236	5	and	and	CCONJ
aji-167	236	6	health	health	NOUN
aji-167	236	7	,	,	PUNCT
aji-167	236	8	23(4	23(4	NOUN
aji-167	236	9	)	)	PUNCT
aji-167	236	10	,	,	PUNCT
aji-167	236	11	153	153	NUM
aji-167	236	12	-	-	SYM
aji-167	236	13	162	162	NUM
aji-167	236	14	.	.	PUNCT
aji-167	237	1	https://doi.org/10.9734/ajmah/2025/v23i41	https://doi.org/10.9734/ajmah/2025/v23i41	PUNCT
aji-167	237	2	216	216	NUM
aji-167	237	3	.	.	PUNCT
aji-167	238	1	fong	fong	PROPN
aji-167	238	2	,	,	PUNCT
aji-167	238	3	z.v	z.v	PROPN
aji-167	238	4	.	.	PROPN
aji-167	238	5	,	,	PUNCT
aji-167	238	6	ferrone	ferrone	NOUN
aji-167	238	7	,	,	PUNCT
aji-167	238	8	c.r	c.r	PROPN
aji-167	238	9	.	.	PROPN
aji-167	238	10	,	,	PUNCT
aji-167	238	11	thayer	thayer	PROPN
aji-167	238	12	,	,	PUNCT
aji-167	238	13	s.p	s.p	PROPN
aji-167	238	14	.	.	PROPN
aji-167	238	15	,	,	PUNCT
aji-167	238	16	wargo	wargo	PROPN
aji-167	238	17	,	,	PUNCT
aji-167	238	18	j.a	j.a	PROPN
aji-167	238	19	.	.	PROPN
aji-167	238	20	,	,	PUNCT
aji-167	238	21	sahora	sahora	PROPN
aji-167	238	22	,	,	PUNCT
aji-167	238	23	k.	k.	PROPN
aji-167	238	24	,	,	PUNCT
aji-167	238	25	seefeld	seefeld	PROPN
aji-167	238	26	,	,	PUNCT
aji-167	238	27	k.j	k.j	PROPN
aji-167	238	28	.	.	PROPN
aji-167	238	29	,	,	PUNCT
aji-167	238	30	warshaw	warshaw	PROPN
aji-167	238	31	,	,	PUNCT
aji-167	238	32	a.l	a.l	PROPN
aji-167	238	33	.	.	PROPN
aji-167	238	34	,	,	PUNCT
aji-167	238	35	lillemoe	lillemoe	PROPN
aji-167	238	36	,	,	PUNCT
aji-167	238	37	k.d	k.d	PROPN
aji-167	238	38	.	.	PROPN
aji-167	238	39	,	,	PUNCT
aji-167	238	40	hutter	hutter	PROPN
aji-167	238	41	,	,	PUNCT
aji-167	238	42	m.m	m.m	PROPN
aji-167	238	43	.	.	PROPN
aji-167	238	44	,	,	PUNCT
aji-167	238	45	&	&	CCONJ
aji-167	238	46	fernández	fernández	PROPN
aji-167	238	47	-	-	PUNCT
aji-167	238	48	del	del	PROPN
aji-167	238	49	castillo	castillo	PROPN
aji-167	238	50	,	,	PUNCT
aji-167	238	51	c.	c.	PROPN
aji-167	238	52	(	(	PUNCT
aji-167	238	53	2014	2014	NUM
aji-167	238	54	)	)	PUNCT
aji-167	238	55	.	.	PUNCT
aji-167	239	1	understanding	understand	VERB
aji-167	239	2	hospital	hospital	NOUN
aji-167	239	3	readmissions	readmission	NOUN
aji-167	239	4	after	after	ADP
aji-167	239	5	pancreaticoduodenectomy	pancreaticoduodenectomy	NOUN
aji-167	239	6	:	:	PUNCT
aji-167	239	7	can	can	AUX
aji-167	239	8	we	we	PRON
aji-167	239	9	prevent	prevent	VERB
aji-167	239	10	them	they	PRON
aji-167	239	11	?	?	PUNCT
aji-167	239	12	:	:	PUNCT
aji-167	239	13	a	a	DET
aji-167	239	14	10	10	NUM
aji-167	239	15	-	-	PUNCT
aji-167	239	16	year	year	NOUN
aji-167	239	17	contemporary	contemporary	ADJ
aji-167	239	18	experience	experience	NOUN
aji-167	239	19	with	with	ADP
aji-167	239	20	1,173	1,173	NUM
aji-167	239	21	patients	patient	NOUN
aji-167	239	22	at	at	ADP
aji-167	239	23	the	the	DET
aji-167	239	24	massachusetts	massachusetts	PROPN
aji-167	239	25	general	general	PROPN
aji-167	239	26	hospital	hospital	PROPN
aji-167	239	27	.	.	PUNCT
aji-167	240	1	journal	journal	NOUN
aji-167	240	2	of	of	ADP
aji-167	240	3	gastrointestinal	gastrointestinal	ADJ
aji-167	240	4	surgery	surgery	NOUN
aji-167	240	5	:	:	PUNCT
aji-167	240	6	official	official	ADJ
aji-167	240	7	journal	journal	NOUN
aji-167	240	8	of	of	ADP
aji-167	240	9	the	the	DET
aji-167	240	10	society	society	NOUN
aji-167	240	11	for	for	ADP
aji-167	240	12	surgery	surgery	NOUN
aji-167	240	13	of	of	ADP
aji-167	240	14	the	the	DET
aji-167	240	15	alimentary	alimentary	ADJ
aji-167	240	16	tract	tract	NOUN
aji-167	240	17	,	,	PUNCT
aji-167	240	18	18(1	18(1	NUM
aji-167	240	19	)	)	PUNCT
aji-167	240	20	,	,	PUNCT
aji-167	240	21	137–145	137–145	NUM
aji-167	240	22	.	.	PUNCT
aji-167	241	1	https://doi.org/10.1007/s11605-013-2336-9	https://doi.org/10.1007/s11605-013-2336-9	NOUN
aji-167	241	2	hsing	hsing	PROPN
aji-167	241	3	,	,	PUNCT
aji-167	241	4	c.h	c.h	PROPN
aji-167	241	5	.	.	PROPN
aji-167	241	6	,	,	PUNCT
aji-167	241	7	&	&	CCONJ
aji-167	241	8	wang	wang	PROPN
aji-167	241	9	,	,	PUNCT
aji-167	241	10	j.j	j.j	PROPN
aji-167	241	11	.	.	PROPN
aji-167	241	12	(	(	PUNCT
aji-167	241	13	2015	2015	NUM
aji-167	241	14	)	)	PUNCT
aji-167	241	15	.	.	PUNCT
aji-167	242	1	clinical	clinical	ADJ
aji-167	242	2	implication	implication	NOUN
aji-167	242	3	of	of	ADP
aji-167	242	4	perioperative	perioperative	ADJ
aji-167	242	5	inflammatory	inflammatory	ADJ
aji-167	242	6	cytokine	cytokine	NOUN
aji-167	242	7	alteration	alteration	NOUN
aji-167	242	8	.	.	PUNCT
aji-167	243	1	acta	acta	PROPN
aji-167	243	2	anaesthesiologica	anaesthesiologica	PROPN
aji-167	244	1	taiwanica	taiwanica	PROPN
aji-167	244	2	:	:	PUNCT
aji-167	244	3	official	official	ADJ
aji-167	244	4	journal	journal	NOUN
aji-167	244	5	of	of	ADP
aji-167	244	6	the	the	DET
aji-167	244	7	taiwan	taiwan	PROPN
aji-167	244	8	society	society	NOUN
aji-167	244	9	of	of	ADP
aji-167	244	10	anesthesiologists	anesthesiologist	NOUN
aji-167	244	11	,	,	PUNCT
aji-167	244	12	53(1	53(1	NUM
aji-167	244	13	)	)	PUNCT
aji-167	244	14	,	,	PUNCT
aji-167	244	15	23–28	23–28	NUM
aji-167	244	16	.	.	PUNCT
aji-167	245	1	https://doi.org/10.1016/j.aat.2015.03.002	https://doi.org/10.1016/j.aat.2015.03.002	VERB
aji-167	245	2	he	he	PRON
aji-167	245	3	,	,	PUNCT
aji-167	245	4	y.	y.	PROPN
aji-167	245	5	,	,	PUNCT
aji-167	245	6	xiao	xiao	PROPN
aji-167	245	7	,	,	PUNCT
aji-167	245	8	j.	j.	PROPN
aji-167	245	9	,	,	PUNCT
aji-167	245	10	shi	shi	PROPN
aji-167	245	11	,	,	PUNCT
aji-167	245	12	z.	z.	PROPN
aji-167	245	13	,	,	PUNCT
aji-167	245	14	he	he	PRON
aji-167	245	15	,	,	PUNCT
aji-167	245	16	j.	j.	PROPN
aji-167	245	17	,	,	PUNCT
aji-167	245	18	&	&	CCONJ
aji-167	245	19	li	li	PROPN
aji-167	245	20	,	,	PUNCT
aji-167	245	21	t.	t.	PROPN
aji-167	245	22	(	(	PUNCT
aji-167	245	23	2019	2019	NUM
aji-167	245	24	)	)	PUNCT
aji-167	245	25	.	.	PUNCT
aji-167	246	1	supplementation	supplementation	NOUN
aji-167	246	2	of	of	ADP
aji-167	246	3	enteral	enteral	ADJ
aji-167	246	4	nutritional	nutritional	ADJ
aji-167	246	5	powder	powder	NOUN
aji-167	246	6	decreases	decrease	VERB
aji-167	246	7	surgical	surgical	ADJ
aji-167	246	8	site	site	NOUN
aji-167	246	9	infection	infection	NOUN
aji-167	246	10	,	,	PUNCT
aji-167	246	11	prosthetic	prosthetic	ADJ
aji-167	246	12	joint	joint	ADJ
aji-167	246	13	infection	infection	NOUN
aji-167	246	14	,	,	PUNCT
aji-167	246	15	and	and	CCONJ
aji-167	246	16	readmission	readmission	NOUN
aji-167	246	17	after	after	ADP
aji-167	246	18	hip	hip	NOUN
aji-167	246	19	arthroplasty	arthroplasty	NOUN
aji-167	246	20	in	in	ADP
aji-167	246	21	geriatric	geriatric	ADJ
aji-167	246	22	femoral	femoral	ADJ
aji-167	246	23	neck	neck	NOUN
aji-167	246	24	fracture	fracture	NOUN
aji-167	246	25	with	with	ADP
aji-167	246	26	hypoalbuminemia	hypoalbuminemia	NOUN
aji-167	246	27	.	.	PUNCT
aji-167	247	1	journal	journal	PROPN
aji-167	247	2	of	of	ADP
aji-167	247	3	orthopaedic	orthopaedic	ADJ
aji-167	247	4	surgery	surgery	NOUN
aji-167	247	5	and	and	CCONJ
aji-167	247	6	research	research	NOUN
aji-167	247	7	,	,	PUNCT
aji-167	247	8	14(1	14(1	NUM
aji-167	247	9	)	)	PUNCT
aji-167	247	10	,	,	PUNCT
aji-167	247	11	292	292	NUM
aji-167	247	12	.	.	PUNCT
aji-167	247	13	https://doi.org/10.1186/s13018-019-1343-2	https://doi.org/10.1186/s13018-019-1343-2	VERB
aji-167	248	1	he	he	PRON
aji-167	248	2	,	,	PUNCT
aji-167	248	3	z.	z.	PROPN
aji-167	248	4	,	,	PUNCT
aji-167	248	5	zhou	zhou	PROPN
aji-167	248	6	,	,	PUNCT
aji-167	248	7	k.	k.	PROPN
aji-167	248	8	,	,	PUNCT
aji-167	248	9	tang	tang	PROPN
aji-167	248	10	,	,	PUNCT
aji-167	248	11	k.	k.	PROPN
aji-167	248	12	,	,	PUNCT
aji-167	248	13	quan	quan	PROPN
aji-167	248	14	,	,	PUNCT
aji-167	248	15	z.	z.	PROPN
aji-167	248	16	,	,	PUNCT
aji-167	248	17	liu	liu	PROPN
aji-167	248	18	,	,	PUNCT
aji-167	248	19	s.	s.	PROPN
aji-167	248	20	,	,	PUNCT
aji-167	248	21	&	&	CCONJ
aji-167	248	22	su	su	PROPN
aji-167	248	23	,	,	PUNCT
aji-167	248	24	b.	b.	PROPN
aji-167	248	25	(	(	PUNCT
aji-167	248	26	2020	2020	NUM
aji-167	248	27	)	)	PUNCT
aji-167	248	28	.	.	PUNCT
aji-167	249	1	perioperative	perioperative	ADJ
aji-167	249	2	hypoalbuminemia	hypoalbuminemia	NOUN
aji-167	249	3	is	be	AUX
aji-167	249	4	a	a	DET
aji-167	249	5	risk	risk	NOUN
aji-167	249	6	factor	factor	NOUN
aji-167	249	7	for	for	ADP
aji-167	249	8	wound	wound	ADJ
aji-167	249	9	complications	complication	NOUN
aji-167	249	10	following	follow	VERB
aji-167	249	11	posterior	posterior	ADJ
aji-167	249	12	lumbar	lumbar	NOUN
aji-167	249	13	interbody	interbody	NOUN
aji-167	249	14	fusion	fusion	NOUN
aji-167	249	15	.	.	PUNCT
aji-167	250	1	journal	journal	NOUN
aji-167	250	2	of	of	ADP
aji-167	250	3	orthopaedic	orthopaedic	ADJ
aji-167	250	4	surgery	surgery	NOUN
aji-167	250	5	and	and	CCONJ
aji-167	250	6	research	research	NOUN
aji-167	250	7	,	,	PUNCT
aji-167	250	8	15(1	15(1	NUM
aji-167	250	9	)	)	PUNCT
aji-167	250	10	,	,	PUNCT
aji-167	250	11	538	538	NUM
aji-167	250	12	.	.	PUNCT
aji-167	251	1	https://doi.org/10.1186/s13018-020-020514	https://doi.org/10.1186/s13018-020-020514	NOUN
aji-167	251	2	iyer	iyer	PROPN
aji-167	251	3	,	,	PUNCT
aji-167	251	4	s.s	s.s	PROPN
aji-167	251	5	.	.	PROPN
aji-167	251	6	,	,	PUNCT
aji-167	251	7	&	&	CCONJ
aji-167	251	8	cheng	cheng	PROPN
aji-167	251	9	,	,	PUNCT
aji-167	251	10	g.	g.	PROPN
aji-167	251	11	(	(	PUNCT
aji-167	251	12	2012	2012	NUM
aji-167	251	13	)	)	PUNCT
aji-167	251	14	.	.	PUNCT
aji-167	252	1	role	role	NOUN
aji-167	252	2	of	of	ADP
aji-167	252	3	interleukin	interleukin	NOUN
aji-167	252	4	10	10	NUM
aji-167	252	5	transcriptional	transcriptional	ADJ
aji-167	252	6	regulation	regulation	NOUN
aji-167	252	7	in	in	ADP
aji-167	252	8	inflammation	inflammation	NOUN
aji-167	252	9	and	and	CCONJ
aji-167	252	10	autoimmune	autoimmune	ADJ
aji-167	252	11	disease	disease	NOUN
aji-167	252	12	.	.	PUNCT
aji-167	253	1	critical	critical	ADJ
aji-167	253	2	reviews	review	NOUN
aji-167	253	3	in	in	ADP
aji-167	253	4	immunology	immunology	NOUN
aji-167	253	5	,	,	PUNCT
aji-167	253	6	32(1	32(1	NUM
aji-167	253	7	)	)	PUNCT
aji-167	253	8	,	,	PUNCT
aji-167	253	9	23	23	NUM
aji-167	253	10	–	–	PUNCT
aji-167	253	11	63	63	NUM
aji-167	253	12	.	.	PUNCT
aji-167	253	13	https://doi.org/10.3390/jpm14050537	https://doi.org/10.3390/jpm14050537	NOUN
aji-167	253	14	https://doi.org/10.1053/j.ajkd.2003.08.045	https://doi.org/10.1053/j.ajkd.2003.08.045	ADJ
aji-167	253	15	https://doi.org/10.1016/0009-8981(71)90365-2	https://doi.org/10.1016/0009-8981(71)90365-2	PROPN
aji-167	253	16	https://doi.org/10.1016/0009-8981(71)90365-2	https://doi.org/10.1016/0009-8981(71)90365-2	PROPN
aji-167	253	17	https://doi.org/10.1007/s11605-013-2336-9	https://doi.org/10.1007/s11605-013-2336-9	NOUN
aji-167	253	18	https://doi.org/10.1016/j.aat.2015.03.002	https://doi.org/10.1016/j.aat.2015.03.002	NOUN
aji-167	253	19	https://doi.org/10.1186/s13018-019-1343-2	https://doi.org/10.1186/s13018-019-1343-2	PRON
aji-167	253	20	https://doi.org/10.1186/s13018-020-02051-4	https://doi.org/10.1186/s13018-020-02051-4	NUM
aji-167	253	21	https://doi.org/10.1186/s13018-020-02051-4	https://doi.org/10.1186/s13018-020-02051-4	NUM
aji-167	253	22	ehiaghe	ehiaghe	PROPN
aji-167	253	23	et	et	PROPN
aji-167	253	24	al	al	PROPN
aji-167	253	25	.	.	PROPN
aji-167	253	26	;	;	PUNCT
aji-167	254	1	asian	asian	PROPN
aji-167	254	2	j.	j.	PROPN
aji-167	254	3	immunol	immunol	PROPN
aji-167	254	4	.	.	PROPN
aji-167	254	5	,	,	PUNCT
aji-167	254	6	vol	vol	NOUN
aji-167	254	7	.	.	PROPN
aji-167	254	8	8	8	NUM
aji-167	254	9	,	,	PUNCT
aji-167	254	10	no	no	INTJ
aji-167	254	11	.	.	NOUN
aji-167	254	12	1	1	NUM
aji-167	254	13	,	,	PUNCT
aji-167	254	14	pp	pp	ADJ
aji-167	254	15	.	.	PUNCT
aji-167	255	1	134	134	NUM
aji-167	255	2	-	-	SYM
aji-167	255	3	141	141	NUM
aji-167	255	4	,	,	PUNCT
aji-167	255	5	2025	2025	NUM
aji-167	255	6	;	;	PUNCT
aji-167	255	7	article	article	NOUN
aji-167	255	8	no.aji.137461	no.aji.137461	ADJ
aji-167	255	9	140	140	NUM
aji-167	255	10	https://doi.org/10.1615/critrevimmunol.v32.i	https://doi.org/10.1615/critrevimmunol.v32.i	X
aji-167	255	11	1.30	1.30	NUM
aji-167	255	12	jang	jang	PROPN
aji-167	255	13	,	,	PUNCT
aji-167	255	14	d.i	d.i	PROPN
aji-167	255	15	.	.	PROPN
aji-167	255	16	,	,	PUNCT
aji-167	255	17	lee	lee	PROPN
aji-167	255	18	,	,	PUNCT
aji-167	255	19	a.h	a.h	PROPN
aji-167	255	20	.	.	PROPN
aji-167	255	21	,	,	PUNCT
aji-167	255	22	shin	shin	PROPN
aji-167	255	23	,	,	PUNCT
aji-167	255	24	h.y	h.y	PROPN
aji-167	255	25	.	.	PROPN
aji-167	255	26	,	,	PUNCT
aji-167	255	27	song	song	PROPN
aji-167	255	28	,	,	PUNCT
aji-167	255	29	h.r	h.r	PROPN
aji-167	255	30	.	.	PROPN
aji-167	255	31	,	,	PUNCT
aji-167	255	32	park	park	PROPN
aji-167	255	33	,	,	PUNCT
aji-167	255	34	j.h	j.h	PROPN
aji-167	255	35	.	.	PROPN
aji-167	255	36	,	,	PUNCT
aji-167	255	37	kang	kang	PROPN
aji-167	255	38	,	,	PUNCT
aji-167	255	39	t.b	t.b	PROPN
aji-167	255	40	.	.	PROPN
aji-167	255	41	,	,	PUNCT
aji-167	255	42	lee	lee	PROPN
aji-167	255	43	,	,	PUNCT
aji-167	255	44	s.r	s.r	PROPN
aji-167	255	45	.	.	PROPN
aji-167	255	46	,	,	PUNCT
aji-167	255	47	&	&	CCONJ
aji-167	255	48	yang	yang	PROPN
aji-167	255	49	,	,	PUNCT
aji-167	255	50	s.h	s.h	PROPN
aji-167	255	51	.	.	PROPN
aji-167	255	52	(	(	PUNCT
aji-167	255	53	2021	2021	NUM
aji-167	255	54	)	)	PUNCT
aji-167	255	55	.	.	PUNCT
aji-167	256	1	the	the	DET
aji-167	256	2	role	role	NOUN
aji-167	256	3	of	of	ADP
aji-167	256	4	tumor	tumor	NOUN
aji-167	256	5	necrosis	necrosis	NOUN
aji-167	256	6	factor	factor	NOUN
aji-167	256	7	alpha	alpha	NOUN
aji-167	256	8	(	(	PUNCT
aji-167	256	9	tnf	tnf	PROPN
aji-167	256	10	-	-	PUNCT
aji-167	256	11	α	α	NOUN
aji-167	256	12	)	)	PUNCT
aji-167	256	13	in	in	ADP
aji-167	256	14	autoimmune	autoimmune	ADJ
aji-167	256	15	disease	disease	NOUN
aji-167	256	16	and	and	CCONJ
aji-167	256	17	current	current	ADJ
aji-167	256	18	tnf	tnf	PROPN
aji-167	256	19	-	-	PUNCT
aji-167	256	20	α	α	PROPN
aji-167	256	21	inhibitors	inhibitor	NOUN
aji-167	256	22	in	in	ADP
aji-167	256	23	therapeutics	therapeutic	NOUN
aji-167	256	24	.	.	PUNCT
aji-167	257	1	international	international	ADJ
aji-167	257	2	journal	journal	NOUN
aji-167	257	3	of	of	ADP
aji-167	257	4	molecular	molecular	ADJ
aji-167	257	5	sciences	science	NOUN
aji-167	257	6	,	,	PUNCT
aji-167	257	7	22(5	22(5	NOUN
aji-167	257	8	)	)	PUNCT
aji-167	257	9	,	,	PUNCT
aji-167	257	10	2719	2719	NUM
aji-167	257	11	.	.	PUNCT
aji-167	258	1	https://doi.org/10.3390/ijms22052719	https://doi.org/10.3390/ijms22052719	PROPN
aji-167	258	2	javed	javed	PROPN
aji-167	258	3	,	,	PUNCT
aji-167	258	4	a.a	a.a	PROPN
aji-167	258	5	.	.	PROPN
aji-167	258	6	,	,	PUNCT
aji-167	258	7	teinor	teinor	PROPN
aji-167	258	8	,	,	PUNCT
aji-167	258	9	j.	j.	PROPN
aji-167	258	10	,	,	PUNCT
aji-167	258	11	wright	wright	PROPN
aji-167	258	12	,	,	PUNCT
aji-167	258	13	m.	m.	NOUN
aji-167	258	14	,	,	PUNCT
aji-167	258	15	ding	ding	NOUN
aji-167	258	16	,	,	PUNCT
aji-167	258	17	d.	d.	PROPN
aji-167	258	18	,	,	PUNCT
aji-167	258	19	burkhart	burkhart	PROPN
aji-167	258	20	,	,	PUNCT
aji-167	258	21	r.a	r.a	PROPN
aji-167	258	22	.	.	PROPN
aji-167	258	23	,	,	PUNCT
aji-167	258	24	hundt	hundt	PROPN
aji-167	258	25	,	,	PUNCT
aji-167	258	26	j.	j.	PROPN
aji-167	258	27	,	,	PUNCT
aji-167	258	28	cameron	cameron	PROPN
aji-167	258	29	,	,	PUNCT
aji-167	258	30	j.l	j.l	PROPN
aji-167	258	31	.	.	PROPN
aji-167	258	32	,	,	PUNCT
aji-167	258	33	makary	makary	ADJ
aji-167	258	34	,	,	PUNCT
aji-167	258	35	m.a	m.a	PROPN
aji-167	258	36	.	.	PROPN
aji-167	258	37	,	,	PUNCT
aji-167	258	38	he	he	PRON
aji-167	258	39	,	,	PUNCT
aji-167	258	40	j.	j.	PROPN
aji-167	258	41	,	,	PUNCT
aji-167	258	42	eckhauser	eckhauser	PROPN
aji-167	258	43	,	,	PUNCT
aji-167	258	44	f.e	f.e	PROPN
aji-167	258	45	.	.	PROPN
aji-167	258	46	,	,	PUNCT
aji-167	258	47	wolfgang	wolfgang	PROPN
aji-167	258	48	,	,	PUNCT
aji-167	258	49	c.l	c.l	PROPN
aji-167	258	50	.	.	PROPN
aji-167	258	51	,	,	PUNCT
aji-167	258	52	&	&	CCONJ
aji-167	258	53	weiss	weiss	PROPN
aji-167	258	54	,	,	PUNCT
aji-167	258	55	m.j	m.j	PROPN
aji-167	258	56	.	.	PROPN
aji-167	258	57	(	(	PUNCT
aji-167	258	58	2019	2019	NUM
aji-167	258	59	)	)	PUNCT
aji-167	258	60	.	.	PUNCT
aji-167	259	1	negative	negative	ADJ
aji-167	259	2	pressure	pressure	NOUN
aji-167	259	3	wound	wound	NOUN
aji-167	259	4	therapy	therapy	NOUN
aji-167	259	5	for	for	ADP
aji-167	259	6	surgical	surgical	ADJ
aji-167	259	7	-	-	PUNCT
aji-167	259	8	site	site	NOUN
aji-167	259	9	infections	infection	NOUN
aji-167	259	10	:	:	PUNCT
aji-167	259	11	a	a	DET
aji-167	259	12	randomized	randomized	ADJ
aji-167	259	13	trial	trial	NOUN
aji-167	259	14	.	.	PUNCT
aji-167	260	1	annals	annal	NOUN
aji-167	260	2	of	of	ADP
aji-167	260	3	surgery	surgery	NOUN
aji-167	260	4	,	,	PUNCT
aji-167	260	5	269(6	269(6	NUM
aji-167	260	6	)	)	PUNCT
aji-167	260	7	,	,	PUNCT
aji-167	260	8	1034	1034	NUM
aji-167	260	9	–	–	PUNCT
aji-167	260	10	1040	1040	NUM
aji-167	260	11	.	.	PUNCT
aji-167	261	1	https://doi.org/10.1097/sla.000000000000	https://doi.org/10.1097/sla.000000000000	PROPN
aji-167	261	2	3056	3056	NUM
aji-167	261	3	kallakuri	kallakuri	PROPN
aji-167	261	4	,	,	PUNCT
aji-167	261	5	k.	k.	PROPN
aji-167	261	6	,	,	PUNCT
aji-167	261	7	suprada	suprada	PROPN
aji-167	261	8	,	,	PUNCT
aji-167	261	9	k.	k.	PROPN
aji-167	261	10	,	,	PUNCT
aji-167	261	11	bahadur	bahadur	PROPN
aji-167	261	12	,	,	PUNCT
aji-167	261	13	b.	b.	PROPN
aji-167	261	14	r.	r.	PROPN
aji-167	261	15	,	,	PUNCT
aji-167	261	16	&	&	CCONJ
aji-167	261	17	rao	rao	PROPN
aji-167	261	18	,	,	PUNCT
aji-167	261	19	g.	g.	PROPN
aji-167	261	20	(	(	PUNCT
aji-167	261	21	2024	2024	NUM
aji-167	261	22	)	)	PUNCT
aji-167	261	23	.	.	PUNCT
aji-167	262	1	post	post	VERB
aji-167	262	2	operative	operative	ADJ
aji-167	262	3	wound	wound	NOUN
aji-167	262	4	infection	infection	NOUN
aji-167	262	5	:	:	PUNCT
aji-167	262	6	a	a	DET
aji-167	262	7	descriptive	descriptive	ADJ
aji-167	262	8	study	study	NOUN
aji-167	262	9	.	.	PUNCT
aji-167	263	1	international	international	ADJ
aji-167	263	2	journal	journal	PROPN
aji-167	263	3	of	of	ADP
aji-167	263	4	reproduction	reproduction	NOUN
aji-167	263	5	,	,	PUNCT
aji-167	263	6	contraception	contraception	NOUN
aji-167	263	7	,	,	PUNCT
aji-167	263	8	obstetrics	obstetric	NOUN
aji-167	263	9	and	and	CCONJ
aji-167	263	10	gynecology	gynecology	NOUN
aji-167	263	11	,	,	PUNCT
aji-167	263	12	13(7	13(7	NUM
aji-167	263	13	)	)	PUNCT
aji-167	263	14	,	,	PUNCT
aji-167	263	15	1731	1731	NUM
aji-167	263	16	–	–	PUNCT
aji-167	263	17	1734	1734	NUM
aji-167	263	18	.	.	PUNCT
aji-167	264	1	https://doi.org/10.18203/23201770.ijrcog20241767	https://doi.org/10.18203/23201770.ijrcog20241767	PROPN
aji-167	264	2	keller	keller	PROPN
aji-167	264	3	,	,	PUNCT
aji-167	264	4	u.	u.	PROPN
aji-167	264	5	(	(	PUNCT
aji-167	264	6	2019	2019	NUM
aji-167	264	7	)	)	PUNCT
aji-167	264	8	.	.	PUNCT
aji-167	265	1	nutritional	nutritional	ADJ
aji-167	265	2	laboratory	laboratory	NOUN
aji-167	265	3	markers	marker	NOUN
aji-167	265	4	in	in	ADP
aji-167	265	5	malnutrition	malnutrition	NOUN
aji-167	265	6	.	.	PUNCT
aji-167	266	1	journal	journal	NOUN
aji-167	266	2	of	of	ADP
aji-167	266	3	clinical	clinical	ADJ
aji-167	266	4	medicine	medicine	NOUN
aji-167	266	5	,	,	PUNCT
aji-167	266	6	8(6	8(6	NUM
aji-167	266	7	)	)	PUNCT
aji-167	266	8	,	,	PUNCT
aji-167	266	9	775	775	NUM
aji-167	266	10	.	.	PUNCT
aji-167	267	1	https://doi.org/10.3390/jcm8060775	https://doi.org/10.3390/jcm8060775	PROPN
aji-167	267	2	llombart	llombart	PROPN
aji-167	267	3	,	,	PUNCT
aji-167	267	4	r.	r.	PROPN
aji-167	267	5	,	,	PUNCT
aji-167	267	6	mariscal	mariscal	PROPN
aji-167	267	7	,	,	PUNCT
aji-167	267	8	g.	g.	PROPN
aji-167	267	9	,	,	PUNCT
aji-167	267	10	barrios	barrio	NOUN
aji-167	267	11	,	,	PUNCT
aji-167	267	12	c.	c.	NOUN
aji-167	267	13	,	,	PUNCT
aji-167	267	14	de	de	PROPN
aji-167	267	15	la	la	PROPN
aji-167	267	16	rubia	rubia	PROPN
aji-167	267	17	ortí	ortí	NOUN
aji-167	267	18	,	,	PUNCT
aji-167	267	19	j.	j.	PROPN
aji-167	267	20	e.	e.	PROPN
aji-167	267	21	,	,	PUNCT
aji-167	267	22	&	&	CCONJ
aji-167	267	23	llombart	llombart	PROPN
aji-167	267	24	-	-	PUNCT
aji-167	267	25	ais	ais	PROPN
aji-167	267	26	,	,	PUNCT
aji-167	267	27	r.	r.	PROPN
aji-167	267	28	(	(	PUNCT
aji-167	267	29	2023	2023	NUM
aji-167	267	30	)	)	PUNCT
aji-167	267	31	.	.	PUNCT
aji-167	268	1	the	the	DET
aji-167	268	2	impact	impact	NOUN
aji-167	268	3	of	of	ADP
aji-167	268	4	hypoalbuminemia	hypoalbuminemia	ADV
aji-167	268	5	on	on	ADP
aji-167	268	6	postoperative	postoperative	ADJ
aji-167	268	7	complications	complication	NOUN
aji-167	268	8	in	in	ADP
aji-167	268	9	patients	patient	NOUN
aji-167	268	10	undergoing	undergo	VERB
aji-167	268	11	shoulder	shoulder	NOUN
aji-167	268	12	arthroplasty	arthroplasty	NOUN
aji-167	268	13	:	:	PUNCT
aji-167	268	14	a	a	DET
aji-167	268	15	metaanalysis	metaanalysis	NOUN
aji-167	268	16	.	.	PUNCT
aji-167	269	1	the	the	DET
aji-167	269	2	journal	journal	NOUN
aji-167	269	3	of	of	ADP
aji-167	269	4	nutrition	nutrition	PROPN
aji-167	269	5	,	,	PUNCT
aji-167	269	6	health	health	NOUN
aji-167	269	7	&	&	CCONJ
aji-167	269	8	aging	aging	NOUN
aji-167	269	9	,	,	PUNCT
aji-167	269	10	27(12	27(12	NUM
aji-167	269	11	)	)	PUNCT
aji-167	269	12	,	,	PUNCT
aji-167	269	13	1248–1254	1248–1254	NUM
aji-167	269	14	.	.	PUNCT
aji-167	270	1	https://doi.org/10.1007/s12603-023-2050-6	https://doi.org/10.1007/s12603-023-2050-6	PROPN
aji-167	270	2	mengistu	mengistu	PROPN
aji-167	270	3	,	,	PUNCT
aji-167	270	4	d.a	d.a	PROPN
aji-167	270	5	.	.	PROPN
aji-167	270	6	,	,	PUNCT
aji-167	270	7	alemu	alemu	PROPN
aji-167	270	8	,	,	PUNCT
aji-167	270	9	a.	a.	NOUN
aji-167	270	10	,	,	PUNCT
aji-167	270	11	abdukadir	abdukadir	PROPN
aji-167	270	12	,	,	PUNCT
aji-167	270	13	a.a	a.a	PROPN
aji-167	270	14	.	.	PROPN
aji-167	270	15	,	,	PUNCT
aji-167	270	16	mohammed	mohammed	PROPN
aji-167	270	17	husen	husen	PROPN
aji-167	270	18	,	,	PUNCT
aji-167	270	19	a.	a.	PROPN
aji-167	270	20	,	,	PUNCT
aji-167	270	21	ahmed	ahmed	PROPN
aji-167	270	22	,	,	PUNCT
aji-167	270	23	f.	f.	PROPN
aji-167	270	24	,	,	PUNCT
aji-167	270	25	mohammed	mohammed	PROPN
aji-167	270	26	,	,	PUNCT
aji-167	270	27	b.	b.	PROPN
aji-167	270	28	,	,	PUNCT
aji-167	270	29	&	&	CCONJ
aji-167	270	30	musa	musa	PROPN
aji-167	270	31	,	,	PUNCT
aji-167	270	32	i.	i.	PROPN
aji-167	270	33	(	(	PUNCT
aji-167	270	34	2023	2023	NUM
aji-167	270	35	)	)	PUNCT
aji-167	270	36	.	.	PUNCT
aji-167	271	1	global	global	ADJ
aji-167	271	2	incidence	incidence	NOUN
aji-167	271	3	of	of	ADP
aji-167	271	4	surgical	surgical	ADJ
aji-167	271	5	site	site	NOUN
aji-167	271	6	infection	infection	NOUN
aji-167	271	7	among	among	ADP
aji-167	271	8	patients	patient	NOUN
aji-167	271	9	:	:	PUNCT
aji-167	271	10	systematic	systematic	ADJ
aji-167	271	11	review	review	NOUN
aji-167	271	12	and	and	CCONJ
aji-167	271	13	metaanalysis	metaanalysis	NOUN
aji-167	271	14	.	.	PUNCT
aji-167	272	1	inquiry	inquiry	NOUN
aji-167	272	2	:	:	PUNCT
aji-167	272	3	a	a	DET
aji-167	272	4	journal	journal	NOUN
aji-167	272	5	of	of	ADP
aji-167	272	6	medical	medical	ADJ
aji-167	272	7	care	care	PROPN
aji-167	272	8	organization	organization	NOUN
aji-167	272	9	,	,	PUNCT
aji-167	272	10	provision	provision	NOUN
aji-167	272	11	and	and	CCONJ
aji-167	272	12	financing	financing	NOUN
aji-167	272	13	,	,	PUNCT
aji-167	272	14	60	60	NUM
aji-167	272	15	,	,	PUNCT
aji-167	272	16	469580231162549	469580231162549	NUM
aji-167	272	17	.	.	PUNCT
aji-167	273	1	https://doi.org/10.1177/004695802311625	https://doi.org/10.1177/004695802311625	NOUN
aji-167	273	2	49	49	NUM
aji-167	273	3	mittal	mittal	NOUN
aji-167	273	4	,	,	PUNCT
aji-167	273	5	s.k	s.k	PROPN
aji-167	273	6	.	.	PROPN
aji-167	273	7	,	,	PUNCT
aji-167	273	8	cho	cho	PROPN
aji-167	273	9	,	,	PUNCT
aji-167	273	10	k.j	k.j	PROPN
aji-167	273	11	.	.	PROPN
aji-167	273	12	,	,	PUNCT
aji-167	273	13	ishido	ishido	PROPN
aji-167	273	14	,	,	PUNCT
aji-167	273	15	s.	s.	PROPN
aji-167	273	16	,	,	PUNCT
aji-167	273	17	&	&	CCONJ
aji-167	273	18	roche	roche	PROPN
aji-167	273	19	,	,	PUNCT
aji-167	273	20	p.a	p.a	PROPN
aji-167	273	21	.	.	PROPN
aji-167	273	22	(	(	PUNCT
aji-167	273	23	2015	2015	NUM
aji-167	273	24	)	)	PUNCT
aji-167	273	25	.	.	PUNCT
aji-167	274	1	interleukin	interleukin	NOUN
aji-167	274	2	10	10	NUM
aji-167	274	3	(	(	PUNCT
aji-167	274	4	il-10)-mediated	il-10)-mediate	VERB
aji-167	274	5	immunosuppression	immunosuppression	NOUN
aji-167	274	6	:	:	PUNCT
aji-167	274	7	march	march	PROPN
aji-167	274	8	-	-	PUNCT
aji-167	274	9	i	i	PRON
aji-167	274	10	induction	induction	NOUN
aji-167	274	11	regulates	regulate	VERB
aji-167	274	12	antigen	antigen	ADJ
aji-167	274	13	presentation	presentation	NOUN
aji-167	274	14	by	by	ADP
aji-167	274	15	macrophages	macrophage	NOUN
aji-167	274	16	but	but	CCONJ
aji-167	274	17	not	not	PART
aji-167	274	18	dendritic	dendritic	ADJ
aji-167	274	19	cells	cell	NOUN
aji-167	274	20	.	.	PUNCT
aji-167	275	1	the	the	DET
aji-167	275	2	journal	journal	NOUN
aji-167	275	3	of	of	ADP
aji-167	275	4	biological	biological	ADJ
aji-167	275	5	chemistry	chemistry	NOUN
aji-167	275	6	,	,	PUNCT
aji-167	275	7	290(45	290(45	NUM
aji-167	275	8	)	)	PUNCT
aji-167	275	9	,	,	PUNCT
aji-167	275	10	27158–27167	27158–27167	NUM
aji-167	275	11	.	.	PUNCT
aji-167	276	1	https://doi.org/10.1074/jbc.m115.682708	https://doi.org/10.1074/jbc.m115.682708	PROPN
aji-167	276	2	mostafa	mostafa	PROPN
aji-167	276	3	,	,	PUNCT
aji-167	276	4	o.e	o.e	PROPN
aji-167	276	5	.	.	PROPN
aji-167	276	6	,	,	PUNCT
aji-167	276	7	al	al	PROPN
aji-167	276	8	-	-	PUNCT
aji-167	276	9	allaf	allaf	ADJ
aji-167	276	10	,	,	PUNCT
aji-167	276	11	o.	o.	PROPN
aji-167	276	12	,	,	PUNCT
aji-167	276	13	tahir	tahir	PROPN
aji-167	276	14	,	,	PUNCT
aji-167	276	15	m.	m.	NOUN
aji-167	276	16	,	,	PUNCT
aji-167	276	17	hossain	hossain	PROPN
aji-167	276	18	,	,	PUNCT
aji-167	276	19	f.	f.	PROPN
aji-167	276	20	,	,	PUNCT
aji-167	276	21	&	&	CCONJ
aji-167	276	22	blackwell	blackwell	PROPN
aji-167	276	23	,	,	PUNCT
aji-167	276	24	j.	j.	PROPN
aji-167	276	25	(	(	PUNCT
aji-167	276	26	2024	2024	NUM
aji-167	276	27	)	)	PUNCT
aji-167	276	28	.	.	PUNCT
aji-167	277	1	do	do	AUX
aji-167	277	2	hypoalbuminaemia	hypoalbuminaemia	NOUN
aji-167	277	3	increase	increase	VERB
aji-167	277	4	the	the	DET
aji-167	277	5	risk	risk	NOUN
aji-167	277	6	of	of	ADP
aji-167	277	7	surgical	surgical	ADJ
aji-167	277	8	site	site	NOUN
aji-167	277	9	infection	infection	NOUN
aji-167	277	10	in	in	ADP
aji-167	277	11	neck	neck	NOUN
aji-167	277	12	of	of	ADP
aji-167	277	13	femur	femur	ADJ
aji-167	277	14	fracture	fracture	NOUN
aji-167	277	15	patients	patient	NOUN
aji-167	277	16	:	:	PUNCT
aji-167	277	17	a	a	DET
aji-167	277	18	systematic	systematic	ADJ
aji-167	277	19	review	review	NOUN
aji-167	277	20	and	and	CCONJ
aji-167	277	21	meta	meta	ADJ
aji-167	277	22	-	-	PUNCT
aji-167	277	23	analysis	analysis	NOUN
aji-167	277	24	.	.	PUNCT
aji-167	278	1	cureus	cureus	NOUN
aji-167	278	2	,	,	PUNCT
aji-167	278	3	16(5	16(5	NUM
aji-167	278	4	)	)	PUNCT
aji-167	278	5	,	,	PUNCT
aji-167	278	6	e61372	e61372	PROPN
aji-167	278	7	.	.	PUNCT
aji-167	279	1	https://doi.org/10.7759/cureus.61372	https://doi.org/10.7759/cureus.61372	VERB
aji-167	279	2	okpogba	okpogba	PROPN
aji-167	279	3	,	,	PUNCT
aji-167	279	4	a.n	a.n	PROPN
aji-167	279	5	.	.	PROPN
aji-167	279	6	,	,	PUNCT
aji-167	279	7	odeghe	odeghe	ADJ
aji-167	279	8	,	,	PUNCT
aji-167	279	9	o.b	o.b	PROPN
aji-167	279	10	.	.	PROPN
aji-167	279	11	,	,	PUNCT
aji-167	279	12	ogbodo	ogbodo	PROPN
aji-167	279	13	,	,	PUNCT
aji-167	279	14	e.c	e.c	PROPN
aji-167	279	15	.	.	PROPN
aji-167	279	16	,	,	PUNCT
aji-167	279	17	okwara	okwara	PROPN
aji-167	279	18	,	,	PUNCT
aji-167	279	19	n.a	n.a	PROPN
aji-167	279	20	.	.	PROPN
aji-167	279	21	,	,	PUNCT
aji-167	279	22	izuchukwu	izuchukwu	ADJ
aji-167	279	23	,	,	PUNCT
aji-167	279	24	e.c.o	e.c.o	PROPN
aji-167	279	25	.	.	PROPN
aji-167	279	26	,	,	PUNCT
aji-167	279	27	ejovi	ejovi	PROPN
aji-167	279	28	,	,	PUNCT
aji-167	279	29	o.	o.	INTJ
aji-167	279	30	,	,	PUNCT
aji-167	279	31	gbodo	gbodo	NOUN
aji-167	279	32	,	,	PUNCT
aji-167	279	33	e.a	e.a	PROPN
aji-167	279	34	.	.	PROPN
aji-167	279	35	,	,	PUNCT
aji-167	279	36	&	&	CCONJ
aji-167	279	37	obi	obi	PROPN
aji-167	279	38	-	-	PUNCT
aji-167	279	39	ezeani	ezeani	PROPN
aji-167	279	40	,	,	PUNCT
aji-167	279	41	c.n	c.n	PROPN
aji-167	279	42	.	.	PROPN
aji-167	279	43	(	(	PUNCT
aji-167	279	44	2021	2021	NUM
aji-167	279	45	)	)	PUNCT
aji-167	279	46	.	.	PUNCT
aji-167	280	1	effect	effect	NOUN
aji-167	280	2	of	of	ADP
aji-167	280	3	occupational	occupational	ADJ
aji-167	280	4	exposure	exposure	NOUN
aji-167	280	5	to	to	ADP
aji-167	280	6	heavy	heavy	ADJ
aji-167	280	7	metals	metal	NOUN
aji-167	280	8	on	on	ADP
aji-167	280	9	the	the	DET
aji-167	280	10	liver	liver	NOUN
aji-167	280	11	functions	function	NOUN
aji-167	280	12	in	in	ADP
aji-167	280	13	persons	person	NOUN
aji-167	280	14	working	work	VERB
aji-167	280	15	in	in	ADP
aji-167	280	16	cable	cable	NOUN
aji-167	280	17	manufacturing	manufacturing	NOUN
aji-167	280	18	factory	factory	NOUN
aji-167	280	19	in	in	ADP
aji-167	280	20	nnewi	nnewi	NOUN
aji-167	280	21	.	.	PUNCT
aji-167	281	1	ip	ip	PROPN
aji-167	281	2	international	international	ADJ
aji-167	281	3	journal	journal	NOUN
aji-167	281	4	of	of	ADP
aji-167	281	5	forensic	forensic	ADJ
aji-167	281	6	medicine	medicine	NOUN
aji-167	281	7	and	and	CCONJ
aji-167	281	8	toxicological	toxicological	ADJ
aji-167	281	9	science	science	NOUN
aji-167	281	10	,	,	PUNCT
aji-167	281	11	6(1	6(1	NUM
aji-167	281	12	)	)	PUNCT
aji-167	281	13	,	,	PUNCT
aji-167	281	14	20	20	NUM
aji-167	281	15	-	-	SYM
aji-167	281	16	27	27	NUM
aji-167	281	17	.	.	PUNCT
aji-167	282	1	rojas	rojas	PROPN
aji-167	282	2	,	,	PUNCT
aji-167	282	3	j.m	j.m	PROPN
aji-167	282	4	.	.	PROPN
aji-167	282	5	,	,	PUNCT
aji-167	282	6	avia	avia	PROPN
aji-167	282	7	,	,	PUNCT
aji-167	282	8	m.	m.	NOUN
aji-167	282	9	,	,	PUNCT
aji-167	282	10	martín	martín	NOUN
aji-167	282	11	,	,	PUNCT
aji-167	282	12	v.	v.	PROPN
aji-167	282	13	,	,	PUNCT
aji-167	282	14	&	&	CCONJ
aji-167	282	15	sevilla	sevilla	PROPN
aji-167	282	16	,	,	PUNCT
aji-167	282	17	n.	n.	NOUN
aji-167	282	18	(	(	PUNCT
aji-167	282	19	2017	2017	NUM
aji-167	282	20	)	)	PUNCT
aji-167	282	21	.	.	PUNCT
aji-167	283	1	il-10	il-10	PRON
aji-167	283	2	:	:	PUNCT
aji-167	283	3	a	a	DET
aji-167	283	4	multifunctional	multifunctional	ADJ
aji-167	283	5	cytokine	cytokine	NOUN
aji-167	283	6	in	in	ADP
aji-167	283	7	viral	viral	ADJ
aji-167	283	8	infections	infection	NOUN
aji-167	283	9	.	.	PUNCT
aji-167	284	1	journal	journal	NOUN
aji-167	284	2	of	of	ADP
aji-167	284	3	immunology	immunology	NOUN
aji-167	284	4	research	research	NOUN
aji-167	284	5	,	,	PUNCT
aji-167	284	6	2017	2017	NUM
aji-167	284	7	,	,	PUNCT
aji-167	284	8	6104054	6104054	NUM
aji-167	284	9	.	.	PUNCT
aji-167	285	1	https://doi.org/10.1155/2017/6104054	https://doi.org/10.1155/2017/6104054	PROPN
aji-167	285	2	ryan	ryan	PROPN
aji-167	285	3	,	,	PUNCT
aji-167	285	4	s.p	s.p	PROPN
aji-167	285	5	.	.	PROPN
aji-167	285	6	,	,	PUNCT
aji-167	285	7	politzer	politzer	NOUN
aji-167	285	8	,	,	PUNCT
aji-167	285	9	c.	c.	NOUN
aji-167	285	10	,	,	PUNCT
aji-167	285	11	green	green	ADJ
aji-167	285	12	,	,	PUNCT
aji-167	285	13	c.	c.	PROPN
aji-167	285	14	,	,	PUNCT
aji-167	285	15	wellman	wellman	NOUN
aji-167	285	16	,	,	PUNCT
aji-167	285	17	s.	s.	PROPN
aji-167	285	18	,	,	PUNCT
aji-167	285	19	bolognesi	bolognesi	NOUN
aji-167	285	20	,	,	PUNCT
aji-167	285	21	m.	m.	NOUN
aji-167	285	22	,	,	PUNCT
aji-167	285	23	&	&	CCONJ
aji-167	285	24	seyler	seyler	NOUN
aji-167	285	25	,	,	PUNCT
aji-167	285	26	t.	t.	PROPN
aji-167	285	27	(	(	PUNCT
aji-167	285	28	2018	2018	NUM
aji-167	285	29	)	)	PUNCT
aji-167	285	30	.	.	PUNCT
aji-167	286	1	albumin	albumin	PROPN
aji-167	286	2	versus	versus	ADP
aji-167	286	3	american	american	ADJ
aji-167	286	4	society	society	NOUN
aji-167	286	5	of	of	ADP
aji-167	286	6	anesthesiologists	anesthesiologists	PROPN
aji-167	286	7	score	score	VERB
aji-167	286	8	:	:	PUNCT
aji-167	286	9	which	which	PRON
aji-167	286	10	is	be	AUX
aji-167	286	11	more	more	ADV
aji-167	286	12	predictive	predictive	NOUN
aji-167	286	13	of	of	ADP
aji-167	286	14	complications	complication	NOUN
aji-167	286	15	following	follow	VERB
aji-167	286	16	total	total	ADJ
aji-167	286	17	joint	joint	ADJ
aji-167	286	18	arthroplasty	arthroplasty	NOUN
aji-167	286	19	?	?	PUNCT
aji-167	286	20	.	.	PUNCT
aji-167	287	1	orthopedics	orthopedic	NOUN
aji-167	287	2	,	,	PUNCT
aji-167	287	3	41(6	41(6	NOUN
aji-167	287	4	)	)	PUNCT
aji-167	287	5	,	,	PUNCT
aji-167	287	6	354–362	354–362	NUM
aji-167	287	7	.	.	PUNCT
aji-167	288	1	https://doi.org/10.3928/0147744720181010-05	https://doi.org/10.3928/0147744720181010-05	ADJ
aji-167	288	2	saraiva	saraiva	NOUN
aji-167	288	3	,	,	PUNCT
aji-167	288	4	m.	m.	NOUN
aji-167	288	5	,	,	PUNCT
aji-167	288	6	vieira	vieira	NOUN
aji-167	288	7	,	,	PUNCT
aji-167	288	8	p.	p.	NOUN
aji-167	288	9	,	,	PUNCT
aji-167	288	10	&	&	CCONJ
aji-167	288	11	o'garra	o'garra	PROPN
aji-167	288	12	,	,	PUNCT
aji-167	288	13	a.	a.	NOUN
aji-167	288	14	(	(	PUNCT
aji-167	288	15	2020	2020	NUM
aji-167	288	16	)	)	PUNCT
aji-167	288	17	.	.	PUNCT
aji-167	289	1	biology	biology	NOUN
aji-167	289	2	and	and	CCONJ
aji-167	289	3	therapeutic	therapeutic	ADJ
aji-167	289	4	potential	potential	NOUN
aji-167	289	5	of	of	ADP
aji-167	289	6	interleukin-10	interleukin-10	PROPN
aji-167	289	7	.	.	PUNCT
aji-167	290	1	the	the	DET
aji-167	290	2	journal	journal	NOUN
aji-167	290	3	of	of	ADP
aji-167	290	4	experimental	experimental	ADJ
aji-167	290	5	medicine	medicine	NOUN
aji-167	290	6	,	,	PUNCT
aji-167	290	7	217(1	217(1	NUM
aji-167	290	8	)	)	PUNCT
aji-167	290	9	,	,	PUNCT
aji-167	290	10	e20190418	e20190418	PROPN
aji-167	290	11	.	.	PUNCT
aji-167	291	1	https://doi.org/10.1084/jem.20190418	https://doi.org/10.1084/jem.20190418	PROPN
aji-167	291	2	singh	singh	PROPN
aji-167	291	3	,	,	PUNCT
aji-167	291	4	r.k	r.k	PROPN
aji-167	291	5	.	.	PROPN
aji-167	291	6	,	,	PUNCT
aji-167	291	7	shakya	shakya	PROPN
aji-167	291	8	,	,	PUNCT
aji-167	291	9	p.	p.	NOUN
aji-167	291	10	,	,	PUNCT
aji-167	291	11	bhutani	bhutani	NOUN
aji-167	291	12	,	,	PUNCT
aji-167	291	13	s.	s.	PROPN
aji-167	291	14	(	(	PUNCT
aji-167	291	15	2023	2023	NUM
aji-167	291	16	)	)	PUNCT
aji-167	291	17	.	.	PUNCT
aji-167	292	1	role	role	NOUN
aji-167	292	2	of	of	ADP
aji-167	292	3	serum	serum	NOUN
aji-167	292	4	cholesterol	cholesterol	NOUN
aji-167	292	5	and	and	CCONJ
aji-167	292	6	albumin	albumin	ADJ
aji-167	292	7	levels	level	NOUN
aji-167	292	8	as	as	ADP
aji-167	292	9	a	a	DET
aji-167	292	10	risk	risk	NOUN
aji-167	292	11	factor	factor	NOUN
aji-167	292	12	for	for	ADP
aji-167	292	13	developing	develop	VERB
aji-167	292	14	surgical	surgical	ADJ
aji-167	292	15	site	site	NOUN
aji-167	292	16	infection	infection	NOUN
aji-167	292	17	.	.	PUNCT
aji-167	293	1	international	international	ADJ
aji-167	293	2	journal	journal	PROPN
aji-167	293	3	of	of	ADP
aji-167	293	4	academic	academic	ADJ
aji-167	293	5	medicine	medicine	NOUN
aji-167	293	6	and	and	CCONJ
aji-167	293	7	pharmacy	pharmacy	NOUN
aji-167	293	8	,	,	PUNCT
aji-167	293	9	5	5	NUM
aji-167	293	10	(	(	PUNCT
aji-167	293	11	2	2	NUM
aji-167	293	12	)	)	PUNCT
aji-167	293	13	,	,	PUNCT
aji-167	293	14	1271	1271	NUM
aji-167	293	15	-	-	SYM
aji-167	293	16	1278	1278	NUM
aji-167	293	17	.	.	PUNCT
aji-167	294	1	steen	steen	PROPN
aji-167	294	2	,	,	PUNCT
aji-167	294	3	e.h	e.h	PROPN
aji-167	294	4	.	.	PROPN
aji-167	294	5	,	,	PUNCT
aji-167	294	6	wang	wang	PROPN
aji-167	294	7	,	,	PUNCT
aji-167	294	8	x.	x.	PROPN
aji-167	294	9	,	,	PUNCT
aji-167	294	10	balaji	balaji	PROPN
aji-167	294	11	,	,	PUNCT
aji-167	294	12	s.	s.	PROPN
aji-167	294	13	,	,	PUNCT
aji-167	294	14	butte	butte	PROPN
aji-167	294	15	,	,	PUNCT
aji-167	294	16	m.	m.	PROPN
aji-167	294	17	j.	j.	PROPN
aji-167	294	18	,	,	PUNCT
aji-167	294	19	bollyky	bollyky	PROPN
aji-167	294	20	,	,	PUNCT
aji-167	294	21	p.l	p.l	PROPN
aji-167	294	22	.	.	PROPN
aji-167	294	23	,	,	PUNCT
aji-167	294	24	&	&	CCONJ
aji-167	294	25	keswani	keswani	PROPN
aji-167	294	26	,	,	PUNCT
aji-167	294	27	s.g	s.g	PROPN
aji-167	294	28	.	.	PROPN
aji-167	294	29	(	(	PUNCT
aji-167	294	30	2020	2020	NUM
aji-167	294	31	)	)	PUNCT
aji-167	294	32	.	.	PUNCT
aji-167	295	1	the	the	DET
aji-167	295	2	role	role	NOUN
aji-167	295	3	of	of	ADP
aji-167	295	4	the	the	DET
aji-167	295	5	anti	anti	ADJ
aji-167	295	6	-	-	ADJ
aji-167	295	7	inflammatory	inflammatory	ADJ
aji-167	295	8	cytokine	cytokine	NOUN
aji-167	295	9	interleukin-10	interleukin-10	VERB
aji-167	295	10	in	in	ADP
aji-167	295	11	tissue	tissue	NOUN
aji-167	295	12	fibrosis	fibrosis	NOUN
aji-167	295	13	.	.	PUNCT
aji-167	296	1	advances	advance	NOUN
aji-167	296	2	in	in	ADP
aji-167	296	3	wound	wound	NOUN
aji-167	296	4	care	care	NOUN
aji-167	296	5	,	,	PUNCT
aji-167	296	6	9(4	9(4	NOUN
aji-167	296	7	)	)	PUNCT
aji-167	296	8	,	,	PUNCT
aji-167	296	9	184–198	184–198	NUM
aji-167	296	10	.	.	PUNCT
aji-167	297	1	https://doi.org/10.1089/wound.2019.1032	https://doi.org/10.1089/wound.2019.1032	PROPN
aji-167	297	2	sultana	sultana	NOUN
aji-167	297	3	,	,	PUNCT
aji-167	297	4	m.	m.	NOUN
aji-167	297	5	,	,	PUNCT
aji-167	297	6	sultana	sultana	NOUN
aji-167	297	7	,	,	PUNCT
aji-167	297	8	n.	n.	PROPN
aji-167	297	9	,	,	PUNCT
aji-167	297	10	mostafa	mostafa	PROPN
aji-167	297	11	,	,	PUNCT
aji-167	297	12	b.	b.	PROPN
aji-167	297	13	,	,	PUNCT
aji-167	297	14	khair	khair	PROPN
aji-167	297	15	,	,	PUNCT
aji-167	297	16	a.b	a.b	PROPN
aji-167	297	17	.	.	PROPN
aji-167	297	18	,	,	PUNCT
aji-167	297	19	islam	islam	PROPN
aji-167	297	20	,	,	PUNCT
aji-167	297	21	s.	s.	PROPN
aji-167	297	22	,	,	PUNCT
aji-167	297	23	&	&	CCONJ
aji-167	297	24	jannat	jannat	PROPN
aji-167	297	25	,	,	PUNCT
aji-167	297	26	f.	f.	PROPN
aji-167	297	27	(	(	PUNCT
aji-167	297	28	2024	2024	NUM
aji-167	297	29	)	)	PUNCT
aji-167	297	30	.	.	PUNCT
aji-167	298	1	association	association	NOUN
aji-167	298	2	of	of	ADP
aji-167	298	3	serum	serum	NOUN
aji-167	298	4	albumin	albumin	ADJ
aji-167	298	5	level	level	NOUN
aji-167	298	6	with	with	ADP
aji-167	298	7	wound	wound	NOUN
aji-167	298	8	healing	healing	NOUN
aji-167	298	9	after	after	ADP
aji-167	298	10	caesarean	caesarean	ADJ
aji-167	298	11	section	section	NOUN
aji-167	298	12	.	.	PUNCT
aji-167	299	1	scholars	scholars	PROPN
aji-167	299	2	international	international	PROPN
aji-167	299	3	journal	journal	NOUN
aji-167	299	4	of	of	ADP
aji-167	299	5	obstetrics	obstetric	NOUN
aji-167	299	6	and	and	CCONJ
aji-167	299	7	gynecology	gynecology	NOUN
aji-167	299	8	,	,	PUNCT
aji-167	299	9	7(6	7(6	NUM
aji-167	299	10	):	):	PUNCT
aji-167	299	11	263	263	NUM
aji-167	299	12	-	-	SYM
aji-167	299	13	272	272	NUM
aji-167	299	14	sun	sun	NOUN
aji-167	299	15	,	,	PUNCT
aji-167	299	16	z.l	z.l	PROPN
aji-167	299	17	.	.	PROPN
aji-167	299	18	,	,	PUNCT
aji-167	299	19	feng	feng	PROPN
aji-167	299	20	,	,	PUNCT
aji-167	299	21	y.	y.	PROPN
aji-167	299	22	,	,	PUNCT
aji-167	299	23	zou	zou	PROPN
aji-167	299	24	,	,	PUNCT
aji-167	299	25	m.l	m.l	PROPN
aji-167	299	26	.	.	PROPN
aji-167	299	27	,	,	PUNCT
aji-167	299	28	zhao	zhao	PROPN
aji-167	299	29	,	,	PUNCT
aji-167	299	30	b.h	b.h	PROPN
aji-167	299	31	.	.	PROPN
aji-167	299	32	,	,	PUNCT
aji-167	299	33	liu	liu	PROPN
aji-167	299	34	,	,	PUNCT
aji-167	299	35	s.y	s.y	PROPN
aji-167	299	36	.	.	PROPN
aji-167	299	37	,	,	PUNCT
aji-167	299	38	du	du	PROPN
aji-167	299	39	,	,	PUNCT
aji-167	299	40	y.	y.	PROPN
aji-167	299	41	,	,	PUNCT
aji-167	299	42	yu	yu	PROPN
aji-167	299	43	,	,	PUNCT
aji-167	299	44	s.	s.	PROPN
aji-167	299	45	,	,	PUNCT
aji-167	299	46	yang	yang	PROPN
aji-167	299	47	,	,	PUNCT
aji-167	299	48	m.l	m.l	PROPN
aji-167	299	49	.	.	PROPN
aji-167	299	50	,	,	PUNCT
aji-167	299	51	wu	wu	PROPN
aji-167	299	52	,	,	PUNCT
aji-167	299	53	j.j	j.j	PROPN
aji-167	299	54	.	.	PROPN
aji-167	299	55	,	,	PUNCT
aji-167	299	56	yuan	yuan	PROPN
aji-167	299	57	,	,	PUNCT
aji-167	299	58	z.d	z.d	PROPN
aji-167	299	59	.	.	PROPN
aji-167	299	60	,	,	PUNCT
aji-167	299	61	lv	lv	PROPN
aji-167	299	62	,	,	PUNCT
aji-167	299	63	g.z	g.z	PROPN
aji-167	299	64	.	.	PROPN
aji-167	299	65	,	,	PUNCT
aji-167	299	66	zhang	zhang	PROPN
aji-167	299	67	,	,	PUNCT
aji-167	299	68	j.r	j.r	PROPN
aji-167	299	69	.	.	PROPN
aji-167	299	70	,	,	PUNCT
aji-167	299	71	&	&	CCONJ
aji-167	299	72	yuan	yuan	PROPN
aji-167	299	73	,	,	PUNCT
aji-167	299	74	f.l	f.l	PROPN
aji-167	299	75	.	.	PROPN
aji-167	299	76	(	(	PUNCT
aji-167	299	77	2020	2020	NUM
aji-167	299	78	)	)	PUNCT
aji-167	299	79	.	.	PUNCT
aji-167	300	1	emerging	emerge	VERB
aji-167	300	2	role	role	NOUN
aji-167	300	3	of	of	ADP
aji-167	300	4	il-10	il-10	NOUN
aji-167	300	5	in	in	ADP
aji-167	300	6	https://doi.org/10.1615/critrevimmunol.v32.i1.30	https://doi.org/10.1615/critrevimmunol.v32.i1.30	PROPN
aji-167	300	7	https://doi.org/10.1615/critrevimmunol.v32.i1.30	https://doi.org/10.1615/critrevimmunol.v32.i1.30	PROPN
aji-167	300	8	https://doi.org/10.3390/ijms22052719	https://doi.org/10.3390/ijms22052719	VERB
aji-167	300	9	https://doi.org/10.1097/sla.0000000000003056	https://doi.org/10.1097/sla.0000000000003056	PROPN
aji-167	300	10	https://doi.org/10.1097/sla.0000000000003056	https://doi.org/10.1097/sla.0000000000003056	PROPN
aji-167	300	11	https://doi.org/10.3390/jcm8060775	https://doi.org/10.3390/jcm8060775	PRON
aji-167	300	12	https://doi.org/10.1007/s12603-023-2050-6	https://doi.org/10.1007/s12603-023-2050-6	PROPN
aji-167	300	13	https://doi.org/10.1074/jbc.m115.682708	https://doi.org/10.1074/jbc.m115.682708	PROPN
aji-167	300	14	https://doi.org/10.7759/cureus.61372	https://doi.org/10.7759/cureus.61372	VERB
aji-167	300	15	https://doi.org/10.1155/2017/6104054	https://doi.org/10.1155/2017/6104054	NOUN
aji-167	300	16	https://doi.org/10.1084/jem.20190418	https://doi.org/10.1084/jem.20190418	NOUN
aji-167	300	17	https://doi.org/10.1089/wound.2019.1032	https://doi.org/10.1089/wound.2019.1032	PROPN
aji-167	300	18	ehiaghe	ehiaghe	PROPN
aji-167	300	19	et	et	PROPN
aji-167	300	20	al	al	PROPN
aji-167	300	21	.	.	PROPN
aji-167	300	22	;	;	PUNCT
aji-167	301	1	asian	asian	PROPN
aji-167	301	2	j.	j.	PROPN
aji-167	301	3	immunol	immunol	PROPN
aji-167	301	4	.	.	PROPN
aji-167	301	5	,	,	PUNCT
aji-167	301	6	vol	vol	NOUN
aji-167	301	7	.	.	PROPN
aji-167	301	8	8	8	NUM
aji-167	301	9	,	,	PUNCT
aji-167	301	10	no	no	INTJ
aji-167	301	11	.	.	NOUN
aji-167	301	12	1	1	NUM
aji-167	301	13	,	,	PUNCT
aji-167	301	14	pp	pp	ADJ
aji-167	301	15	.	.	PUNCT
aji-167	302	1	134	134	NUM
aji-167	302	2	-	-	SYM
aji-167	302	3	141	141	NUM
aji-167	302	4	,	,	PUNCT
aji-167	302	5	2025	2025	NUM
aji-167	302	6	;	;	PUNCT
aji-167	302	7	article	article	NOUN
aji-167	302	8	no.aji.137461	no.aji.137461	VERB
aji-167	302	9	141	141	NUM
aji-167	302	10	hypertrophic	hypertrophic	ADJ
aji-167	302	11	scars	scar	NOUN
aji-167	302	12	.	.	PUNCT
aji-167	303	1	frontiers	frontier	NOUN
aji-167	303	2	in	in	ADP
aji-167	303	3	medicine	medicine	NOUN
aji-167	303	4	,	,	PUNCT
aji-167	303	5	7	7	NUM
aji-167	303	6	,	,	PUNCT
aji-167	303	7	438	438	NUM
aji-167	303	8	.	.	PUNCT
aji-167	304	1	https://doi.org/10.3389/fmed.2020.00438	https://doi.org/10.3389/fmed.2020.00438	ADV
aji-167	304	2	tfaily	tfaily	ADV
aji-167	304	3	,	,	PUNCT
aji-167	304	4	m.a	m.a	PROPN
aji-167	304	5	.	.	PROPN
aji-167	304	6	,	,	PUNCT
aji-167	304	7	ghanem	ghanem	PROPN
aji-167	304	8	,	,	PUNCT
aji-167	304	9	p.	p.	PROPN
aji-167	304	10	,	,	PUNCT
aji-167	304	11	farran	farran	NOUN
aji-167	304	12	,	,	PUNCT
aji-167	304	13	s.h	s.h	PROPN
aji-167	304	14	.	.	PROPN
aji-167	304	15	,	,	PUNCT
aji-167	304	16	dabdoub	dabdoub	NOUN
aji-167	304	17	,	,	PUNCT
aji-167	304	18	f.	f.	PROPN
aji-167	304	19	,	,	PUNCT
aji-167	304	20	&	&	CCONJ
aji-167	304	21	kanafani	kanafani	PROPN
aji-167	304	22	,	,	PUNCT
aji-167	304	23	z.a	z.a	PROPN
aji-167	304	24	.	.	PUNCT
aji-167	304	25	(	(	PUNCT
aji-167	304	26	2022	2022	NUM
aji-167	304	27	)	)	PUNCT
aji-167	304	28	.	.	PUNCT
aji-167	305	1	the	the	DET
aji-167	305	2	role	role	NOUN
aji-167	305	3	of	of	ADP
aji-167	305	4	preoperative	preoperative	ADJ
aji-167	305	5	albumin	albumin	NOUN
aji-167	305	6	and	and	CCONJ
aji-167	305	7	white	white	ADJ
aji-167	305	8	blood	blood	NOUN
aji-167	305	9	cell	cell	NOUN
aji-167	305	10	count	count	NOUN
aji-167	305	11	in	in	ADP
aji-167	305	12	surgical	surgical	ADJ
aji-167	305	13	site	site	NOUN
aji-167	305	14	infections	infection	NOUN
aji-167	305	15	following	follow	VERB
aji-167	305	16	whipple	whipple	PROPN
aji-167	305	17	surgery	surgery	NOUN
aji-167	305	18	.	.	PUNCT
aji-167	306	1	scientific	scientific	ADJ
aji-167	306	2	reports	report	NOUN
aji-167	306	3	,	,	PUNCT
aji-167	306	4	12(1	12(1	NUM
aji-167	306	5	)	)	PUNCT
aji-167	306	6	,	,	PUNCT
aji-167	306	7	19184	19184	NUM
aji-167	306	8	.	.	PUNCT
aji-167	307	1	https://doi.org/10.1038/s41598022-21849-2	https://doi.org/10.1038/s41598022-21849-2	NOUN
aji-167	307	2	utariani	utariani	PROPN
aji-167	307	3	,	,	PUNCT
aji-167	307	4	a.	a.	NOUN
aji-167	307	5	,	,	PUNCT
aji-167	307	6	rahardjo	rahardjo	PROPN
aji-167	307	7	,	,	PUNCT
aji-167	307	8	e.	e.	PROPN
aji-167	307	9	,	,	PUNCT
aji-167	307	10	&	&	CCONJ
aji-167	307	11	perdanakusuma	perdanakusuma	PROPN
aji-167	307	12	,	,	PUNCT
aji-167	307	13	d.	d.	PROPN
aji-167	307	14	s.	s.	PROPN
aji-167	307	15	(	(	PUNCT
aji-167	307	16	2020	2020	NUM
aji-167	307	17	)	)	PUNCT
aji-167	307	18	.	.	PUNCT
aji-167	308	1	effects	effect	NOUN
aji-167	308	2	of	of	ADP
aji-167	308	3	albumin	albumin	ADJ
aji-167	308	4	infusion	infusion	NOUN
aji-167	308	5	on	on	ADP
aji-167	308	6	serum	serum	NOUN
aji-167	308	7	levels	level	NOUN
aji-167	308	8	of	of	ADP
aji-167	308	9	albumin	albumin	ADJ
aji-167	308	10	,	,	PUNCT
aji-167	308	11	proinflammatory	proinflammatory	ADJ
aji-167	308	12	cytokines	cytokine	NOUN
aji-167	308	13	(	(	PUNCT
aji-167	308	14	tnf	tnf	PROPN
aji-167	308	15	-	-	PUNCT
aji-167	308	16	α	α	PROPN
aji-167	308	17	,	,	PUNCT
aji-167	308	18	il-1	il-1	ADP
aji-167	308	19	,	,	PUNCT
aji-167	308	20	and	and	CCONJ
aji-167	308	21	il-6	il-6	NUM
aji-167	308	22	)	)	PUNCT
aji-167	308	23	,	,	PUNCT
aji-167	308	24	crp	crp	PROPN
aji-167	308	25	,	,	PUNCT
aji-167	308	26	and	and	CCONJ
aji-167	308	27	mmp-8	mmp-8	ADV
aji-167	308	28	;	;	PUNCT
aji-167	308	29	tissue	tissue	NOUN
aji-167	308	30	expression	expression	NOUN
aji-167	308	31	of	of	ADP
aji-167	308	32	egrf	egrf	NOUN
aji-167	308	33	,	,	PUNCT
aji-167	308	34	erk1	erk1	PROPN
aji-167	308	35	,	,	PUNCT
aji-167	308	36	erk2	erk2	PROPN
aji-167	308	37	,	,	PUNCT
aji-167	308	38	tgf	tgf	PROPN
aji-167	308	39	-	-	PUNCT
aji-167	308	40	β	β	PROPN
aji-167	308	41	,	,	PUNCT
aji-167	308	42	collagen	collagen	NOUN
aji-167	308	43	,	,	PUNCT
aji-167	308	44	and	and	CCONJ
aji-167	308	45	mmp8	mmp8	PROPN
aji-167	308	46	;	;	PUNCT
aji-167	308	47	and	and	CCONJ
aji-167	308	48	wound	wound	VERB
aji-167	308	49	healing	healing	NOUN
aji-167	308	50	in	in	ADP
aji-167	308	51	sprague	sprague	NOUN
aji-167	308	52	dawley	dawley	NOUN
aji-167	308	53	rats	rat	NOUN
aji-167	308	54	.	.	PUNCT
aji-167	309	1	international	international	ADJ
aji-167	309	2	journal	journal	NOUN
aji-167	309	3	of	of	ADP
aji-167	309	4	inflammation	inflammation	NOUN
aji-167	309	5	,	,	PUNCT
aji-167	309	6	2020	2020	NUM
aji-167	309	7	,	,	PUNCT
aji-167	309	8	3254017	3254017	NUM
aji-167	309	9	.	.	PUNCT
aji-167	310	1	https://doi.org/10.1155/2020/3254017	https://doi.org/10.1155/2020/3254017	PROPN
aji-167	310	2	weaving	weaving	NOUN
aji-167	310	3	,	,	PUNCT
aji-167	310	4	g.	g.	PROPN
aji-167	310	5	,	,	PUNCT
aji-167	310	6	batstone	batstone	PROPN
aji-167	310	7	,	,	PUNCT
aji-167	310	8	g.f	g.f	PROPN
aji-167	310	9	.	.	PROPN
aji-167	310	10	,	,	PUNCT
aji-167	310	11	jones	jones	PROPN
aji-167	310	12	,	,	PUNCT
aji-167	310	13	r.g	r.g	PROPN
aji-167	310	14	.	.	PROPN
aji-167	310	15	(	(	PUNCT
aji-167	310	16	2016	2016	NUM
aji-167	310	17	)	)	PUNCT
aji-167	310	18	.	.	PUNCT
aji-167	311	1	age	age	NOUN
aji-167	311	2	and	and	CCONJ
aji-167	311	3	sex	sex	NOUN
aji-167	311	4	variation	variation	NOUN
aji-167	311	5	in	in	ADP
aji-167	311	6	serum	serum	NOUN
aji-167	311	7	albumin	albumin	ADJ
aji-167	311	8	concentration	concentration	NOUN
aji-167	311	9	:	:	PUNCT
aji-167	311	10	an	an	DET
aji-167	311	11	observational	observational	ADJ
aji-167	311	12	study	study	NOUN
aji-167	311	13	.	.	PUNCT
aji-167	312	1	annals	annal	NOUN
aji-167	312	2	of	of	ADP
aji-167	312	3	clinical	clinical	ADJ
aji-167	312	4	biochemistry	biochemistry	NOUN
aji-167	312	5	,	,	PUNCT
aji-167	312	6	53	53	NUM
aji-167	312	7	pt	pt	NOUN
aji-167	312	8	1	1	NUM
aji-167	312	9	,	,	PUNCT
aji-167	312	10	106–111	106–111	NUM
aji-167	312	11	.	.	NOUN
aji-167	313	1	weledji	weledji	PROPN
aji-167	313	2	,	,	PUNCT
aji-167	313	3	e.p	e.p	PROPN
aji-167	313	4	.	.	PROPN
aji-167	313	5	(	(	PUNCT
aji-167	313	6	2021	2021	NUM
aji-167	313	7	)	)	PUNCT
aji-167	313	8	.	.	PUNCT
aji-167	314	1	the	the	DET
aji-167	314	2	role	role	NOUN
aji-167	314	3	of	of	ADP
aji-167	314	4	cytokines	cytokine	NOUN
aji-167	314	5	in	in	ADP
aji-167	314	6	enhanced	enhanced	ADJ
aji-167	314	7	recovery	recovery	NOUN
aji-167	314	8	after	after	ADP
aji-167	314	9	surgery	surgery	NOUN
aji-167	314	10	.	.	PUNCT
aji-167	315	1	international	international	ADJ
aji-167	315	2	journal	journal	NOUN
aji-167	315	3	of	of	ADP
aji-167	315	4	surgery	surgery	NOUN
aji-167	315	5	:	:	PUNCT
aji-167	315	6	short	short	ADJ
aji-167	315	7	reports	report	NOUN
aji-167	315	8	,	,	PUNCT
aji-167	315	9	2021;6(1	2021;6(1	NUM
aji-167	315	10	)	)	PUNCT
aji-167	315	11	,	,	PUNCT
aji-167	316	1	pe21	pe21	PROPN
aji-167	316	2	.	.	PUNCT
aji-167	317	1	https://doi.org/10.1097/sr9.000000000000	https://doi.org/10.1097/sr9.000000000000	PROPN
aji-167	317	2	0021	0021	NUM
aji-167	318	1	wong	wong	PROPN
aji-167	318	2	,	,	PUNCT
aji-167	318	3	r.s.y	r.s.y	NOUN
aji-167	318	4	.	.	PUNCT
aji-167	318	5	,	,	PUNCT
aji-167	318	6	tan	tan	PROPN
aji-167	318	7	,	,	PUNCT
aji-167	318	8	t.	t.	PROPN
aji-167	318	9	,	,	PUNCT
aji-167	318	10	pang	pang	NOUN
aji-167	318	11	,	,	PUNCT
aji-167	318	12	a.s.r	a.s.r	PROPN
aji-167	318	13	.	.	PROPN
aji-167	318	14	,	,	PUNCT
aji-167	318	15	srinivasan	srinivasan	NOUN
aji-167	318	16	,	,	PUNCT
aji-167	318	17	d.k	d.k	PROPN
aji-167	318	18	.	.	PROPN
aji-167	318	19	(	(	PUNCT
aji-167	318	20	2025	2025	NUM
aji-167	318	21	)	)	PUNCT
aji-167	318	22	.	.	PUNCT
aji-167	319	1	the	the	DET
aji-167	319	2	role	role	NOUN
aji-167	319	3	of	of	ADP
aji-167	319	4	cytokines	cytokine	NOUN
aji-167	319	5	in	in	ADP
aji-167	319	6	wound	wound	ADJ
aji-167	319	7	healing	healing	NOUN
aji-167	319	8	:	:	PUNCT
aji-167	319	9	from	from	ADP
aji-167	319	10	mechanistic	mechanistic	ADJ
aji-167	319	11	insights	insight	NOUN
aji-167	319	12	to	to	ADP
aji-167	319	13	therapeutic	therapeutic	ADJ
aji-167	319	14	applications	application	NOUN
aji-167	319	15	.	.	PUNCT
aji-167	320	1	exploration	exploration	NOUN
aji-167	320	2	of	of	ADP
aji-167	320	3	immunology	immunology	NOUN
aji-167	320	4	,	,	PUNCT
aji-167	320	5	5	5	NUM
aji-167	320	6	,	,	PUNCT
aji-167	320	7	1003183	1003183	NUM
aji-167	320	8	.	.	PUNCT
aji-167	321	1	https://doi.org/10.37349/ei.2025.1003183	https://doi.org/10.37349/ei.2025.1003183	PROPN
aji-167	321	2	yildirim	yildirim	PROPN
aji-167	321	3	,	,	PUNCT
aji-167	321	4	k.	k.	PROPN
aji-167	321	5	,	,	PUNCT
aji-167	321	6	karatay	karatay	PROPN
aji-167	321	7	,	,	PUNCT
aji-167	321	8	s.	s.	PROPN
aji-167	321	9	,	,	PUNCT
aji-167	321	10	melikoglu	melikoglu	PROPN
aji-167	321	11	,	,	PUNCT
aji-167	321	12	m.	m.	NOUN
aji-167	321	13	a.	a.	PROPN
aji-167	321	14	,	,	PUNCT
aji-167	321	15	gureser	gureser	NOUN
aji-167	321	16	,	,	PUNCT
aji-167	321	17	g.	g.	PROPN
aji-167	321	18	,	,	PUNCT
aji-167	321	19	ugur	ugur	PROPN
aji-167	321	20	,	,	PUNCT
aji-167	321	21	m.	m.	NOUN
aji-167	321	22	,	,	PUNCT
aji-167	321	23	&	&	CCONJ
aji-167	321	24	senel	senel	PROPN
aji-167	321	25	,	,	PUNCT
aji-167	321	26	k.	k.	PROPN
aji-167	321	27	(	(	PUNCT
aji-167	321	28	2004	2004	NUM
aji-167	321	29	)	)	PUNCT
aji-167	321	30	.	.	PUNCT
aji-167	322	1	associations	association	NOUN
aji-167	322	2	between	between	ADP
aji-167	322	3	acute	acute	ADJ
aji-167	322	4	phase	phase	NOUN
aji-167	322	5	reactant	reactant	NOUN
aji-167	322	6	levels	level	NOUN
aji-167	322	7	and	and	CCONJ
aji-167	322	8	disease	disease	NOUN
aji-167	322	9	activity	activity	NOUN
aji-167	322	10	score	score	NOUN
aji-167	322	11	(	(	PUNCT
aji-167	322	12	das28	das28	INTJ
aji-167	322	13	)	)	PUNCT
aji-167	322	14	in	in	ADP
aji-167	322	15	patients	patient	NOUN
aji-167	322	16	with	with	ADP
aji-167	322	17	rheumatoid	rheumatoid	NOUN
aji-167	322	18	arthritis	arthritis	NOUN
aji-167	322	19	.	.	PUNCT
aji-167	323	1	annals	annal	NOUN
aji-167	323	2	of	of	ADP
aji-167	323	3	clinical	clinical	ADJ
aji-167	323	4	and	and	CCONJ
aji-167	323	5	laboratory	laboratory	NOUN
aji-167	323	6	science	science	NOUN
aji-167	323	7	,	,	PUNCT
aji-167	323	8	34(4	34(4	NUM
aji-167	323	9	)	)	PUNCT
aji-167	323	10	,	,	PUNCT
aji-167	323	11	423–426	423–426	NUM
aji-167	323	12	.	.	PUNCT
aji-167	324	1	zabaglo	zabaglo	PROPN
aji-167	324	2	,	,	PUNCT
aji-167	324	3	m.	m.	NOUN
aji-167	324	4	,	,	PUNCT
aji-167	324	5	leslie	leslie	PROPN
aji-167	324	6	,	,	PUNCT
aji-167	324	7	s.w	s.w	PROPN
aji-167	324	8	.	.	PROPN
aji-167	324	9	,	,	PUNCT
aji-167	324	10	sharman	sharman	PROPN
aji-167	324	11	,	,	PUNCT
aji-167	324	12	t.	t.	PROPN
aji-167	324	13	(	(	PUNCT
aji-167	324	14	2025	2025	NUM
aji-167	324	15	)	)	PUNCT
aji-167	324	16	.	.	PUNCT
aji-167	325	1	postoperative	postoperative	ADJ
aji-167	325	2	wound	wound	NOUN
aji-167	325	3	infections	infection	NOUN
aji-167	325	4	.	.	PUNCT
aji-167	326	1	in	in	ADP
aji-167	326	2	:	:	PUNCT
aji-167	326	3	statpearls	statpearls	NUM
aji-167	326	4	treasure	treasure	NOUN
aji-167	326	5	island	island	NOUN
aji-167	326	6	(	(	PUNCT
aji-167	326	7	fl	fl	PROPN
aji-167	326	8	):	):	PUNCT
aji-167	326	9	statpearls	statpearl	NOUN
aji-167	326	10	publishing	publishing	NOUN
aji-167	326	11	;	;	PUNCT
aji-167	326	12	2025	2025	NUM
aji-167	326	13	jan-	jan-	NOUN
aji-167	326	14	.	.	PUNCT
aji-167	327	1	available	available	ADJ
aji-167	327	2	from	from	ADP
aji-167	327	3	:	:	PUNCT
aji-167	327	4	https://www.ncbi.nlm.nih.gov/books/nbk56	https://www.ncbi.nlm.nih.gov/books/nbk56	NUM
aji-167	327	5	0533/	0533/	NUM
aji-167	327	6	disclaimer	disclaimer	NOUN
aji-167	327	7	/	/	SYM
aji-167	327	8	publisher	publisher	NOUN
aji-167	327	9	’s	’s	PART
aji-167	327	10	note	note	NOUN
aji-167	327	11	:	:	PUNCT
aji-167	327	12	the	the	DET
aji-167	327	13	statements	statement	NOUN
aji-167	327	14	,	,	PUNCT
aji-167	327	15	opinions	opinion	NOUN
aji-167	327	16	and	and	CCONJ
aji-167	327	17	data	datum	NOUN
aji-167	327	18	contained	contain	VERB
aji-167	327	19	in	in	ADP
aji-167	327	20	all	all	DET
aji-167	327	21	publications	publication	NOUN
aji-167	327	22	are	be	AUX
aji-167	327	23	solely	solely	ADV
aji-167	327	24	those	those	PRON
aji-167	327	25	of	of	ADP
aji-167	327	26	the	the	DET
aji-167	327	27	individual	individual	ADJ
aji-167	327	28	author(s	author(s	PROPN
aji-167	327	29	)	)	PUNCT
aji-167	327	30	and	and	CCONJ
aji-167	327	31	contributor(s	contributor(s	NOUN
aji-167	327	32	)	)	PUNCT
aji-167	327	33	and	and	CCONJ
aji-167	327	34	not	not	PART
aji-167	327	35	of	of	ADP
aji-167	327	36	the	the	DET
aji-167	327	37	publisher	publisher	NOUN
aji-167	327	38	and/or	and/or	CCONJ
aji-167	327	39	the	the	DET
aji-167	327	40	editor(s	editor(s	NOUN
aji-167	327	41	)	)	PUNCT
aji-167	327	42	.	.	PUNCT
aji-167	328	1	this	this	DET
aji-167	328	2	publisher	publisher	NOUN
aji-167	328	3	and/or	and/or	CCONJ
aji-167	328	4	the	the	DET
aji-167	328	5	editor(s	editor(s	NOUN
aji-167	328	6	)	)	PUNCT
aji-167	328	7	disclaim	disclaim	VERB
aji-167	328	8	responsibility	responsibility	NOUN
aji-167	328	9	for	for	ADP
aji-167	328	10	any	any	DET
aji-167	328	11	injury	injury	NOUN
aji-167	328	12	to	to	ADP
aji-167	328	13	people	people	NOUN
aji-167	328	14	or	or	CCONJ
aji-167	328	15	property	property	NOUN
aji-167	328	16	resulting	result	VERB
aji-167	328	17	from	from	ADP
aji-167	328	18	any	any	DET
aji-167	328	19	ideas	idea	NOUN
aji-167	328	20	,	,	PUNCT
aji-167	328	21	methods	method	NOUN
aji-167	328	22	,	,	PUNCT
aji-167	328	23	instructions	instruction	NOUN
aji-167	328	24	or	or	CCONJ
aji-167	328	25	products	product	NOUN
aji-167	328	26	referred	refer	VERB
aji-167	328	27	to	to	ADP
aji-167	328	28	in	in	ADP
aji-167	328	29	the	the	DET
aji-167	328	30	content	content	NOUN
aji-167	328	31	.	.	PUNCT
aji-167	329	1	_	_	PUNCT
aji-167	330	1	_	_	PUNCT
aji-167	331	1	_	_	PUNCT
aji-167	332	1	_	_	PUNCT
aji-167	333	1	_	_	PUNCT
aji-167	334	1	_	_	PUNCT
aji-167	335	1	_	_	PUNCT
aji-167	336	1	_	_	PUNCT
aji-167	337	1	_	_	PUNCT
aji-167	338	1	_	_	PUNCT
aji-167	339	1	_	_	PUNCT
aji-167	340	1	_	_	PUNCT
aji-167	341	1	_	_	PUNCT
aji-167	342	1	_	_	PUNCT
aji-167	343	1	_	_	PUNCT
aji-167	344	1	_	_	PUNCT
aji-167	345	1	_	_	PUNCT
aji-167	346	1	_	_	PUNCT
aji-167	347	1	_	_	PUNCT
aji-167	348	1	_	_	PUNCT
aji-167	349	1	_	_	PUNCT
aji-167	350	1	_	_	PUNCT
aji-167	351	1	_	_	PUNCT
aji-167	352	1	_	_	PUNCT
aji-167	353	1	_	_	PUNCT
aji-167	354	1	_	_	PUNCT
aji-167	355	1	_	_	PUNCT
aji-167	356	1	_	_	PUNCT
aji-167	357	1	_	_	PUNCT
aji-167	358	1	_	_	PUNCT
aji-167	359	1	_	_	PUNCT
aji-167	360	1	_	_	PUNCT
aji-167	361	1	_	_	PUNCT
aji-167	362	1	_	_	PUNCT
aji-167	363	1	_	_	PUNCT
aji-167	364	1	_	_	PUNCT
aji-167	365	1	_	_	PUNCT
aji-167	366	1	_	_	PUNCT
aji-167	367	1	_	_	PUNCT
aji-167	368	1	_	_	PUNCT
aji-167	369	1	_	_	PUNCT
aji-167	370	1	_	_	PUNCT
aji-167	371	1	_	_	PUNCT
aji-167	372	1	_	_	PUNCT
aji-167	373	1	_	_	PUNCT
aji-167	374	1	_	_	PUNCT
aji-167	375	1	_	_	PUNCT
aji-167	376	1	_	_	PUNCT
aji-167	377	1	_	_	PUNCT
aji-167	378	1	_	_	PUNCT
aji-167	379	1	_	_	PUNCT
aji-167	380	1	_	_	PUNCT
aji-167	381	1	_	_	PUNCT
aji-167	382	1	_	_	PUNCT
aji-167	383	1	_	_	PUNCT
aji-167	384	1	_	_	PUNCT
aji-167	385	1	_	_	PUNCT
aji-167	386	1	_	_	PUNCT
aji-167	387	1	_	_	PUNCT
aji-167	388	1	_	_	PUNCT
aji-167	389	1	_	_	PUNCT
aji-167	390	1	_	_	PUNCT
aji-167	391	1	_	_	PUNCT
aji-167	392	1	_	_	PUNCT
aji-167	393	1	_	_	PUNCT
aji-167	394	1	_	_	PUNCT
aji-167	395	1	_	_	PUNCT
aji-167	396	1	_	_	PUNCT
aji-167	397	1	_	_	PUNCT
aji-167	398	1	_	_	PUNCT
aji-167	399	1	_	_	PUNCT
aji-167	400	1	_	_	PUNCT
aji-167	401	1	_	_	PUNCT
aji-167	402	1	_	_	PUNCT
aji-167	403	1	_	_	PUNCT
aji-167	404	1	_	_	PUNCT
aji-167	405	1	_	_	PUNCT
aji-167	406	1	_	_	PUNCT
aji-167	407	1	_	_	PUNCT
aji-167	408	1	_	_	PUNCT
aji-167	409	1	_	_	PUNCT
aji-167	410	1	©	©	PRON
aji-167	410	2	copyright	copyright	NOUN
aji-167	410	3	(	(	PUNCT
aji-167	410	4	2025	2025	NUM
aji-167	410	5	):	):	PUNCT
aji-167	410	6	author(s	author(s	NOUN
aji-167	410	7	)	)	PUNCT
aji-167	410	8	.	.	PUNCT
aji-167	411	1	the	the	DET
aji-167	411	2	licensee	licensee	NOUN
aji-167	411	3	is	be	AUX
aji-167	411	4	the	the	DET
aji-167	411	5	journal	journal	PROPN
aji-167	411	6	publisher	publisher	NOUN
aji-167	411	7	.	.	PUNCT
aji-167	412	1	this	this	PRON
aji-167	412	2	is	be	AUX
aji-167	412	3	an	an	DET
aji-167	412	4	open	open	ADJ
aji-167	412	5	access	access	NOUN
aji-167	412	6	article	article	NOUN
aji-167	412	7	distributed	distribute	VERB
aji-167	412	8	under	under	ADP
aji-167	412	9	the	the	DET
aji-167	412	10	terms	term	NOUN
aji-167	412	11	of	of	ADP
aji-167	412	12	the	the	DET
aji-167	412	13	creative	creative	ADJ
aji-167	412	14	commons	common	NOUN
aji-167	412	15	attribution	attribution	NOUN
aji-167	412	16	license	license	NOUN
aji-167	412	17	(	(	PUNCT
aji-167	412	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-167	412	19	)	)	PUNCT
aji-167	412	20	,	,	PUNCT
aji-167	412	21	which	which	PRON
aji-167	412	22	permits	permit	VERB
aji-167	412	23	unrestricted	unrestricted	ADJ
aji-167	412	24	use	use	NOUN
aji-167	412	25	,	,	PUNCT
aji-167	412	26	distribution	distribution	NOUN
aji-167	412	27	,	,	PUNCT
aji-167	412	28	and	and	CCONJ
aji-167	412	29	reproduction	reproduction	NOUN
aji-167	412	30	in	in	ADP
aji-167	412	31	any	any	DET
aji-167	412	32	medium	medium	NOUN
aji-167	412	33	,	,	PUNCT
aji-167	412	34	provided	provide	VERB
aji-167	412	35	the	the	DET
aji-167	412	36	original	original	ADJ
aji-167	412	37	work	work	NOUN
aji-167	412	38	is	be	AUX
aji-167	412	39	properly	properly	ADV
aji-167	412	40	cited	cite	VERB
aji-167	412	41	.	.	PUNCT
aji-167	413	1	peer	peer	NOUN
aji-167	413	2	-	-	PUNCT
aji-167	413	3	review	review	NOUN
aji-167	413	4	history	history	NOUN
aji-167	413	5	:	:	PUNCT
aji-167	413	6	the	the	DET
aji-167	413	7	peer	peer	NOUN
aji-167	413	8	review	review	NOUN
aji-167	413	9	history	history	NOUN
aji-167	413	10	for	for	ADP
aji-167	413	11	this	this	DET
aji-167	413	12	paper	paper	NOUN
aji-167	413	13	can	can	AUX
aji-167	413	14	be	be	AUX
aji-167	413	15	accessed	access	VERB
aji-167	413	16	here	here	ADV
aji-167	413	17	:	:	PUNCT
aji-167	413	18	https://pr.sdiarticle5.com/review-history/137461	https://pr.sdiarticle5.com/review-history/137461	NUM
aji-167	413	19	https://doi.org/10.1038/s41598-022-21849-2	https://doi.org/10.1038/s41598-022-21849-2	NUM
aji-167	413	20	https://doi.org/10.1038/s41598-022-21849-2	https://doi.org/10.1038/s41598-022-21849-2	NUM
aji-167	413	21	https://doi.org/10.1155/2020/3254017	https://doi.org/10.1155/2020/3254017	PROPN
aji-167	413	22	https://doi.org/10.37349/ei.2025.1003183	https://doi.org/10.37349/ei.2025.1003183	NOUN
aji-167	414	1	https://www.ncbi.nlm.nih.gov/books/nbk560533/	https://www.ncbi.nlm.nih.gov/books/nbk560533/	PROPN
aji-167	414	2	https://www.ncbi.nlm.nih.gov/books/nbk560533/	https://www.ncbi.nlm.nih.gov/books/nbk560533/	PROPN
aji-167	414	3	https://pr.sdiarticle5.com/review-history/137461	https://pr.sdiarticle5.com/review-history/137461	NOUN